| 1st level
|
2nd level
|
3rd level
|
4th level
|
5th level
|
Contents
|
| A
|
|
|
|
|
Alimentary tract and metabolism
|
|
|
A01
|
|
|
|
Stomatological preparations
|
|
|
|
A01A
|
|
|
Stomatological preparations
|
|
|
|
|
A01AA
|
|
Caries prophylactic agents
|
|
|
|
|
|
A01AA01
|
Sodium fluoride
|
|
|
|
|
|
A01AA02
|
Sodium monofluorophosphate
|
|
|
|
|
|
A01AA03
|
Olaflur
|
|
|
|
|
|
A01AA04
|
Stannous fluoride
|
|
|
|
|
|
A01AA30
|
Combinations
|
|
|
|
|
|
A01AA51
|
Sodium fluoride, combinations
|
|
|
|
|
A01AB
|
|
Anti-infectives and antiseptics for local oral treatment
|
|
|
|
|
|
A01AB02
|
Hydrogen peroxide
|
|
|
|
|
|
A01AB03
|
Chlorhexidine
|
|
|
|
|
|
A01AB04
|
Amphotericin B
|
|
|
|
|
|
A01AB05
|
Polynoxylin
|
|
|
|
|
|
A01AB06
|
Domiphen
|
|
|
|
|
|
A01AB07
|
Oxyquinoline
|
|
|
|
|
|
A01AB08
|
Neomycin
|
|
|
|
|
|
A01AB09
|
Miconazole
|
|
|
|
|
|
A01AB10
|
Natamycin
|
|
|
|
|
|
A01AB11
|
Various
|
|
|
|
|
|
A01AB12
|
Hexetidine
|
|
|
|
|
|
A01AB13
|
Tetracycline
|
|
|
|
|
|
A01AB14
|
Benzoxonium chloride
|
|
|
|
|
|
A01AB15
|
Tibezonium iodide
|
|
|
|
|
|
A01AB16
|
Mepartricin
|
|
|
|
|
|
A01AB17
|
Metronidazole
|
|
|
|
|
|
A01AB18
|
Clotrimazole
|
|
|
|
|
|
A01AB19
|
Sodium perborate
|
|
|
|
|
|
A01AB21
|
Chlortetracycline
|
|
|
|
|
|
A01AB22
|
Doxycycline
|
|
|
|
|
|
A01AB23
|
Minocycline
|
|
|
|
|
A01AC
|
|
Corticosteroids for local oral treatment
|
|
|
|
|
|
A01AC01
|
Triamcinolone
|
|
|
|
|
|
A01AC02
|
Dexamethasone
|
|
|
|
|
|
A01AC03
|
Hydrocortisone
|
|
|
|
|
|
A01AC54
|
Prednisolone, combinations
|
|
|
|
|
A01AD
|
|
Other agents for local oral treatment
|
|
|
|
|
|
A01AD01
|
Epinephrine
|
|
|
|
|
|
A01AD02
|
Benzydamine
|
|
|
|
|
|
A01AD05
|
Acetylsalicylic acid
|
|
|
|
|
|
A01AD06
|
Adrenalone
|
|
|
|
|
|
A01AD07
|
Amlexanox
|
|
|
|
|
|
A01AD08
|
Becaplermin
|
|
|
|
|
|
A01AD11
|
Various
|
|
|
A02
|
|
|
|
Drugs for acid related disorders
|
|
|
|
A02A
|
|
|
Antacids
|
|
|
|
|
A02AA
|
|
Magnesium compounds
|
|
|
|
|
|
A02AA01
|
Magnesium carbonate
|
|
|
|
|
|
A02AA02
|
Magnesium oxide
|
|
|
|
|
|
A02AA03
|
Magnesium peroxide
|
|
|
|
|
|
A02AA04
|
Magnesium hydroxide
|
|
|
|
|
|
A02AA05
|
Magnesium silicate
|
|
|
|
|
|
A02AA10
|
Combinations
|
|
|
|
|
A02AB
|
|
Aluminium compounds
|
|
|
|
|
|
A02AB01
|
Aluminium hydroxide
|
|
|
|
|
|
A02AB02
|
Algeldrate
|
|
|
|
|
|
A02AB03
|
Aluminium phosphate
|
|
|
|
|
|
A02AB04
|
Dihydroxialumini sodium carbonate
|
|
|
|
|
|
A02AB05
|
Aluminium acetoacetate
|
|
|
|
|
|
A02AB06
|
Aloglutamol
|
|
|
|
|
|
A02AB07
|
Aluminium glycinate
|
|
|
|
|
|
A02AB10
|
Combinations
|
|
|
|
|
A02AC
|
|
Calcium compounds
|
|
|
|
|
|
A02AC01
|
Calcium carbonate
|
|
|
|
|
|
A02AC02
|
Calcium silicate
|
|
|
|
|
|
A02AC10
|
Combinations
|
|
|
|
|
A02AD
|
|
Combinations and complexes of aluminium, calcium and magnesium compounds
|
|
|
|
|
|
A02AD01
|
Ordinary salt combinations
|
|
|
|
|
|
A02AD02
|
Magaldrate
|
|
|
|
|
|
A02AD03
|
Almagate
|
|
|
|
|
|
A02AD04
|
Hydrotalcite
|
|
|
|
|
|
A02AD05
|
Almasilate
|
|
|
|
|
A02AF
|
|
Antacids with antiflatulents
|
|
|
|
|
|
A02AF01
|
Magaldrate and antiflatulents
|
|
|
|
|
|
A02AF02
|
Ordinary salt combinations and antiflatulents
|
|
|
|
|
A02AG
|
|
Antacids with antispasmodics
|
|
|
|
|
|
|
Empty
|
|
|
|
|
A02AH
|
|
Antacids with sodium bicarbonate
|
|
|
|
|
|
|
Empty
|
|
|
|
|
A02AX
|
|
Antacids, other combinations
|
|
|
|
|
|
|
Empty
|
|
|
|
A02B
|
|
|
Drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
|
|
|
|
|
A02BA
|
|
H2-receptor antagonists
|
|
|
|
|
|
A02BA01
|
Cimetidine
|
|
|
|
|
|
A02BA02
|
Ranitidine
|
|
|
|
|
|
A02BA03
|
Famotidine
|
|
|
|
|
|
A02BA04
|
Nizatidine
|
|
|
|
|
|
A02BA05
|
Niperotidine
|
|
|
|
|
|
A02BA06
|
Roxatidine
|
|
|
|
|
|
A02BA07
|
Ranitidine bismuth citrate
|
|
|
|
|
|
A02BA08
|
Lafutidine
|
|
|
|
|
|
A02BA51
|
Cimetidine, combinations
|
|
|
|
|
|
A02BA53
|
Famotidine, combinations
|
|
|
|
|
A02BB
|
|
Prostaglandins
|
|
|
|
|
|
A02BB01
|
Misoprostol
|
|
|
|
|
|
A02BB02
|
Enprostil
|
|
|
|
|
A02BC
|
|
Proton pump inhibitors
|
|
|
|
|
|
A02BC01
|
Omeprazole
|
|
|
|
|
|
A02BC02
|
Pantoprazole
|
|
|
|
|
|
A02BC03
|
Lansoprazole
|
|
|
|
|
|
A02BC04
|
Rabeprazole
|
|
|
|
|
|
A02BC05
|
Esomeprazole
|
|
|
|
|
|
A02BC06
|
Dexlansoprazole
|
|
|
|
|
A02BD
|
|
Combinations for eradication of Helicobacter pylori
|
|
|
|
|
|
A02BD01
|
Omeprazole, amoxicillin and metronidazole
|
|
|
|
|
|
A02BD02
|
Lansoprazole, tetracycline and metronidazole
|
|
|
|
|
|
A02BD03
|
Lansoprazole, amoxicillin and metronidazole
|
|
|
|
|
|
A02BD04
|
Pantoprazole, amoxicillin and clarithromycin
|
|
|
|
|
|
A02BD05
|
Omeprazole, amoxicillin and clarithromycin
|
|
|
|
|
|
A02BD06
|
Esomeprazole, amoxicillin and clarithromycin
|
|
|
|
|
|
A02BD07
|
Lansoprazole, amoxicillin and clarithromycin
|
|
|
|
|
|
A02BD08
|
Bismuth subcitrate, tetracycline and metronidazole
|
|
|
|
|
A02BX
|
|
Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
|
|
|
|
|
|
A02BX01
|
Carbenoxolone
|
|
|
|
|
|
A02BX02
|
Sucralfate
|
|
|
|
|
|
A02BX03
|
Pirenzepine
|
|
|
|
|
|
A02BX04
|
Methiosulfonium chloride
|
|
|
|
|
|
A02BX05
|
Bismuth subcitrate
|
|
|
|
|
|
A02BX06
|
Proglumide
|
|
|
|
|
|
A02BX07
|
Gefarnate
|
|
|
|
|
|
A02BX08
|
Sulglicotide
|
|
|
|
|
|
A02BX09
|
Acetoxolone
|
|
|
|
|
|
A02BX10
|
Zolimidine
|
|
|
|
|
|
A02BX11
|
Troxipide
|
|
|
|
|
|
A02BX12
|
Bismuth subnitrate
|
|
|
|
|
|
A02BX13
|
Alginic acid
|
|
|
|
|
|
A02BX51
|
Carbenoxolone, combinations excluding psycholeptics
|
|
|
|
|
|
A02BX71
|
Carbenoxolone, combinations with psycholeptics
|
|
|
|
|
|
A02BX77
|
Gefarnate, combinations with psycholeptics
|
|
|
|
A02X
|
|
|
Other drugs for acid related disorders
|
|
|
|
|
|
|
Empty
|
|
|
A03
|
|
|
|
Drugs for functional gastrointestinal disorders
|
|
|
|
A03A
|
|
|
Drugs for functional gastrointestinal disorders
|
|
|
|
|
A03AA
|
|
Synthetic anticholinergics, esters with tertiary amino group
|
|
|
|
|
|
A03AA01
|
Oxyphencyclimine
|
|
|
|
|
|
A03AA03
|
Camylofin
|
|
|
|
|
|
A03AA04
|
Mebeverine
|
|
|
|
|
|
A03AA05
|
Trimebutine
|
|
|
|
|
|
A03AA06
|
Rociverine
|
|
|
|
|
|
A03AA07
|
Dicycloverine
|
|
|
|
|
|
A03AA08
|
Dihexyverine
|
|
|
|
|
|
A03AA09
|
Difemerine
|
|
|
|
|
|
A03AA30
|
Piperidolate
|
|
|
|
|
A03AB
|
|
Synthetic anticholinergics, quaternary ammonium compounds
|
|
|
|
|
|
A03AB01
|
Benzilone
|
|
|
|
|
|
A03AB02
|
Glycopyrronium
|
|
|
|
|
|
A03AB03
|
Oxyphenonium
|
|
|
|
|
|
A03AB04
|
Penthienate
|
|
|
|
|
|
A03AB05
|
Propantheline
|
|
|
|
|
|
A03AB06
|
Otilonium bromide
|
|
|
|
|
|
A03AB07
|
Methantheline
|
|
|
|
|
|
A03AB08
|
Tridihexethyl
|
|
|
|
|
|
A03AB09
|
Isopropamide
|
|
|
|
|
|
A03AB10
|
Hexocyclium
|
|
|
|
|
|
A03AB11
|
Poldine
|
|
|
|
|
|
A03AB12
|
Mepenzolate
|
|
|
|
|
|
A03AB13
|
Bevonium
|
|
|
|
|
|
A03AB14
|
Pipenzolate
|
|
|
|
|
|
A03AB15
|
Diphemanil
|
|
|
|
|
|
A03AB16
|
(2-benzhydryloxyethyl)diethyl-methylammonium iodide
|
|
|
|
|
|
A03AB17
|
Tiemonium iodide
|
|
|
|
|
|
A03AB18
|
Prifinium bromide
|
|
|
|
|
|
A03AB19
|
Timepidium bromide
|
|
|
|
|
|
A03AB21
|
Fenpiverinium
|
|
|
|
|
|
A03AB53
|
Oxyphenonium, combinations
|
|
|
|
|
A03AC
|
|
Synthetic antispasmodics, amides with tertiary amines
|
|
|
|
|
|
A03AC02
|
Dimethylaminopropionylphenothiazine
|
|
|
|
|
|
A03AC04
|
Nicofetamide
|
|
|
|
|
|
A03AC05
|
Tiropramide
|
|
|
|
|
A03AD
|
|
Papaverine and derivatives
|
|
|
|
|
|
A03AD01
|
Papaverine
|
|
|
|
|
|
A03AD02
|
Drotaverine
|
|
|
|
|
|
A03AD30
|
Moxaverine
|
|
|
|
|
A03AE
|
|
Serotonin receptor antagonists
|
|
|
|
|
|
A03AE01
|
Alosetron
|
|
|
|
|
|
A03AE03
|
Cilansetron
|
|
|
|
|
A03AX
|
|
Other drugs for functional gastrointestinal disorders
|
|
|
|
|
|
A03AX01
|
Fenpiprane
|
|
|
|
|
|
A03AX02
|
Diisopromine
|
|
|
|
|
|
A03AX03
|
Chlorbenzoxamine
|
|
|
|
|
|
A03AX04
|
Pinaverium
|
|
|
|
|
|
A03AX05
|
Fenoverine
|
|
|
|
|
|
A03AX06
|
Idanpramine
|
|
|
|
|
|
A03AX07
|
Proxazole
|
|
|
|
|
|
A03AX08
|
Alverine
|
|
|
|
|
|
A03AX09
|
Trepibutone
|
|
|
|
|
|
A03AX10
|
Isometheptene
|
|
|
|
|
|
A03AX11
|
Caroverine
|
|
|
|
|
|
A03AX12
|
Phloroglucinol
|
|
|
|
|
|
A03AX13
|
Silicones
|
|
|
|
|
|
A03AX30
|
Trimethyldiphenylpropylamine
|
|
|
|
|
|
A03AX58
|
Alverine, combinations
|
|
|
|
A03B
|
|
|
Belladonna and derivatives, plain
|
|
|
|
|
A03BA
|
|
Belladonna alkaloids, tertiary amines
|
|
|
|
|
|
A03BA01
|
Atropine
|
|
|
|
|
|
A03BA03
|
Hyoscyamine
|
|
|
|
|
|
A03BA04
|
Belladonna total alkaloids
|
|
|
|
|
A03BB
|
|
Belladonna alkaloids, semisynthetic, quaternary ammonium compounds
|
|
|
|
|
|
A03BB01
|
Butylscopolamine
|
|
|
|
|
|
A03BB02
|
Methylatropine
|
|
|
|
|
|
A03BB03
|
Methylscopolamine
|
|
|
|
|
|
A03BB04
|
Fentonium
|
|
|
|
|
|
A03BB05
|
Cimetropium bromide
|
|
|
|
A03C
|
|
|
Antispasmodics in combination with psycholeptics
|
|
|
|
|
A03CA
|
|
Synthetic anticholinergic agents in combination with psycholeptics
|
|
|
|
|
|
A03CA01
|
Isopropamide and psycholeptics
|
|
|
|
|
|
A03CA02
|
Clidinium and psycholeptics
|
|
|
|
|
|
A03CA03
|
Oxyphencyclimine and psycholeptics
|
|
|
|
|
|
A03CA04
|
Otilonium bromide and psycholeptics
|
|
|
|
|
|
A03CA05
|
Glycopyrronium and psycholeptics
|
|
|
|
|
|
A03CA06
|
Bevonium and psycholeptics
|
|
|
|
|
|
A03CA07
|
Ambutonium and psycholeptics
|
|
|
|
|
|
A03CA08
|
Diphemanil and psycholeptics
|
|
|
|
|
|
A03CA30
|
Emepronium and psycholeptics
|
|
|
|
|
|
A03CA34
|
Propantheline and psycholeptics
|
|
|
|
|
A03CB
|
|
Belladonna and derivatives in combination with psycholeptics
|
|
|
|
|
|
A03CB01
|
Methylscopolamine and psycholeptics
|
|
|
|
|
|
A03CB02
|
Belladonna total alkaloids and psycholeptics
|
|
|
|
|
|
A03CB03
|
Atropine and psycholeptics
|
|
|
|
|
|
A03CB04
|
Methylhomatropine and psycholeptics
|
|
|
|
|
|
A03CB31
|
Hyoscyamine and psycholeptics
|
|
|
|
|
A03CC
|
|
Other antispasmodics in combination with psycholeptics
|
|
|
|
|
|
|
empty
|
|
|
|
A03D
|
|
|
Antispasmodics in combination with analgesics
|
|
|
|
|
A03DA
|
|
Synthetic anticholinergic agents in combination with analgesics
|
|
|
|
|
|
A03DA01
|
Tropenzilone and analgesics
|
|
|
|
|
|
A03DA02
|
Pitofenone and analgesics
|
|
|
|
|
|
A03DA03
|
Bevonium and analgesics
|
|
|
|
|
|
A03DA04
|
Ciclonium and analgesics
|
|
|
|
|
|
A03DA05
|
Camylofin and analgesics
|
|
|
|
|
|
A03DA06
|
Trospium and analgesics
|
|
|
|
|
|
A03DA07
|
Tiemonium iodide and analgesics
|
|
|
|
|
A03DB
|
|
Belladonna and derivatives in combination with analgesics
|
|
|
|
|
|
A03DB04
|
Butylscopolamine and analgesics
|
|
|
|
|
A03DC
|
|
Other antispasmodics in combination with analgesics
|
|
|
|
|
|
|
empty
|
|
|
|
A03E
|
|
|
Antispasmodics and anticholinergics in combination with other drugs
|
|
|
|
|
A03EA
|
|
Antispasmodics, psycholeptics and analgesics in combination
|
|
|
|
|
|
|
empty
|
|
|
|
|
A03ED
|
|
Antispasmodics in combination with other drugs
|
|
|
|
|
|
|
empty
|
|
|
|
A03F
|
|
|
Propulsives
|
|
|
|
|
A03FA
|
|
Propulsives
|
|
|
|
|
|
A03FA01
|
Metoclopramide
|
|
|
|
|
|
A03FA02
|
Cisapride
|
|
|
|
|
|
A03FA03
|
Domperidone
|
|
|
|
|
|
A03FA04
|
Bromopride
|
|
|
|
|
|
A03FA05
|
Alizapride
|
|
|
|
|
|
A03FA06
|
Clebopride
|
|
|
A04
|
|
|
|
Antiemetics and antinauseants
|
|
|
|
A04A
|
|
|
Antiemetics and antinauseants
|
|
|
|
|
A04AA
|
|
Serotonin (5-HT3) antagonists
|
|
|
|
|
|
A04AA01
|
Ondansetron
|
|
|
|
|
|
A04AA02
|
Granisetron
|
|
|
|
|
|
A04AA03
|
Tropisetron
|
|
|
|
|
|
A04AA04
|
Dolasetron
|
|
|
|
|
|
A04AA05
|
Palonosetron
|
|
|
|
|
A04AD
|
|
Other antiemetics
|
|
|
|
|
|
A04AD01
|
Scopolamine
|
|
|
|
|
|
A04AD02
|
Cerium oxalate
|
|
|
|
|
|
A04AD04
|
Chlorobutanol
|
|
|
|
|
|
A04AD05
|
Metopimazine
|
|
|
|
|
|
A04AD10
|
Dronabinol
|
|
|
|
|
|
A04AD11
|
Nabilone
|
|
|
|
|
|
A04AD12
|
Aprepitant
|
|
|
|
|
|
A04AD13
|
Casopitant
|
|
|
|
|
|
A04AD51
|
Scopolamine, combinations
|
|
|
|
|
|
A04AD54
|
Chlorobutanol, combinations
|
|
|
A05
|
|
|
|
Bile and liver therapy
|
|
|
|
A05A
|
|
|
Bile therapy
|
|
|
|
|
A05AA
|
|
Bile acid preparations
|
|
|
|
|
|
A05AA01
|
Chenodeoxycholic acid
|
|
|
|
|
|
A05AA02
|
Ursodeoxycholic acid
|
|
|
|
|
|
A05AA03
|
Cholic acid
|
|
|
|
|
A05AB
|
|
Preparations for biliary tract therapy
|
|
|
|
|
|
A05AB01
|
Nicotinyl methylamide
|
|
|
|
|
A05AX
|
|
Other drugs for bile therapy
|
|
|
|
|
|
A05AX01
|
Piprozolin
|
|
|
|
|
|
A05AX02
|
Hymecromone
|
|
|
|
|
|
A05AX03
|
Cyclobutyrol
|
|
|
|
A05B
|
|
|
Liver therapy, lipotropics
|
|
|
|
|
A05BA
|
|
Liver therapy
|
|
|
|
|
|
A05BA01
|
Arginine glutamate
|
|
|
|
|
|
A05BA03
|
Silymarin
|
|
|
|
|
|
A05BA04
|
Citiolone
|
|
|
|
|
|
A05BA05
|
Epomediol
|
|
|
|
|
|
A05BA06
|
Ornithine oxoglutarate
|
|
|
|
|
|
A05BA07
|
Tidiacic arginine
|
|
|
|
|
|
A05BA08
|
Glycyrrhizic acid (glycyrrhizin)
|
|
|
|
A05C
|
|
|
Drugs for bile therapy and lipotropics in combination
|
|
|
|
|
|
|
Empty
|
|
|
A06
|
|
|
|
Drugs for constipation
|
|
|
|
A06A
|
|
|
Drugs for constipation
|
|
|
|
|
A06AA
|
|
Softeners, emollients
|
|
|
|
|
|
A06AA01
|
Liquid paraffin
|
|
|
|
|
|
A06AA02
|
Docusate sodium
|
|
|
|
|
|
A06AA51
|
Liquid paraffin, combinations
|
|
|
|
|
A06AB
|
|
Contact laxatives
|
|
|
|
|
|
A06AB01
|
Oxyphenisatine
|
|
|
|
|
|
A06AB02
|
Bisacodyl
|
|
|
|
|
|
A06AB03
|
Dantron
|
|
|
|
|
|
A06AB04
|
Phenolphthalein
|
|
|
|
|
|
A06AB05
|
Castor oil
|
|
|
|
|
|
A06AB06
|
Senna glycosides
|
|
|
|
|
|
A06AB07
|
Cascara
|
|
|
|
|
|
A06AB08
|
Sodium picosulfate
|
|
|
|
|
|
A06AB09
|
Bisoxatin
|
|
|
|
|
|
A06AB20
|
Contact laxatives in combination
|
|
|
|
|
|
A06AB30
|
Contact laxatives in combination with belladonna alkaloids
|
|
|
|
|
|
A06AB52
|
Bisacodyl, combinations
|
|
|
|
|
|
A06AB53
|
Dantron, combinations
|
|
|
|
|
|
A06AB56
|
Senna glycosides, combinations
|
|
|
|
|
|
A06AB57
|
Cascara, combinations
|
|
|
|
|
|
A06AB58
|
Sodium picosulfate, combinations
|
|
|
|
|
A06AC
|
|
Bulk-forming laxatives
|
|
|
|
|
|
A06AC01
|
Ispaghula (psylla seeds)
|
|
|
|
|
|
A06AC02
|
Ethulose
|
|
|
|
|
|
A06AC03
|
Sterculia
|
|
|
|
|
|
A06AC05
|
Linseed
|
|
|
|
|
|
A06AC06
|
Methylcellulose
|
|
|
|
|
|
A06AC07
|
Triticum (wheat fibre)
|
|
|
|
|
|
A06AC08
|
Polycarbophil calcium
|
|
|
|
|
|
A06AC51
|
Ispaghula, combinations
|
|
|
|
|
|
A06AC53
|
Sterculia, combinations
|
|
|
|
|
|
A06AC55
|
Linseed, combinations
|
|
|
|
|
A06AD
|
|
Osmotically acting laxatives
|
|
|
|
|
|
A06AD01
|
Magnesium carbonate
|
|
|
|
|
|
A06AD02
|
Magnesium oxide
|
|
|
|
|
|
A06AD03
|
Magnesium peroxide
|
|
|
|
|
|
A06AD04
|
Magnesium sulfate
|
|
|
|
|
|
A06AD10
|
Mineral salts in combination
|
|
|
|
|
|
A06AD11
|
Lactulose
|
|
|
|
|
|
A06AD12
|
Lactitol
|
|
|
|
|
|
A06AD13
|
Sodium sulfate
|
|
|
|
|
|
A06AD14
|
Pentaerithrityl
|
|
|
|
|
|
A06AD15
|
Macrogol
|
|
|
|
|
|
A06AD16
|
Mannitol
|
|
|
|
|
|
A06AD17
|
Sodium phosphate
|
|
|
|
|
|
A06AD18
|
Sorbitol
|
|
|
|
|
|
A06AD19
|
Magnesium citrate
|
|
|
|
|
|
A06AD21
|
Sodium tartrate
|
|
|
|
|
|
A06AD61
|
Lactulose, combinations
|
|
|
|
|
|
A06AD65
|
Macrogol, combinations
|
|
|
|
|
A06AG
|
|
Enemas
|
|
|
|
|
|
A06AG01
|
Sodium phosphate
|
|
|
|
|
|
A06AG02
|
Bisacodyl
|
|
|
|
|
|
A06AG03
|
Dantron, including combinations
|
|
|
|
|
|
A06AG04
|
Glycerol
|
|
|
|
|
|
A06AG06
|
Oil
|
|
|
|
|
|
A06AG07
|
Sorbitol
|
|
|
|
|
|
A06AG10
|
Docusate sodium, including combinations
|
|
|
|
|
|
A06AG11
|
Laurilsulfate, including combinations
|
|
|
|
|
|
A06AG20
|
Combinations
|
|
|
|
|
A06AH
|
|
Peripheral opioid receptor antagonists
|
|
|
|
|
|
A06AH01
|
Methylnaltrexone bromide
|
|
|
|
|
|
A06AH02
|
Alvimopan
|
|
|
|
|
A06AX
|
|
Other drugs for constipation
|
|
|
|
|
|
A06AX01
|
Glycerol
|
|
|
|
|
|
A06AX02
|
Carbon dioxide producing drugs
|
|
|
|
|
|
A06AX03
|
Lubiprostone
|
|
|
|
|
|
A06AX04
|
Linaclotide
|
|
|
|
|
|
A06AX05
|
Prucalopride
|
|
|
|
|
|
A06AX06
|
Tegaserod
|
|
|
A07
|
|
|
|
Antidiarrheals, intestinal anti-inflammatory/anti-infective agents
|
|
|
|
A07A
|
|
|
Intestinal anti-infectives
|
|
|
|
|
A07AA
|
|
Antibiotics
|
|
|
|
|
|
A07AA01
|
Neomycin
|
|
|
|
|
|
A07AA02
|
Nystatin
|
|
|
|
|
|
A07AA03
|
Natamycin
|
|
|
|
|
|
A07AA04
|
Streptomycin
|
|
|
|
|
|
A07AA05
|
Polymyxin B
|
|
|
|
|
|
A07AA06
|
Paromomycin
|
|
|
|
|
|
A07AA07
|
Amphotericin B
|
|
|
|
|
|
A07AA08
|
Kanamycin
|
|
|
|
|
|
A07AA09
|
Vancomycin
|
|
|
|
|
|
A07AA10
|
Colistin
|
|
|
|
|
|
A07AA11
|
Rifaximin
|
|
|
|
|
|
A07AA12
|
Fidaxomicin
|
|
|
|
|
|
A07AA51
|
Neomycin, combinations
|
|
|
|
|
|
A07AA54
|
Streptomycin, combinations
|
|
|
|
|
A07AB
|
|
Sulfonamides
|
|
|
|
|
|
A07AB02
|
Phthalylsulfathiazole
|
|
|
|
|
|
A07AB03
|
Sulfaguanidine
|
|
|
|
|
|
A07AB04
|
Succinylsulfathiazole
|
|
|
|
|
A07AC
|
|
Imidazole derivatives
|
|
|
|
|
|
A07AC01
|
Miconazole
|
|
|
|
|
A07AX
|
|
Other intestinal anti-infectives
|
|
|
|
|
|
A07AX01
|
Broxyquinoline
|
|
|
|
|
|
A07AX02
|
Acetarsol
|
|
|
|
|
|
A07AX03
|
Nifuroxazide
|
|
|
|
|
|
A07AX04
|
Nifurzide
|
|
|
|
A07B
|
|
|
Intestinal adsorbents
|
|
|
|
|
A07BA
|
|
Charcoal preparations
|
|
|
|
|
|
A07BA01
|
Medicinal charcoal
|
|
|
|
|
|
A07BA51
|
Medicinal charcoal, combinations
|
|
|
|
|
A07BB
|
|
Bismuth preparations
|
|
|
|
|
|
|
empty
|
|
|
|
|
A07BC
|
|
Other intestinal adsorbents
|
|
|
|
|
|
A07BC01
|
Pectin
|
|
|
|
|
|
A07BC02
|
Kaolin
|
|
|
|
|
|
A07BC03
|
Crospovidone
|
|
|
|
|
|
A07BC04
|
Attapulgite
|
|
|
|
|
|
A07BC05
|
Diosmectite
|
|
|
|
|
|
A07BC30
|
Combinations
|
|
|
|
|
|
A07BC54
|
Attapulgite, combinations
|
|
|
|
A07C
|
|
|
Electrolytes with carbohydrates
|
|
|
|
|
A07CA
|
|
Oral rehydration salt formulations
|
|
|
|
|
|
|
human ATC classification.
|
|
|
|
A07D
|
|
|
Antipropulsives
|
|
|
|
|
A07DA
|
|
Antipropulsives
|
|
|
|
|
|
A07DA01
|
Diphenoxylate
|
|
|
|
|
|
A07DA02
|
Opium
|
|
|
|
|
|
A07DA03
|
Loperamide
|
|
|
|
|
|
A07DA04
|
Difenoxin
|
|
|
|
|
|
A07DA05
|
Loperamide oxide
|
|
|
|
|
|
A07DA52
|
Morphine, combinations
|
|
|
|
|
|
A07DA53
|
Loperamide, combinations
|
|
|
|
A07E
|
|
|
Intestinal anti-inflammatory agents
|
|
|
|
|
A07EA
|
|
Corticosteroids acting locally
|
|
|
|
|
|
A07EA01
|
Prednisolone
|
|
|
|
|
|
A07EA02
|
Hydrocortisone
|
|
|
|
|
|
A07EA03
|
Prednisone
|
|
|
|
|
|
A07EA04
|
Betamethasone
|
|
|
|
|
|
A07EA05
|
Tixocortol
|
|
|
|
|
|
A07EA06
|
Budesonide
|
|
|
|
|
|
A07EA07
|
Beclometasone
|
|
|
|
|
A07EB
|
|
Antiallergic agents, excluding corticosteroids
|
|
|
|
|
|
A07EB01
|
Cromoglicic acid
|
|
|
|
|
A07EC
|
|
Aminosalicylic acid and similar agents
|
|
|
|
|
|
A07EC01
|
Sulfasalazine
|
|
|
|
|
|
A07EC02
|
Mesalazine
|
|
|
|
|
|
A07EC03
|
Olsalazine
|
|
|
|
|
|
A07EC04
|
Balsalazide
|
|
|
|
A07F
|
|
|
Antidiarrheal micro-organisms
|
|
|
|
|
A07FA
|
|
Antidiarrheal micro-organisms
|
|
|
|
|
|
A07FA01
|
Lactic acid producing organisms
|
|
|
|
|
|
A07FA02
|
Saccharomyces boulardii
|
|
|
|
|
|
A07FA51
|
Lactic acid producing organisms, combinations
|
|
|
|
A07X
|
|
|
Other antidiarrheals
|
|
|
|
|
A07XA
|
|
Other antidiarrheals
|
|
|
|
|
|
A07XA01
|
Albumin tannate
|
|
|
|
|
|
A07XA02
|
Ceratonia
|
|
|
|
|
|
A07XA03
|
Calcium compounds
|
|
|
|
|
|
A07XA04
|
Racecadotril
|
|
|
|
|
|
A07XA51
|
Albumin tannate, combinations
|
|
|
A08
|
|
|
|
Antiobesity preparations, excluding diet products
|
|
|
|
A08A
|
|
|
Antiobesity preparations, excluding diet products
|
|
|
|
|
A08AA
|
|
Centrally acting antiobesity products
|
|
|
|
|
|
A08AA01
|
Phentermine
|
|
|
|
|
|
A08AA02
|
Fenfluramine
|
|
|
|
|
|
A08AA03
|
Amfepramone
|
|
|
|
|
|
A08AA04
|
Dexfenfluramine
|
|
|
|
|
|
A08AA05
|
Mazindol
|
|
|
|
|
|
A08AA06
|
Etilamfetamine
|
|
|
|
|
|
A08AA07
|
Cathine
|
|
|
|
|
|
A08AA08
|
Clobenzorex
|
|
|
|
|
|
A08AA09
|
Mefenorex
|
|
|
|
|
|
A08AA10
|
Sibutramine
|
|
|
|
|
|
A08AA56
|
Ephedrine, combinations
|
|
|
|
|
A08AB
|
|
Peripherally acting antiobesity products
|
|
|
|
|
|
A08AB01
|
Orlistat
|
|
|
|
|
A08AX
|
|
Other antiobesity drugs
|
|
|
|
|
|
A08AX01
|
Rimonabant
|
|
|
A09
|
|
|
|
Digestives,including enzymes
|
|
|
|
A09A
|
|
|
Digestives, including enzymes
|
|
|
|
|
A09AA
|
|
Enzyme preparations
|
|
|
|
|
|
A09AA01
|
Diastase
|
|
|
|
|
|
A09AA02
|
Multienzymes (lipase, protease, etc.)
|
|
|
|
|
|
A09AA03
|
Pepsin
|
|
|
|
|
|
A09AA04
|
Tilactase
|
|
|
|
|
A09AB
|
|
Acid preparations
|
|
|
|
|
|
A09AB01
|
Glutamic acid hydrochloride
|
|
|
|
|
|
A09AB02
|
Betaine hydrochloride
|
|
|
|
|
|
A09AB03
|
Hydrochloric acid
|
|
|
|
|
|
A09AB04
|
Citric acid
|
|
|
|
|
A09AC
|
|
Enzyme and acid preparations, combinations
|
|
|
|
|
|
A09AC01
|
Pepsin and acid preparations
|
|
|
|
|
|
A09AC02
|
Multienzymes and acid preparations
|
|
|
A10
|
|
|
|
Drugs used in diabetes
|
|
|
|
A10A
|
|
|
Insulins and analogues
|
|
|
|
|
A10AB
|
|
Insulins and analogues for injection, fast-acting
|
|
|
|
|
|
A10AB01
|
Insulin (human)
|
|
|
|
|
|
A10AB02
|
Insulin (beef)
|
|
|
|
|
|
A10AB03
|
Insulin (pork)
|
|
|
|
|
|
A10AB04
|
Insulin lispro
|
|
|
|
|
|
A10AB05
|
Insulin aspart
|
|
|
|
|
|
A10AB06
|
Insulin glulisine
|
|
|
|
|
|
A10AB30
|
Combinations
|
|
|
|
|
A10AC
|
|
Insulins and analogues for injection, intermediate-acting
|
|
|
|
|
|
A10AC01
|
Insulin (human)
|
|
|
|
|
|
A10AC02
|
Insulin (beef)
|
|
|
|
|
|
A10AC03
|
Insulin (pork)
|
|
|
|
|
|
A10AC04
|
Insulin lispro
|
|
|
|
|
|
A10AC30
|
Combinations
|
|
|
|
|
A10AD
|
|
Insulins and analogues for injection, intermediate-acting combined with fast-acting
|
|
|
|
|
|
A10AD01
|
Insulin (human)
|
|
|
|
|
|
A10AD02
|
Insulin (beef)
|
|
|
|
|
|
A10AD03
|
Insulin (pork)
|
|
|
|
|
|
A10AD04
|
Insulin lispro
|
|
|
|
|
|
A10AD05
|
Insulin aspart
|
|
|
|
|
|
A10AD30
|
Combinations
|
|
|
|
|
A10AE
|
|
Insulins and analogues for injection, long-acting
|
|
|
|
|
|
A10AE01
|
Insulin (human)
|
|
|
|
|
|
A10AE02
|
Insulin (beef)
|
|
|
|
|
|
A10AE03
|
Insulin (pork)
|
|
|
|
|
|
A10AE04
|
Insulin glargine
|
|
|
|
|
|
A10AE05
|
Insulin detemir
|
|
|
|
|
|
A10AE30
|
Combinations
|
|
|
|
|
A10AF
|
|
Insulins and analogues for inhalation
|
|
|
|
|
|
A10AF01
|
Insulin (human)
|
|
|
|
A10B
|
|
|
Blood glucose lowering drugs, excluding insulins
|
|
|
|
|
A10BA
|
|
Biguanides
|
|
|
|
|
|
A10BA01
|
Phenformin
|
|
|
|
|
|
A10BA02
|
Metformin
|
|
|
|
|
|
A10BA03
|
Buformin
|
|
|
|
|
A10BB
|
|
Sulfonamides, urea derivatives
|
|
|
|
|
|
A10BB01
|
Glibenclamide
|
|
|
|
|
|
A10BB02
|
Chlorpropamide
|
|
|
|
|
|
A10BB03
|
Tolbutamide
|
|
|
|
|
|
A10BB04
|
Glibornuride
|
|
|
|
|
|
A10BB05
|
Tolazamide
|
|
|
|
|
|
A10BB06
|
Carbutamide
|
|
|
|
|
|
A10BB07
|
Glipizide
|
|
|
|
|
|
A10BB08
|
Gliquidone
|
|
|
|
|
|
A10BB09
|
Gliclazide
|
|
|
|
|
|
A10BB10
|
Metahexamide
|
|
|
|
|
|
A10BB11
|
Glisoxepide
|
|
|
|
|
|
A10BB12
|
Glimepiride
|
|
|
|
|
|
A10BB31
|
Acetohexamide
|
|
|
|
|
A10BC
|
|
Sulfonamides (heterocyclic)
|
|
|
|
|
|
A10BC01
|
Glymidine
|
|
|
|
|
A10BD
|
|
Combinations of oral blood glucose lowering drugs
|
|
|
|
|
|
A10BD01
|
Phenformin and sulfonamides
|
|
|
|
|
|
A10BD02
|
Metformin and sulfonamides
|
|
|
|
|
|
A10BD03
|
Metformin and rosiglitazone
|
|
|
|
|
|
A10BD04
|
Glimepiride and rosiglitazone
|
|
|
|
|
|
A10BD05
|
Metformin and pioglitazone
|
|
|
|
|
|
A10BD06
|
Glimepiride and pioglitazone
|
|
|
|
|
|
A10BD07
|
Metformin and sitagliptin
|
|
|
|
|
|
A10BD08
|
Metformin and vildagliptin
|
|
|
|
|
|
A10BD09
|
Pioglitazone and alogliptin
|
|
|
|
|
|
A10BD10
|
Metformin and saxagliptin
|
|
|
|
|
|
A10BD11
|
Metformin and linagliptin
|
|
|
|
|
|
A10BD12
|
Pioglitazone and sitagliptin
|
|
|
|
|
|
A10BD13
|
Metformin and alogliptin
|
|
|
|
|
A10BF
|
|
Alpha glucosidase inhibitors
|
|
|
|
|
|
A10BF01
|
Acarbose
|
|
|
|
|
|
A10BF02
|
Miglitol
|
|
|
|
|
|
A10BF03
|
Voglibose
|
|
|
|
|
A10BG
|
|
Thiazolidinediones
|
|
|
|
|
|
A10BG01
|
Troglitazone
|
|
|
|
|
|
A10BG02
|
Rosiglitazone
|
|
|
|
|
|
A10BG03
|
Pioglitazone
|
|
|
|
|
A10BH
|
|
Dipeptidyl peptidase 4 (DPP-4) inhibitors
|
|
|
|
|
|
A10BH01
|
Sitagliptin
|
|
|
|
|
|
A10BH02
|
Vildagliptin
|
|
|
|
|
|
A10BH03
|
Saxagliptin
|
|
|
|
|
|
A10BH04
|
Alogliptin
|
|
|
|
|
|
A10BH05
|
Linagliptin
|
|
|
|
|
|
A10BH51
|
Sitagliptin and simvastatin
|
|
|
|
|
A10BX
|
|
Other blood glucose lowering drugs, excluding insulins
|
|
|
|
|
|
A10BX01
|
Guar gum
|
|
|
|
|
|
A10BX02
|
Repaglinide
|
|
|
|
|
|
A10BX03
|
Nateglinide
|
|
|
|
|
|
A10BX04
|
Exenatide
|
|
|
|
|
|
A10BX05
|
Pramlintide
|
|
|
|
|
|
A10BX06
|
Benfluorex
|
|
|
|
|
|
A10BX07
|
Liraglutide
|
|
|
|
|
|
A10BX08
|
Mitiglinide
|
|
|
|
|
|
A10BX09
|
Dapagliflozin
|
|
|
|
A10X
|
|
|
Other drugs used in diabetes
|
|
|
|
|
A10XA
|
|
Aldose reductase inhibitors
|
|
|
|
|
|
A10XA01
|
Tolrestat
|
|
|
A11
|
|
|
|
Vitamins
|
|
|
|
A11A
|
|
|
Multivitamins, combinations
|
|
|
|
|
A11AA
|
|
Multivitamins with minerals
|
|
|
|
|
|
A11AA01
|
Multivitamins and iron
|
|
|
|
|
|
A11AA02
|
Multivitamins and calcium
|
|
|
|
|
|
A11AA03
|
Multivitamins and other minerals, including combinations
|
|
|
|
|
|
A11AA04
|
Multivitamins and trace elements
|
|
|
|
|
A11AB
|
|
Multivitamins, other combinations
|
|
|
|
|
|
|
empty
|
|
|
|
A11B
|
|
|
Multivitamins, plain
|
|
|
|
|
A11BA
|
|
Multivitamins, plain
|
|
|
|
|
|
|
empty
|
|
|
|
A11C
|
|
|
Vitamin A and D, including combinations of the two
|
|
|
|
|
A11CA
|
|
Vitamin A, plain
|
|
|
|
|
|
A11CA01
|
Retinol (vitamin A)
|
|
|
|
|
|
A11CA02
|
Betacarotene
|
|
|
|
|
A11CB
|
|
Vitamin A and D in combination
|
|
|
|
|
|
|
empty
|
|
|
|
|
A11CC
|
|
Vitamin D and analogues
|
|
|
|
|
|
A11CC01
|
Ergocalciferol
|
|
|
|
|
|
A11CC02
|
Dihydrotachysterol
|
|
|
|
|
|
A11CC03
|
Alfacalcidol
|
|
|
|
|
|
A11CC04
|
Calcitriol
|
|
|
|
|
|
A11CC05
|
Colecalciferol
|
|
|
|
|
|
A11CC06
|
Calcifediol
|
|
|
|
|
|
A11CC20
|
Combinations
|
|
|
|
A11D
|
|
|
Vitamin B1, plain and in combination with vitamin B6 and B12
|
|
|
|
|
A11DA
|
|
Vitamin B1, plain
|
|
|
|
|
|
A11DA01
|
Thiamine (vitamin B1)
|
|
|
|
|
|
A11DA02
|
Sulbutiamine
|
|
|
|
|
|
A11DA03
|
Benfotiamine
|
|
|
|
|
A11DB
|
|
Vitamin B1 in combination with vitamin B6 and/or vitamin B12
|
|
|
|
|
|
|
empty
|
|
|
|
A11E
|
|
|
Vitamin B-complex, including combinations
|
|
|
|
|
A11EA
|
|
Vitamin B-complex, plain
|
|
|
|
|
|
|
empty
|
|
|
|
|
A11EB
|
|
Vitamin B-complex with vitamin C
|
|
|
|
|
|
|
empty
|
|
|
|
|
A11EC
|
|
Vitamin B-complex with minerals
|
|
|
|
|
|
|
empty
|
|
|
|
|
A11ED
|
|
Vitamin B-complex with anabolic steroids
|
|
|
|
|
|
|
empty
|
|
|
|
|
A11EX
|
|
Vitamin B-complex, other combinations
|
|
|
|
|
|
|
empty
|
|
|
|
A11G
|
|
|
Ascorbic acid (vitamin C), including combinations
|
|
|
|
|
A11GA
|
|
Ascorbic acid (vitamin C), plain
|
|
|
|
|
|
A11GA01
|
Ascorbic acid (vitamin C)
|
|
|
|
|
A11GB
|
|
Ascorbic acid (vitamin C), combinations
|
|
|
|
|
|
A11GB01
|
Ascorbic acid (vitamin C) and calcium
|
|
|
|
A11H
|
|
|
Other plain vitamin preparations
|
|
|
|
|
A11HA
|
|
Other plain vitamin preparations A11HA01 Nicotinamide
|
|
|
|
|
|
A11HA02
|
Pyridoxine (vitamin B6)
|
|
|
|
|
|
A11HA03
|
Tocopherol (vitamin E)
|
|
|
|
|
|
A11HA04
|
Riboflavin (vitamin B2)
|
|
|
|
|
|
A11HA05
|
Biotin
|
|
|
|
|
|
A11HA06
|
Pyridoxal phosphate
|
|
|
|
|
|
A11HA07
|
Inositol
|
|
|
|
|
|
A11HA08
|
Tocofersolan
|
|
|
|
|
|
A11HA30
|
Dexpanthenol
|
|
|
|
|
|
A11HA31
|
Calcium pantothenate
|
|
|
|
|
|
A11HA32
|
Pantethine
|
|
|
|
A11J
|
|
|
Other vitamin products, combinations
|
|
|
|
|
A11JA
|
|
Combinations of vitamins
|
|
|
|
|
|
|
empty
|
|
|
|
|
A11JB
|
|
Vitamins with minerals
|
|
|
|
|
|
|
empty
|
|
|
|
|
A11JC
|
|
Vitamins, other combinations
|
|
|
|
|
|
|
empty
|
|
|
A12
|
|
|
|
Mineral supplements
|
|
|
|
A12A
|
|
|
Calcium
|
|
|
|
|
A12AA
|
|
Calcium
|
|
|
|
|
|
A12AA01
|
Calcium phosphate
|
|
|
|
|
|
A12AA02
|
Calcium glubionate
|
|
|
|
|
|
A12AA03
|
Calcium gluconate
|
|
|
|
|
|
A12AA04
|
Calcium carbonate
|
|
|
|
|
|
A12AA05
|
Calcium lactate
|
|
|
|
|
|
A12AA06
|
Calcium lactate gluconate
|
|
|
|
|
|
A12AA07
|
Calcium chloride
|
|
|
|
|
|
A12AA08
|
Calcium glycerylphosphate
|
|
|
|
|
|
A12AA09
|
Calcium citrate lysine complex
|
|
|
|
|
|
A12AA10
|
Calcium glucoheptonate
|
|
|
|
|
|
A12AA11
|
Calcium pangamate
|
|
|
|
|
|
A12AA12
|
Calcium acetate anhydrous
|
|
|
|
|
|
A12AA20
|
Calcium (different salts in combination)
|
|
|
|
|
|
A12AA30
|
Calcium laevulate
|
|
|
|
|
A12AX
|
|
Calcium, combinations with vitamin D and/or other drugs
|
|
|
|
|
|
|
empty
|
|
|
|
A12B
|
|
|
Potassium
|
|
|
|
|
A12BA
|
|
Potassium
|
|
|
|
|
|
A12BA01
|
Potassium chloride
|
|
|
|
|
|
A12BA02
|
Potassium citrate
|
|
|
|
|
|
A12BA03
|
Potassium hydrogentartrate
|
|
|
|
|
|
A12BA04
|
Potassium hydrogencarbonate
|
|
|
|
|
|
A12BA05
|
Potassium gluconate
|
|
|
|
|
|
A12BA30
|
Combinations
|
|
|
|
|
|
A12BA51
|
Potassium chloride, combinations
|
|
|
|
A12C
|
|
|
Other mineral supplements
|
|
|
|
|
A12CA
|
|
Sodium
|
|
|
|
|
|
A12CA01
|
Sodium chloride
|
|
|
|
|
|
A12CA02
|
Sodium sulfate
|
|
|
|
|
A12CB
|
|
Zinc
|
|
|
|
|
|
A12CB01
|
Zinc sulfate
|
|
|
|
|
|
A12CB02
|
Zinc gluconate
|
|
|
|
|
|
A12CB03
|
Zinc protein complex
|
|
|
|
|
A12CC
|
|
Magnesium
|
|
|
|
|
|
A12CC01
|
Magnesium chloride
|
|
|
|
|
|
A12CC02
|
Magnesium sulfate
|
|
|
|
|
|
A12CC03
|
Magnesium gluconate
|
|
|
|
|
|
A12CC04
|
Magnesium citrate
|
|
|
|
|
|
A12CC05
|
Magnesium aspartate
|
|
|
|
|
|
A12CC06
|
Magnesium lactate
|
|
|
|
|
|
A12CC07
|
Magnesium levulinate
|
|
|
|
|
|
A12CC08
|
Magnesium pidolate
|
|
|
|
|
|
A12CC09
|
Magnesium orotate
|
|
|
|
|
|
A12CC10
|
Magnesium oxide
|
|
|
|
|
|
A12CC30
|
Magnesium (different salts in combination)
|
|
|
|
|
A12CD
|
|
Fluoride
|
|
|
|
|
|
A12CD01
|
Sodium fluoride
|
|
|
|
|
|
A12CD02
|
Sodium monofluorophosphate
|
|
|
|
|
|
A12CD51
|
Fluoride, combinations
|
|
|
|
|
A12CE
|
|
Selenium
|
|
|
|
|
|
A12CE01
|
Sodium selenate
|
|
|
|
|
|
A12CE02
|
Sodium selenite
|
|
|
|
|
A12CX
|
|
Other mineral products
|
|
|
|
|
|
|
empty
|
|
|
A13
|
|
|
|
Tonics
|
|
|
|
A13A
|
|
|
Tonics
|
|
|
|
|
|
|
empty
|
|
|
A14
|
|
|
|
Anabolic agents for systemic use
|
|
|
|
A14A
|
|
|
Anabolic steroids
|
|
|
|
|
A14AA
|
|
Androstan derivatives
|
|
|
|
|
|
A14AA01
|
Androstanolone
|
|
|
|
|
|
A14AA02
|
Stanozolol
|
|
|
|
|
|
A14AA03
|
Metandienone
|
|
|
|
|
|
A14AA04
|
Metenolone
|
|
|
|
|
|
A14AA05
|
Oxymetholone
|
|
|
|
|
|
A14AA06
|
Quinbolone
|
|
|
|
|
|
A14AA07
|
Prasterone
|
|
|
|
|
|
A14AA08
|
Oxandrolone
|
|
|
|
|
|
A14AA09
|
Norethandrolone
|
|
|
|
|
A14AB
|
|
Estren derivatives
|
|
|
|
|
|
A14AB01
|
Nandrolone
|
|
|
|
|
|
A14AB02
|
Ethylestrenol
|
|
|
|
|
|
A14AB03
|
Oxabolone cipionate
|
|
|
|
A14B
|
|
|
Other anabolic agents
|
|
|
|
|
|
|
empty
|
|
|
A15
|
|
|
|
Appetite stimulants
|
|
|
|
|
|
|
empty
|
|
|
A16
|
|
|
|
Other alimentary tract and metabolism products
|
|
|
|
A16A
|
|
|
Other alimentary tract and metabolism products
|
|
|
|
|
A16AA
|
|
Amino acids and derivatives
|
|
|
|
|
|
A16AA01
|
Levocarnitine
|
|
|
|
|
|
A16AA02
|
Ademetionine
|
|
|
|
|
|
A16AA03
|
Levoglutamide
|
|
|
|
|
|
A16AA04
|
Mercaptamine
|
|
|
|
|
|
A16AA05
|
Carglumic acid
|
|
|
|
|
|
A16AA06
|
Betaine
|
|
|
|
|
A16AB
|
|
Enzymes
|
|
|
|
|
|
A16AB01
|
Alglucerase
|
|
|
|
|
|
A16AB02
|
Imiglucerase
|
|
|
|
|
|
A16AB03
|
Agalsidase alfa
|
|
|
|
|
|
A16AB04
|
Agalsidase beta
|
|
|
|
|
|
A16AB05
|
Laronidase
|
|
|
|
|
|
A16AB06
|
Sacrosidase
|
|
|
|
|
|
A16AB07
|
Alglucosidase alfa
|
|
|
|
|
|
A16AB08
|
Galsulfase
|
|
|
|
|
|
A16AB09
|
Idursulfase
|
|
|
|
|
|
A16AB10
|
Velaglucerase alfa
|
|
|
|
|
|
A16AB11
|
Taliglucerase alfa
|
|
|
|
|
A16AX
|
|
Various alimentary tract and metabolism products
|
|
|
|
|
|
A16AX01
|
Thioctic acid
|
|
|
|
|
|
A16AX02
|
Anethole trithione
|
|
|
|
|
|
A16AX03
|
Sodium phenylbutyrate
|
|
|
|
|
|
A16AX04
|
Nitisinone
|
|
|
|
|
|
A16AX05
|
Zinc acetate
|
|
|
|
|
|
A16AX06
|
Miglustat
|
|
|
|
|
|
A16AX07
|
Sapropterin
|
|
|
|
|
|
A16AX08
|
Teduglutide
|
|
|
|
|
|
A16AX09
|
Glycerol phenylbutyrate
|
| B
|
|
|
|
|
Blood and blood forming organs
|
|
|
B01
|
|
|
|
Antithrombotic agents
|
|
|
|
B01A
|
|
|
Antithrombotic agents
|
|
|
|
|
B01AA
|
|
Vitamin K antagonists
|
|
|
|
|
|
B01AA01
|
Dicoumarol
|
|
|
|
|
|
B01AA02
|
Phenindione
|
|
|
|
|
|
B01AA03
|
Warfarin
|
|
|
|
|
|
B01AA04
|
Phenprocoumon
|
|
|
|
|
|
B01AA07
|
Acenocoumarol
|
|
|
|
|
|
B01AA08
|
Ethyl biscoumacetate
|
|
|
|
|
|
B01AA09
|
Clorindione
|
|
|
|
|
|
B01AA10
|
Diphenadione
|
|
|
|
|
|
B01AA11
|
Tioclomarol
|
|
|
|
|
|
B01AA12
|
Fluindione
|
|
|
|
|
B01AB
|
|
Heparin group
|
|
|
|
|
|
B01AB01
|
Heparin
|
|
|
|
|
|
B01AB02
|
Antithrombin III
|
|
|
|
|
|
B01AB04
|
Dalteparin
|
|
|
|
|
|
B01AB05
|
Enoxaparin
|
|
|
|
|
|
B01AB06
|
Nadroparin
|
|
|
|
|
|
B01AB07
|
Parnaparin
|
|
|
|
|
|
B01AB08
|
Reviparin
|
|
|
|
|
|
B01AB09
|
Danaparoid
|
|
|
|
|
|
B01AB10
|
Tinzaparin
|
|
|
|
|
|
B01AB11
|
Sulodexide
|
|
|
|
|
|
B01AB12
|
Bemiparin
|
|
|
|
|
|
B01AB51
|
Heparin, combinations
|
|
|
|
|
B01AC
|
|
Platelet aggregation inhibitors excluding heparin
|
|
|
|
|
|
B01AC01
|
Ditazole
|
|
|
|
|
|
B01AC02
|
Cloricromen
|
|
|
|
|
|
B01AC03
|
Picotamide
|
|
|
|
|
|
B01AC04
|
Clopidogrel
|
|
|
|
|
|
B01AC05
|
Ticlopidine
|
|
|
|
|
|
B01AC06
|
Acetylsalicylic acid
|
|
|
|
|
|
B01AC07
|
Dipyridamole
|
|
|
|
|
|
B01AC08
|
Carbasalate calcium
|
|
|
|
|
|
B01AC09
|
Epoprostenol
|
|
|
|
|
|
B01AC10
|
Indobufen
|
|
|
|
|
|
B01AC11
|
Iloprost
|
|
|
|
|
|
B01AC13
|
Abciximab
|
|
|
|
|
|
B01AC15
|
Aloxiprin
|
|
|
|
|
|
B01AC16
|
Eptifibatide
|
|
|
|
|
|
B01AC17
|
Tirofiban
|
|
|
|
|
|
B01AC18
|
Triflusal
|
|
|
|
|
|
B01AC19
|
Beraprost
|
|
|
|
|
|
B01AC21
|
Treprostinil
|
|
|
|
|
|
B01AC22
|
Prasugrel
|
|
|
|
|
|
B01AC23
|
Cilostazol
|
|
|
|
|
|
B01AC24
|
Ticagrelor
|
|
|
|
|
|
B01AC30
|
Combinations
|
|
|
|
|
|
B01AC56
|
Acetylsalicylic acid and esomeprazole
|
|
|
|
|
B01AD
|
|
Enzymes
|
|
|
|
|
|
B01AD01
|
Streptokinase
|
|
|
|
|
|
B01AD02
|
Alteplase
|
|
|
|
|
|
B01AD03
|
Anistreplase
|
|
|
|
|
|
B01AD04
|
Urokinase
|
|
|
|
|
|
B01AD05
|
Fibrinolysin
|
|
|
|
|
|
B01AD06
|
Brinase
|
|
|
|
|
|
B01AD07
|
Reteplase
|
|
|
|
|
|
B01AD08
|
Saruplase
|
|
|
|
|
|
B01AD09
|
Ancrod
|
|
|
|
|
|
B01AD10
|
Drotrecogin alfa (activated)
|
|
|
|
|
|
B01AD11
|
Tenecteplase
|
|
|
|
|
|
B01AD12
|
Protein C
|
|
|
|
|
B01AE
|
|
Direct thrombin inhibitors
|
|
|
|
|
|
B01AE01
|
Desirudin
|
|
|
|
|
|
B01AE02
|
Lepirudin
|
|
|
|
|
|
B01AE03
|
Argatroban
|
|
|
|
|
|
B01AE04
|
Melagatran
|
|
|
|
|
|
B01AE05
|
Ximelagatran
|
|
|
|
|
|
B01AE06
|
Bivalirudin
|
|
|
|
|
|
B01AE07
|
Dabigatran etexilate
|
|
|
|
|
B01AF
|
|
Direct factor Xa inhibitors
|
|
|
|
|
|
B01AF01
|
Rivaroxaban
|
|
|
|
|
|
B01AF02
|
Apixaban
|
|
|
|
|
B01AX
|
|
Other antithrombotic agents
|
|
|
|
|
|
B01AX01
|
Defibrotide
|
|
|
|
|
|
B01AX04
|
Dermatan sulfate
|
|
|
|
|
|
B01AX05
|
Fondaparinux
|
|
|
B02
|
|
|
|
Antihemorrhagics
|
|
|
|
B02A
|
|
|
Antifibrinolytics
|
|
|
|
|
B02AA
|
|
Amino acids
|
|
|
|
|
|
B02AA01
|
Aminocaproic acid
|
|
|
|
|
|
B02AA02
|
Tranexamic acid
|
|
|
|
|
|
B02AA03
|
Aminomethylbenzoic acid
|
|
|
|
|
B02AB
|
|
Proteinase inhibitors
|
|
|
|
|
|
B02AB01
|
Aprotinin
|
|
|
|
|
|
B02AB02
|
Alfa1 antitrypsin
|
|
|
|
|
|
B02AB04
|
Camostat
|
|
|
|
B02B
|
|
|
Vitamin K and other hemostatics
|
|
|
|
|
B02BA
|
|
Vitamin K
|
|
|
|
|
|
B02BA01
|
Phytomenadione
|
|
|
|
|
|
B02BA02
|
Menadione
|
|
|
|
|
B02BB
|
|
Fibrinogen
|
|
|
|
|
|
B02BB01
|
Human fibrinogen
|
|
|
|
|
B02BC
|
|
Local hemostatics
|
|
|
|
|
|
B02BC01
|
Absorbable gelatin sponge
|
|
|
|
|
|
B02BC02
|
Oxidized cellulose
|
|
|
|
|
|
B02BC03
|
Tetragalacturonic acid hydroxymethylester
|
|
|
|
|
|
B02BC05
|
Adrenalone
|
|
|
|
|
|
B02BC06
|
Thrombin
|
|
|
|
|
|
B02BC07
|
Collagen
|
|
|
|
|
|
B02BC08
|
Calcium alginate
|
|
|
|
|
|
B02BC09
|
Epinephrine
|
|
|
|
|
|
B02BC10
|
Fibrinogen, human
|
|
|
|
|
|
B02BC30
|
Combinations
|
|
|
|
|
B02BD
|
|
Blood coagulation factors
|
|
|
|
|
|
B02BD01
|
Coagulation factor IX, II, VII and X in combination (Prothrombin complex concentrate)
|
|
|
|
|
|
B02BD02
|
Coagulation factor VIII
|
|
|
|
|
|
B02BD03
|
Factor VIII inhibitor bypassing activity
|
|
|
|
|
|
B02BD04
|
Coagulation factor IX
|
|
|
|
|
|
B02BD05
|
Coagulation factor VII
|
|
|
|
|
|
B02BD06
|
Von Willebrand factor and coagulation factor VIII in combination
|
|
|
|
|
|
B02BD07
|
Coagulation factor XIII
|
|
|
|
|
|
B02BD08
|
Eptacog alfa (activated)
|
|
|
|
|
|
B02BD09
|
Nonacog alfa
|
|
|
|
|
|
B02BD10
|
von Willebrand factor
|
|
|
|
|
|
B02BD11
|
Catridecacog
|
|
|
|
|
|
B02BD12
|
Trenonacog alfa
|
|
|
|
|
|
B02BD30
|
Thrombin
|
|
|
|
|
B02BX
|
|
Other systemic hemostatics
|
|
|
|
|
|
B02BX01
|
Etamsylate
|
|
|
|
|
|
B02BX02
|
Carbazochrome
|
|
|
|
|
|
B02BX03
|
Batroxobin
|
|
|
|
|
|
B02BX04
|
Romiplostim
|
|
|
|
|
|
B02BX05
|
Eltrombopag
|
|
|
B03
|
|
|
|
Antianemic preparations
|
|
|
|
B03A
|
|
|
Iron preparations
|
|
|
|
|
B03AA
|
|
Iron bivalent, oral preparations
|
|
|
|
|
|
B03AA01
|
Ferrous glycine sulfate
|
|
|
|
|
|
B03AA02
|
Ferrous fumarate
|
|
|
|
|
|
B03AA03
|
Ferrous gluconate
|
|
|
|
|
|
B03AA04
|
Ferrous carbonate
|
|
|
|
|
|
B03AA05
|
Ferrous chloride
|
|
|
|
|
|
B03AA06
|
Ferrous succinate
|
|
|
|
|
|
B03AA07
|
Ferrous sulfate
|
|
|
|
|
|
B03AA08
|
Ferrous tartrate
|
|
|
|
|
|
B03AA09
|
Ferrous aspartate
|
|
|
|
|
|
B03AA10
|
Ferrous ascorbate
|
|
|
|
|
|
B03AA11
|
Ferrous iodine
|
|
|
|
|
B03AB
|
|
Iron trivalent, oral preparations
|
|
|
|
|
|
B03AB01
|
Ferric sodium citrate
|
|
|
|
|
|
B03AB02
|
Saccharated iron oxide
|
|
|
|
|
|
B03AB03
|
Sodium feredetate
|
|
|
|
|
|
B03AB04
|
Ferric hydroxide
|
|
|
|
|
|
B03AB05
|
Ferric oxide polymaltose complexes
|
|
|
|
|
|
B03AB06
|
Ferric citrate
|
|
|
|
|
|
B03AB07
|
Chondroitin sulfate-iron complex
|
|
|
|
|
|
B03AB08
|
Ferric acetyl transferrin
|
|
|
|
|
|
B03AB09
|
Ferric proteinsuccinylate
|
|
|
|
|
B03AC
|
|
Iron trivalent, parenteral preparations
|
|
|
|
|
|
B03AC01
|
Ferric oxide polymaltose complexes
|
|
|
|
|
|
B03AC02
|
Saccharated iron oxide
|
|
|
|
|
|
B03AC03
|
Iron-sorbitol-citric acid complex
|
|
|
|
|
|
B03AC05
|
Ferric sorbitol gluconic acid complex
|
|
|
|
|
|
B03AC06
|
Ferric oxide dextran complexes
|
|
|
|
|
|
B03AC07
|
Ferric sodium gluconate complex
|
|
|
|
|
B03AD
|
|
Iron in combination with folic acid
|
|
|
|
|
|
B03AD01
|
Ferrous amino acid complex
|
|
|
|
|
|
B03AD02
|
Ferrous fumarate
|
|
|
|
|
|
B03AD03
|
Ferrous sulfate
|
|
|
|
|
|
B03AD04
|
Ferric oxide polymaltose complexes
|
|
|
|
|
B03AE
|
|
Iron in other combinations
|
|
|
|
|
|
B03AE01
|
Iron, vitamin B12 and folic acid
|
|
|
|
|
|
B03AE02
|
Iron, multivitamins and folic acid
|
|
|
|
|
|
B03AE03
|
Iron and multivitamins
|
|
|
|
|
|
B03AE04
|
Iron, multivitamins and minerals
|
|
|
|
|
|
B03AE10
|
Various combinations
|
|
|
|
B03B
|
|
|
Vitamin B12 and folic acid
|
|
|
|
|
B03BA
|
|
Vitamin B12 (cyanocobalamin and analogues)
|
|
|
|
|
|
B03BA01
|
Cyanocobalamin
|
|
|
|
|
|
B03BA02
|
Cyanocobalamin tannin complex
|
|
|
|
|
|
B03BA03
|
Hydroxocobalamin
|
|
|
|
|
|
B03BA04
|
Cobamamide
|
|
|
|
|
|
B03BA05
|
Mecobalamin
|
|
|
|
|
|
B03BA51
|
Cyanocobalamin, combinations
|
|
|
|
|
|
B03BA53
|
Hydroxocobalamin, combinations
|
|
|
|
|
B03BB
|
|
Folic acid and derivatives
|
|
|
|
|
|
B03BB01
|
Folic acid
|
|
|
|
|
|
B03BB51
|
Folic acid, combinations
|
|
|
|
B03X
|
|
|
Other antianemic preparations
|
|
|
|
|
B03XA
|
|
Other antianemic preparations
|
|
|
|
|
|
B03XA01
|
Erythropoietin
|
|
|
|
|
|
B03XA02
|
Darbepoetin alfa
|
|
|
|
|
|
B03XA03
|
Methoxy polyethylene glycol-epoetin beta
|
|
|
|
|
|
B03XA04
|
Peginesatide
|
|
|
B05
|
|
|
|
Blood substitutes and perfusion solutions
|
|
|
|
B05A
|
|
|
Blood and related products
|
|
|
|
|
B05AA
|
|
Blood substitutes and plasma protein fractions
|
|
|
|
|
|
B05AA01
|
Serum albumin
|
|
|
|
|
|
B05AA02
|
Other plasma protein fractions
|
|
|
|
|
|
B05AA03
|
Fluorocarbon blood substitutes
|
|
|
|
|
|
B05AA05
|
Dextran
|
|
|
|
|
|
B05AA06
|
Gelatin agents
|
|
|
|
|
|
B05AA07
|
Hydroxyethylstarch
|
|
|
|
|
|
B05AA08
|
Hemoglobin crosfumaril
|
|
|
|
|
|
B05AA09
|
Hemoglobin raffimer
|
|
|
|
|
|
B05AA10
|
Hemoglobin glutamer (bovine)
|
|
|
|
|
B05AX
|
|
Other blood products
|
|
|
|
|
|
B05AX01
|
Erythrocytes
|
|
|
|
|
|
B05AX02
|
Thrombocytes
|
|
|
|
|
|
B05AX03
|
Blood plasma
|
|
|
|
|
|
B05AX04
|
Stem cells from umbilical cord blood
|
|
|
|
B05B
|
|
|
I.v. solutions
|
|
|
|
|
B05BA
|
|
Solutions for parenteral nutrition
|
|
|
|
|
|
B05BA01
|
Amino acids
|
|
|
|
|
|
B05BA02
|
Fat emulsions
|
|
|
|
|
|
B05BA03
|
Carbohydrates
|
|
|
|
|
|
B05BA04
|
Protein hydrolysates
|
|
|
|
|
|
B05BA10
|
Combinations
|
|
|
|
|
B05BB
|
|
Solutions affecting the electrolyte balance
|
|
|
|
|
|
B05BB01
|
Electrolytes
|
|
|
|
|
|
B05BB02
|
Electrolytes with carbohydrates
|
|
|
|
|
|
B05BB03
|
Trometamol
|
|
|
|
|
|
B05BB04
|
Electrolytes in combination with other drugs
|
|
|
|
|
B05BC
|
|
Solutions producing osmotic diuresis
|
|
|
|
|
|
B05BC01
|
Mannitol
|
|
|
|
|
|
B05BC02
|
Carbamide
|
|
|
|
B05C
|
|
|
Irrigating solutions
|
|
|
|
|
B05CA
|
|
Antiinfectives
|
|
|
|
|
|
B05CA01
|
Cetylpyridinium
|
|
|
|
|
|
B05CA02
|
Chlorhexidine
|
|
|
|
|
|
B05CA03
|
Nitrofural
|
|
|
|
|
|
B05CA04
|
Sulfamethizole
|
|
|
|
|
|
B05CA05
|
Taurolidine
|
|
|
|
|
|
B05CA06
|
Mandelic acid
|
|
|
|
|
|
B05CA07
|
Noxytiolin
|
|
|
|
|
|
B05CA08
|
Ethacridine lactate
|
|
|
|
|
|
B05CA09
|
Neomycin
|
|
|
|
|
|
B05CA10
|
Combinations
|
|
|
|
|
B05CB
|
|
Salt solutions
|
|
|
|
|
|
B05CB01
|
Sodium chloride
|
|
|
|
|
|
B05CB02
|
Sodium citrate
|
|
|
|
|
|
B05CB03
|
Magnesium citrate
|
|
|
|
|
|
B05CB04
|
Sodium bicarbonate
|
|
|
|
|
|
B05CB10
|
Combinations
|
|
|
|
|
B05CX
|
|
Other irrigating solutions
|
|
|
|
|
|
B05CX01
|
Glucose
|
|
|
|
|
|
B05CX02
|
Sorbitol
|
|
|
|
|
|
B05CX03
|
Glycine
|
|
|
|
|
|
B05CX04
|
Mannitol
|
|
|
|
|
|
B05CX10
|
Combinations
|
|
|
|
B05D
|
|
|
Peritoneal dialytics
|
|
|
|
|
B05DA
|
|
Isotonic solutions
|
|
|
|
|
|
|
empty
|
|
|
|
|
B05DB
|
|
Hypertonic solutions
|
|
|
|
|
|
|
empty
|
|
|
|
B05X
|
|
|
I.v. solution additives
|
|
|
|
|
B05XA
|
|
Electrolyte solutions
|
|
|
|
|
|
B05XA01
|
Potassium chloride
|
|
|
|
|
|
B05XA02
|
Sodium bicarbonate
|
|
|
|
|
|
B05XA03
|
Sodium chloride
|
|
|
|
|
|
B05XA04
|
Ammonium chloride
|
|
|
|
|
|
B05XA05
|
Magnesium sulfate
|
|
|
|
|
|
B05XA06
|
Potassium phosphate, including combinations with other potassium salts
|
|
|
|
|
|
B05XA07
|
Calcium chloride
|
|
|
|
|
|
B05XA08
|
Sodium acetate
|
|
|
|
|
|
B05XA09
|
Sodium phosphate
|
|
|
|
|
|
B05XA10
|
Magnesium phosphate
|
|
|
|
|
|
B05XA11
|
Magnesium chloride
|
|
|
|
|
|
B05XA12
|
Zinc chloride
|
|
|
|
|
|
B05XA13
|
Hydrochloric acid
|
|
|
|
|
|
B05XA14
|
Sodium glycerophosphate
|
|
|
|
|
|
B05XA15
|
Potassium lactate
|
|
|
|
|
|
B05XA16
|
Cardioplegia solutions
|
|
|
|
|
|
B05XA17
|
Potassium acetate
|
|
|
|
|
|
B05XA30
|
Combinations of electrolytes
|
|
|
|
|
|
B05XA31
|
Electrolytes in combination with other drugs
|
|
|
|
|
B05XB
|
|
Amino acids
|
|
|
|
|
|
B05XB01
|
Arginine hydrochloride
|
|
|
|
|
|
B05XB02
|
Alanyl glutamine
|
|
|
|
|
|
B05XB03
|
Lysine
|
|
|
|
|
B05XC
|
|
Vitamins
|
|
|
|
|
|
|
empty
|
|
|
|
|
B05XX
|
|
Other i.v. solution additives
|
|
|
|
|
|
B05XX02
|
Trometamol
|
|
|
|
B05Z
|
|
|
Hemodialytics and hemofiltrates
|
|
|
|
|
B05ZA
|
|
Hemodialytics, concentrates
|
|
|
|
|
|
|
empty
|
|
|
|
|
B05ZB
|
|
Hemofiltrates
|
|
|
|
|
|
|
empty
|
|
|
B06
|
|
|
|
Other hematological agents
|
|
|
|
B06A
|
|
|
Other hematological agents
|
|
|
|
|
B06AA
|
|
Enzymes
|
|
|
|
|
|
B06AA02
|
Fibrinolysin and desoxyribonuclease
|
|
|
|
|
|
B06AA03
|
Hyaluronidase
|
|
|
|
|
|
B06AA04
|
Chymotrypsin
|
|
|
|
|
|
B06AA07
|
Trypsin
|
|
|
|
|
|
B06AA10
|
Desoxyribonuclease
|
|
|
|
|
|
B06AA11
|
Bromelain
|
|
|
|
|
|
B06AA55
|
Streptokinase, combinations
|
|
|
|
|
B06AB
|
|
Other hematological products
|
|
|
|
|
|
B06AB01
|
Hematin
|
|
|
|
|
B06AC
|
|
Drugs used in hereditary angioedema
|
|
|
|
|
|
B06AC01
|
C1-inhibitor, plasma derived
|
|
|
|
|
|
B06AC02
|
Icatibant
|
|
|
|
|
|
B06AC03
|
Ecallantide
|
|
|
|
|
|
B06AC04
|
Conestat alfa
|
| C
|
|
|
|
|
Cardiovascular system
|
|
|
C01
|
|
|
|
Cardiac therapy
|
|
|
|
C01A
|
|
|
Cardiac glycosides
|
|
|
|
|
C01AA
|
|
Digitalis glycosides
|
|
|
|
|
|
C01AA01
|
Acetyldigitoxin
|
|
|
|
|
|
C01AA02
|
Acetyldigoxin
|
|
|
|
|
|
C01AA03
|
Digitalis leaves
|
|
|
|
|
|
C01AA04
|
Digitoxin
|
|
|
|
|
|
C01AA05
|
Digoxin
|
|
|
|
|
|
C01AA06
|
Lanatoside C
|
|
|
|
|
|
C01AA07
|
Deslanoside
|
|
|
|
|
|
C01AA08
|
Metildigoxin
|
|
|
|
|
|
C01AA09
|
Gitoformate
|
|
|
|
|
|
C01AA52
|
Acetyldigoxin, combinations
|
|
|
|
|
C01AB
|
|
Scilla glycosides
|
|
|
|
|
|
C01AB01
|
Proscillaridin
|
|
|
|
|
|
C01AB51
|
Proscillaridin, combinations
|
|
|
|
|
C01AC
|
|
Strophantus glycosides
|
|
|
|
|
|
C01AC01
|
G-strophanthin
|
|
|
|
|
|
C01AC03
|
Cymarin
|
|
|
|
|
C01AX
|
|
Other cardiac glycosides
|
|
|
|
|
|
C01AX02
|
Peruvoside
|
|
|
|
C01B
|
|
|
Antiarrhythmics, class I and III
|
|
|
|
|
C01BA
|
|
Antiarrhythmics, class Ia
|
|
|
|
|
|
C01BA01
|
Quinidine
|
|
|
|
|
|
C01BA02
|
Procainamide
|
|
|
|
|
|
C01BA03
|
Disopyramide
|
|
|
|
|
|
C01BA04
|
Sparteine
|
|
|
|
|
|
C01BA05
|
Ajmaline
|
|
|
|
|
|
C01BA08
|
Prajmaline
|
|
|
|
|
|
C01BA12
|
Lorajmine
|
|
|
|
|
|
C01BA51
|
Quinidine, combinations excluding psycholeptics
|
|
|
|
|
|
C01BA71
|
Quinidine, combinations with psycholeptics
|
|
|
|
|
C01BB
|
|
Antiarrhythmics, class Ib
|
|
|
|
|
|
C01BB01
|
Lidocaine
|
|
|
|
|
|
C01BB02
|
Mexiletine
|
|
|
|
|
|
C01BB03
|
Tocainide
|
|
|
|
|
|
C01BB04
|
Aprindine
|
|
|
|
|
C01BC
|
|
Antiarrhythmics, class Ic
|
|
|
|
|
|
C01BC03
|
Propafenone
|
|
|
|
|
|
C01BC04
|
Flecainide
|
|
|
|
|
|
C01BC07
|
Lorcainide
|
|
|
|
|
|
C01BC08
|
Encainide
|
|
|
|
|
|
C01BC09
|
Ethacizine
|
|
|
|
|
C01BD
|
|
Antiarrhythmics, class III
|
|
|
|
|
|
C01BD01
|
Amiodarone
|
|
|
|
|
|
C01BD02
|
Bretylium tosilate
|
|
|
|
|
|
C01BD03
|
Bunaftine
|
|
|
|
|
|
C01BD04
|
Dofetilide
|
|
|
|
|
|
C01BD05
|
Ibutilide
|
|
|
|
|
|
C01BD06
|
Tedisamil
|
|
|
|
|
|
C01BD07
|
Dronedarone
|
|
|
|
|
C01BG
|
|
Other antiarrhythmics, class I and III
|
|
|
|
|
|
C01BG01
|
Moracizine
|
|
|
|
|
|
C01BG07
|
Cibenzoline
|
|
|
|
|
|
C01BG11
|
Vernakalant
|
|
|
|
C01C
|
|
|
Cardiac stimulants excluding cardiac glycosides
|
|
|
|
|
C01CA
|
|
Adrenergic and dopaminergic agents
|
|
|
|
|
|
C01CA01
|
Etilefrine
|
|
|
|
|
|
C01CA02
|
Isoprenaline
|
|
|
|
|
|
C01CA03
|
Norepinephrine
|
|
|
|
|
|
C01CA04
|
Dopamine
|
|
|
|
|
|
C01CA05
|
Norfenefrine
|
|
|
|
|
|
C01CA06
|
Phenylephrine
|
|
|
|
|
|
C01CA07
|
Dobutamine
|
|
|
|
|
|
C01CA08
|
Oxedrine
|
|
|
|
|
|
C01CA09
|
Metaraminol
|
|
|
|
|
|
C01CA10
|
Methoxamine
|
|
|
|
|
|
C01CA11
|
Mephentermine
|
|
|
|
|
|
C01CA12
|
Dimetofrine
|
|
|
|
|
|
C01CA13
|
Prenalterol
|
|
|
|
|
|
C01CA14
|
Dopexamine
|
|
|
|
|
|
C01CA15
|
Gepefrine
|
|
|
|
|
|
C01CA16
|
Ibopamine
|
|
|
|
|
|
C01CA17
|
Midodrine
|
|
|
|
|
|
C01CA18
|
Octopamine
|
|
|
|
|
|
C01CA19
|
Fenoldopam
|
|
|
|
|
|
C01CA21
|
Cafedrine
|
|
|
|
|
|
C01CA22
|
Arbutamine
|
|
|
|
|
|
C01CA23
|
Theodrenaline
|
|
|
|
|
|
C01CA24
|
Epinephrine
|
|
|
|
|
|
C01CA25
|
Amezinium metilsulfate
|
|
|
|
|
|
C01CA26
|
Ephedrine
|
|
|
|
|
|
C01CA30
|
Combinations
|
|
|
|
|
|
C01CA51
|
Etilefrine, combinations
|
|
|
|
|
C01CE
|
|
Phosphodiesterase inhibitors
|
|
|
|
|
|
C01CE01
|
Amrinone
|
|
|
|
|
|
C01CE02
|
Milrinone
|
|
|
|
|
|
C01CE03
|
Enoximone
|
|
|
|
|
|
C01CE04
|
Bucladesine
|
|
|
|
|
C01CX
|
|
Other cardiac stimulants
|
|
|
|
|
|
C01CX06
|
Angiotensinamide
|
|
|
|
|
|
C01CX07
|
Xamoterol
|
|
|
|
|
|
C01CX08
|
Levosimendan
|
|
|
|
C01D
|
|
|
Vasodilators used in cardiac diseases
|
|
|
|
|
C01DA
|
|
Organic nitrates
|
|
|
|
|
|
C01DA02
|
Glyceryl trinitrate
|
|
|
|
|
|
C01DA04
|
Methylpropylpropanediol dinitrate
|
|
|
|
|
|
C01DA05
|
Pentaerithrityl tetranitrate
|
|
|
|
|
|
C01DA07
|
Propatylnitrate
|
|
|
|
|
|
C01DA08
|
Isosorbide dinitrate
|
|
|
|
|
|
C01DA09
|
Trolnitrate
|
|
|
|
|
|
C01DA13
|
Eritrityl tetranitrate
|
|
|
|
|
|
C01DA14
|
Isosorbide mononitrate
|
|
|
|
|
|
C01DA20
|
Organic nitrates in combination
|
|
|
|
|
|
C01DA38
|
Tenitramine
|
|
|
|
|
|
C01DA52
|
Glyceryl trinitrate, combinations
|
|
|
|
|
|
C01DA54
|
Methylpropylpropanediol dinitrate, combinations
|
|
|
|
|
|
C01DA55
|
Pentaerithrityl tetranitrate, combinations
|
|
|
|
|
|
C01DA57
|
Propatylnitrate, combinations
|
|
|
|
|
|
C01DA58
|
Isosorbide dinitrate, combinations
|
|
|
|
|
|
C01DA59
|
Trolnitrate, combinations
|
|
|
|
|
|
C01DA63
|
Eritrityl tetranitrate, combinations
|
|
|
|
|
|
C01DA70
|
Organic nitrates in combination with psycholeptics
|
|
|
|
|
C01DB
|
|
Quinolone vasodilators
|
|
|
|
|
|
C01DB01
|
Flosequinan
|
|
|
|
|
C01DX
|
|
Other vasodilators used in cardiac diseases
|
|
|
|
|
|
C01DX01
|
Itramin tosilate
|
|
|
|
|
|
C01DX02
|
Prenylamine
|
|
|
|
|
|
C01DX03
|
Oxyfedrine
|
|
|
|
|
|
C01DX04
|
Benziodarone
|
|
|
|
|
|
C01DX05
|
Carbocromen
|
|
|
|
|
|
C01DX06
|
Hexobendine
|
|
|
|
|
|
C01DX07
|
Etafenone
|
|
|
|
|
|
C01DX08
|
Heptaminol
|
|
|
|
|
|
C01DX09
|
Imolamine
|
|
|
|
|
|
C01DX10
|
Dilazep
|
|
|
|
|
|
C01DX11
|
Trapidil
|
|
|
|
|
|
C01DX12
|
Molsidomine
|
|
|
|
|
|
C01DX13
|
Efloxate
|
|
|
|
|
|
C01DX14
|
Cinepazet
|
|
|
|
|
|
C01DX15
|
Cloridarol
|
|
|
|
|
|
C01DX16
|
Nicorandil
|
|
|
|
|
|
C01DX18
|
Linsidomine
|
|
|
|
|
|
C01DX19
|
Nesiritide
|
|
|
|
|
|
C01DX51
|
Itramin tosilate, combinations
|
|
|
|
|
|
C01DX52
|
Prenylamine, combinations
|
|
|
|
|
|
C01DX53
|
Oxyfedrine, combinations
|
|
|
|
|
|
C01DX54
|
Benziodarone, combinations
|
|
|
|
C01E
|
|
|
Other cardiac preparations
|
|
|
|
|
C01EA
|
|
Prostaglandins
|
|
|
|
|
|
C01EA01
|
Alprostadil
|
|
|
|
|
C01EB
|
|
Other cardiac preparations
|
|
|
|
|
|
C01EB02
|
Camphor
|
|
|
|
|
|
C01EB03
|
Indometacin
|
|
|
|
|
|
C01EB04
|
Crataegus glycosides
|
|
|
|
|
|
C01EB05
|
Creatinolfosfate
|
|
|
|
|
|
C01EB06
|
Fosfocreatine
|
|
|
|
|
|
C01EB07
|
Fructose 1,6-diphosphate
|
|
|
|
|
|
C01EB09
|
Ubidecarenone
|
|
|
|
|
|
C01EB10
|
Adenosine
|
|
|
|
|
|
C01EB11
|
Tiracizine
|
|
|
|
|
|
C01EB13
|
Acadesine
|
|
|
|
|
|
C01EB15
|
Trimetazidine
|
|
|
|
|
|
C01EB16
|
Ibuprofen
|
|
|
|
|
|
C01EB17
|
Ivabradine
|
|
|
|
|
|
C01EB18
|
Ranolazine
|
|
|
|
|
|
C01EB21
|
Regadenoson
|
|
|
|
|
C01EX
|
|
Other cardiac combination products
|
|
|
|
|
|
|
empty
|
|
|
C02
|
|
|
|
Antihypertensives
|
|
|
|
C02A
|
|
|
Antiadrenergic agents, centrally acting
|
|
|
|
|
C02AA
|
|
Rauvolfia alkaloids
|
|
|
|
|
|
C02AA01
|
Rescinnamine
|
|
|
|
|
|
C02AA02
|
Reserpine
|
|
|
|
|
|
C02AA03
|
Combinations of rauwolfia alkaloids
|
|
|
|
|
|
C02AA04
|
Rauwolfia alkaloids, whole root
|
|
|
|
|
|
C02AA05
|
Deserpidine
|
|
|
|
|
|
C02AA06
|
Methoserpidine
|
|
|
|
|
|
C02AA07
|
Bietaserpine
|
|
|
|
|
|
C02AA52
|
Reserpine, combinations
|
|
|
|
|
|
C02AA53
|
Combinations of rauwolfia alkoloids, combinations
|
|
|
|
|
|
C02AA57
|
Bietaserpine, combinations
|
|
|
|
|
C02AB
|
|
Methyldopa
|
|
|
|
|
|
C02AB01
|
Methyldopa (levorotatory)
|
|
|
|
|
|
C02AB02
|
Methyldopa (racemic)
|
|
|
|
|
C02AC
|
|
Imidazoline receptor agonists
|
|
|
|
|
|
C02AC01
|
Clonidine
|
|
|
|
|
|
C02AC02
|
Guanfacine
|
|
|
|
|
|
C02AC04
|
Tolonidine
|
|
|
|
|
|
C02AC05
|
Moxonidine
|
|
|
|
|
|
C02AC06
|
Rilmenidine
|
|
|
|
C02B
|
|
|
Antiadrenergic agents, ganglion-blocking
|
|
|
|
|
C02BA
|
|
Sulfonium derivatives
|
|
|
|
|
|
C02BA01
|
Trimetaphan
|
|
|
|
|
C02BB
|
|
Secondary and tertiary amines
|
|
|
|
|
|
C02BB01
|
Mecamylamine
|
|
|
|
|
C02BC
|
|
Bisquaternary ammonium compounds
|
|
|
|
|
|
|
empty
|
|
|
|
C02C
|
|
|
Antiadrenergic agents, peripherally acting
|
|
|
|
|
C02CA
|
|
Alpha-adrenoreceptor antagonists
|
|
|
|
|
|
C02CA01
|
Prazosin
|
|
|
|
|
|
C02CA02
|
Indoramin
|
|
|
|
|
|
C02CA03
|
Trimazosin
|
|
|
|
|
|
C02CA04
|
Doxazosin
|
|
|
|
|
|
C02CA06
|
Urapidil
|
|
|
|
|
C02CC
|
|
Guanidine derivatives
|
|
|
|
|
|
C02CC01
|
Betanidine
|
|
|
|
|
|
C02CC02
|
Guanethidine
|
|
|
|
|
|
C02CC03
|
Guanoxan
|
|
|
|
|
|
C02CC04
|
Debrisoquine
|
|
|
|
|
|
C02CC05
|
Guanoclor
|
|
|
|
|
|
C02CC06
|
Guanazodine
|
|
|
|
|
|
C02CC07
|
Guanoxabenz
|
|
|
|
C02D
|
|
|
Arteriolar smooth muscle, agents acting on
|
|
|
|
|
C02DA
|
|
Thiazide derivatives
|
|
|
|
|
|
C02DA01
|
Diazoxide
|
|
|
|
|
C02DB
|
|
Hydrazinophthalazine derivatives
|
|
|
|
|
|
C02DB01
|
Dihydralazine
|
|
|
|
|
|
C02DB02
|
Hydralazine
|
|
|
|
|
|
C02DB03
|
Endralazine
|
|
|
|
|
|
C02DB04
|
Cadralazine
|
|
|
|
|
C02DC
|
|
Pyrimidine derivatives
|
|
|
|
|
|
C02DC01
|
Minoxidil
|
|
|
|
|
C02DD
|
|
Nitroferricyanide derivatives
|
|
|
|
|
|
C02DD01
|
Nitroprusside
|
|
|
|
|
C02DG
|
|
Guanidine derivatives
|
|
|
|
|
|
C02DG01
|
Pinacidil
|
|
|
|
C02K
|
|
|
Other antihypertensives
|
|
|
|
|
C02KA
|
|
Alkaloids, excluding rauwolfia
|
|
|
|
|
|
C02KA01
|
Veratrum
|
|
|
|
|
C02KB
|
|
Tyrosine hydroxylase inhibitors
|
|
|
|
|
|
C02KB01
|
Metirosine
|
|
|
|
|
C02KC
|
|
MAO inhibitors
|
|
|
|
|
|
C02KC01
|
Pargyline
|
|
|
|
|
C02KD
|
|
Serotonin antagonists
|
|
|
|
|
|
C02KD01
|
Ketanserin
|
|
|
|
|
C02KX
|
|
Other antihypertensives
|
|
|
|
|
|
C02KX01
|
Bosentan
|
|
|
|
|
|
C02KX02
|
Ambrisentan
|
|
|
|
|
|
C02KX03
|
Sitaxentan
|
|
|
|
C02L
|
|
|
Antihypertensives and diuretics in combination
|
|
|
|
|
C02LA
|
|
Rauwolfia alkaloids and diuretics in combination
|
|
|
|
|
|
C02LA01
|
Reserpine and diuretics
|
|
|
|
|
|
C02LA02
|
Rescinnamine and diuretics
|
|
|
|
|
|
C02LA03
|
Deserpidine and diuretics
|
|
|
|
|
|
C02LA04
|
Methoserpidine and diuretics
|
|
|
|
|
|
C02LA07
|
Bietaserpine and diuretics
|
|
|
|
|
|
C02LA08
|
Rauwolfia alkaloids, whole root and diuretics
|
|
|
|
|
|
C02LA09
|
Syrosingopine and diuretics
|
|
|
|
|
|
C02LA50
|
Combinations of rauwolfia alkaloids and diuretics including other combinations
|
|
|
|
|
|
C02LA51
|
Reserpine and diuretics, combinations with other drugs
|
|
|
|
|
|
C02LA52
|
Rescinnamine and diuretics, combinations with other drugs
|
|
|
|
|
|
C02LA71
|
Reserpine and diuretics, combinations with psycholeptics
|
|
|
|
|
C02LB
|
|
Methyldopa and diuretics in combination
|
|
|
|
|
|
C02LB01
|
Methyldopa (levorotatory) and diuretics
|
|
|
|
|
C02LC
|
|
Imidazoline receptor agonists in combination with diuretics
|
|
|
|
|
|
C02LC01
|
Clonidine and diuretics
|
|
|
|
|
|
C02LC05
|
Moxonidine and diuretics
|
|
|
|
|
|
C02LC51
|
Clonidine and diuretics, combinations with other drugs
|
|
|
|
|
C02LE
|
|
Alpha-adrenoreceptor antagonists and diuretics
|
|
|
|
|
|
C02LE01
|
Prazosin and diuretics
|
|
|
|
|
C02LF
|
|
Guanidine derivatives and diuretics
|
|
|
|
|
|
C02LF01
|
Guanethidine and diuretics
|
|
|
|
|
C02LG
|
|
Hydrazinophthalazine derivatives and diuretics
|
|
|
|
|
|
C02LG01
|
Dihydralazine and diuretics
|
|
|
|
|
|
C02LG02
|
Hydralazine and diuretics
|
|
|
|
|
|
C02LG03
|
Picodralazine and diuretics
|
|
|
|
|
|
C02LG51
|
Dihydralazine and diuretics, combinations with other drugs
|
|
|
|
|
|
C02LG73
|
Picodralazine and diuretics, combinations with psycholeptics
|
|
|
|
|
C02LK
|
|
Alkaloids, excluding rauwolfia, in combination with diuretics
|
|
|
|
|
|
C02LK01
|
Veratrum and diuretics
|
|
|
|
|
C02LL
|
|
MAO inhibitors and diuretics
|
|
|
|
|
|
C02LL01
|
Pargyline and diuretics
|
|
|
|
C02LN
|
|
|
Serotonin antagonists and diuretics
|
|
|
|
|
|
|
empty
|
|
|
|
C02LX
|
|
|
Other antihypertensives and diuretics
|
|
|
|
|
|
C02LX01
|
Pinacidil and diuretics
|
|
|
|
C02N
|
|
|
Combinations of antihypertensives in ATC-group C02
|
|
|
|
|
|
|
empty
|
|
|
C03
|
|
|
|
Diuretics
|
|
|
|
C03A
|
|
|
Low-ceiling diuretics, thiazides
|
|
|
|
|
C03AA
|
|
Thiazides, plain
|
|
|
|
|
|
C03AA01
|
Bendroflumethiazide
|
|
|
|
|
|
C03AA02
|
Hydroflumethiazide
|
|
|
|
|
|
C03AA03
|
Hydrochlorothiazide
|
|
|
|
|
|
C03AA04
|
Chlorothiazide
|
|
|
|
|
|
C03AA05
|
Polythiazide
|
|
|
|
|
|
C03AA06
|
Trichlormethiazide
|
|
|
|
|
|
C03AA07
|
Cyclopenthiazide
|
|
|
|
|
|
C03AA08
|
Methyclothiazide
|
|
|
|
|
|
C03AA09
|
Cyclothiazide
|
|
|
|
|
|
C03AA13
|
Mebutizide
|
|
|
|
|
C03AB
|
|
Thiazides and potassium in combination
|
|
|
|
|
|
C03AB01
|
Bendroflumethiazide and potassium
|
|
|
|
|
|
C03AB02
|
Hydroflumethiazide and potassium
|
|
|
|
|
|
C03AB03
|
Hydrochlorothiazide and potassium
|
|
|
|
|
|
C03AB04
|
Chlorothiazide and potassium
|
|
|
|
|
|
C03AB05
|
Polythiazide and potassium
|
|
|
|
|
|
C03AB06
|
Trichlormethiazide and potassium
|
|
|
|
|
|
C03AB07
|
Cyclopenthiazide and potassium
|
|
|
|
|
|
C03AB08
|
Methyclothiazide and potassium
|
|
|
|
|
|
C03AB09
|
Cyclothiazide and potassium
|
|
|
|
|
C03AH
|
|
Thiazides, combinations with psycholeptics and/or analgesics
|
|
|
|
|
|
C03AH01
|
Chlorothiazide, combinations
|
|
|
|
|
|
C03AH02
|
Hydroflumethiazide, combinations
|
|
|
|
|
C03AX
|
|
Thiazides, combinations with other drugs
|
|
|
|
|
|
C03AX01
|
Hydrochlorothiazide, combinations
|
|
|
|
C03B
|
|
|
Low-ceiling diuretics, excluding thiazides
|
|
|
|
|
C03BA
|
|
Sulfonamides, plain
|
|
|
|
|
|
C03BA02
|
Quinethazone
|
|
|
|
|
|
C03BA03
|
Clopamide
|
|
|
|
|
|
C03BA04
|
Chlortalidone
|
|
|
|
|
|
C03BA05
|
Mefruside
|
|
|
|
|
|
C03BA07
|
Clofenamide
|
|
|
|
|
|
C03BA08
|
Metolazone
|
|
|
|
|
|
C03BA09
|
Meticrane
|
|
|
|
|
|
C03BA10
|
Xipamide
|
|
|
|
|
|
C03BA11
|
Indapamide
|
|
|
|
|
|
C03BA12
|
Clorexolone
|
|
|
|
|
|
C03BA13
|
Fenquizone
|
|
|
|
|
|
C03BA82
|
Clorexolone, combinations with psycholeptics
|
|
|
|
|
C03BB
|
|
Sulfonamides and potassium in combination
|
|
|
|
|
|
C03BB02
|
Quinethazone and potassium
|
|
|
|
|
|
C03BB03
|
Clopamide and potassium
|
|
|
|
|
|
C03BB04
|
Chlortalidone and potassium
|
|
|
|
|
|
C03BB05
|
Mefruside and potassium
|
|
|
|
|
|
C03BB07
|
Clofenamide and potassium
|
|
|
|
|
C03BC
|
|
Mercurial diuretics
|
|
|
|
|
|
C03BC01
|
Mersalyl
|
|
|
|
|
C03BD
|
|
Xanthine derivatives
|
|
|
|
|
|
C03BD01
|
Theobromine
|
|
|
|
|
C03BK
|
|
Sulfonamides, combinations with other drugs
|
|
|
|
|
|
|
empty
|
|
|
|
|
C03BX
|
|
Other low-ceiling diuretics
|
|
|
|
|
|
C03BX03
|
Cicletanine
|
|
|
|
C03C
|
|
|
High-ceiling diuretics
|
|
|
|
|
C03CA
|
|
Sulfonamides, plain
|
|
|
|
|
|
C03CA01
|
Furosemide
|
|
|
|
|
|
C03CA02
|
Bumetanide
|
|
|
|
|
|
C03CA03
|
Piretanide
|
|
|
|
|
|
C03CA04
|
Torasemide
|
|
|
|
|
C03CB
|
|
Sulfonamides and potassium in combination
|
|
|
|
|
|
C03CB01
|
Furosemide and potassium
|
|
|
|
|
|
C03CB02
|
Bumetanide and potassium
|
|
|
|
|
C03CC
|
|
Aryloxyacetic acid derivatives
|
|
|
|
|
|
C03CC01
|
Etacrynic acid
|
|
|
|
|
|
C03CC02
|
Tienilic acid
|
|
|
|
|
C03CD
|
|
Pyrazolone derivatives
|
|
|
|
|
|
C03CD01
|
Muzolimine
|
|
|
|
|
C03CX
|
|
Other high-ceiling diuretics
|
|
|
|
|
|
C03CX01
|
Etozolin
|
|
|
|
C03D
|
|
|
Potassium-sparing agents
|
|
|
|
|
C03DA
|
|
Aldosterone antagonists
|
|
|
|
|
|
C03DA01
|
Spironolactone
|
|
|
|
|
|
C03DA02
|
Potassium canrenoate
|
|
|
|
|
|
C03DA03
|
Canrenone
|
|
|
|
|
|
C03DA04
|
Eplerenone
|
|
|
|
|
C03DB
|
|
Other potassium-sparing agents
|
|
|
|
|
|
C03DB01
|
Amiloride
|
|
|
|
|
|
C03DB02
|
Triamterene
|
|
|
|
C03E
|
|
|
Diuretics and potassium-sparing agents in combination
|
|
|
|
|
C03EA
|
|
Low-ceiling diuretics and potassium-sparing agents
|
|
|
|
|
|
C03EA01
|
Hydrochlorothiazide and potassium-sparing agents
|
|
|
|
|
|
C03EA02
|
Trichlormethiazide and potassium-sparing agents
|
|
|
|
|
|
C03EA03
|
Epitizide and potassium-sparing agents
|
|
|
|
|
|
C03EA04
|
Altizide and potassium-sparing agents
|
|
|
|
|
|
C03EA05
|
Mebutizide and potassium-sparing agents
|
|
|
|
|
|
C03EA06
|
Chlortalidone and potassium-sparing agents
|
|
|
|
|
|
C03EA07
|
Cyclopenthiazide and potassium-sparing agents
|
|
|
|
|
|
C03EA12
|
Metolazone and potassium-sparing agents
|
|
|
|
|
|
C03EA13
|
Bendroflumethiazide and potassium-sparing agents
|
|
|
|
|
|
C03EA14
|
Butizide and potassium-sparing agents
|
|
|
|
|
C03EB
|
|
High-ceiling diuretics and potassium-sparing agents
|
|
|
|
|
|
C03EB01
|
Furosemide and potassium-sparing agents
|
|
|
|
|
|
C03EB02
|
Bumetanide and potassium-sparing agents
|
|
|
|
C03X
|
|
|
Other diuretics
|
|
|
|
|
C03XA
|
|
Vasopressin antagonists
|
|
|
|
|
|
C03XA01
|
Tolvaptan
|
|
|
|
|
|
C03XA02
|
Conivaptan
|
|
|
C04
|
|
|
|
Peripheral vasodilators
|
|
|
|
C04A
|
|
|
Peripheral vasodilators
|
|
|
|
|
C04AA
|
|
2-amino-1-phenylethanol derivatives
|
|
|
|
|
|
C04AA01
|
Isoxsuprine
|
|
|
|
|
|
C04AA02
|
Buphenine
|
|
|
|
|
|
C04AA31
|
Bamethan
|
|
|
|
|
C04AB
|
|
Imidazoline derivatives
|
|
|
|
|
|
C04AB01
|
Phentolamine
|
|
|
|
|
|
C04AB02
|
Tolazoline
|
|
|
|
|
C04AC
|
|
Nicotinic acid and derivatives
|
|
|
|
|
|
C04AC01
|
Nicotinic acid
|
|
|
|
|
|
C04AC02
|
Nicotinyl alcohol (pyridylcarbinol)
|
|
|
|
|
|
C04AC03
|
Inositol nicotinate
|
|
|
|
|
|
C04AC07
|
Ciclonicate
|
|
|
|
|
C04AD
|
|
Purine derivatives
|
|
|
|
|
|
C04AD01
|
Pentifylline
|
|
|
|
|
|
C04AD02
|
Xantinol nicotinate
|
|
|
|
|
|
C04AD03
|
Pentoxifylline
|
|
|
|
|
|
C04AD04
|
Etofylline nicotinate
|
|
|
|
|
C04AE
|
|
Ergot alkaloids
|
|
|
|
|
|
C04AE01
|
Ergoloid mesylates
|
|
|
|
|
|
C04AE02
|
Nicergoline
|
|
|
|
|
|
C04AE04
|
Dihydroergocristine
|
|
|
|
|
|
C04AE51
|
Ergoloid mesylates, combinations
|
|
|
|
|
|
C04AE54
|
Dihydroergocristine, combinations
|
|
|
|
|
C04AF
|
|
Enzymes
|
|
|
|
|
|
C04AF01
|
Kallidinogenase
|
|
|
|
|
C04AX
|
|
Other peripheral vasodilators
|
|
|
|
|
|
C04AX01
|
Cyclandelate
|
|
|
|
|
|
C04AX02
|
Phenoxybenzamine
|
|
|
|
|
|
C04AX07
|
Vincamine
|
|
|
|
|
|
C04AX10
|
Moxisylyte
|
|
|
|
|
|
C04AX11
|
Bencyclane
|
|
|
|
|
|
C04AX17
|
Vinburnine
|
|
|
|
|
|
C04AX19
|
Sulcotidil
|
|
|
|
|
|
C04AX20
|
Buflomedil
|
|
|
|
|
|
C04AX21
|
Naftidrofuryl
|
|
|
|
|
|
C04AX23
|
Butalamine
|
|
|
|
|
|
C04AX24
|
Visnadine
|
|
|
|
|
|
C04AX26
|
Cetiedil
|
|
|
|
|
|
C04AX27
|
Cinepazide
|
|
|
|
|
|
C04AX28
|
Ifenprodil
|
|
|
|
|
|
C04AX30
|
Azapetine
|
|
|
|
|
|
C04AX32
|
Fasudil
|
|
|
C05
|
|
|
|
Vasoprotectives
|
|
|
|
C05A
|
|
|
Agents for treatment of hemorrhoids and anal fissures for topical use
|
|
|
|
|
C05AA
|
|
Corticosteroids
|
|
|
|
|
|
C05AA01
|
Hydrocortisone
|
|
|
|
|
|
C05AA04
|
Prednisolone
|
|
|
|
|
|
C05AA05
|
Betamethasone
|
|
|
|
|
|
C05AA06
|
Fluorometholone
|
|
|
|
|
|
C05AA08
|
Fluocortolone
|
|
|
|
|
|
C05AA09
|
Dexamethasone
|
|
|
|
|
|
C05AA10
|
Fluocinolone acetonide
|
|
|
|
|
|
C05AA11
|
Fluocinonide
|
|
|
|
|
|
C05AA12
|
Triamcinolone
|
|
|
|
|
C05AB
|
|
Antibiotics
|
|
|
|
|
|
|
empty
|
|
|
|
|
C05AD
|
|
Local anesthetics
|
|
|
|
|
|
C05AD01
|
Lidocaine
|
|
|
|
|
|
C05AD02
|
Tetracaine
|
|
|
|
|
|
C05AD03
|
Benzocaine
|
|
|
|
|
|
C05AD04
|
Cinchocaine
|
|
|
|
|
|
C05AD05
|
Procaine
|
|
|
|
|
|
C05AD06
|
Oxetacaine
|
|
|
|
|
|
C05AD07
|
Pramocaine
|
|
|
|
|
C05AE
|
|
Muscle relaxants
|
|
|
|
|
|
C05AE01
|
Glyceryl trinitrate
|
|
|
|
|
|
C05AE02
|
Isosorbide dinitrate
|
|
|
|
|
C05AX
|
|
Other agents for treatment of hemorrhoids and anal fissures for topical use
|
|
|
|
|
|
C05AX01
|
Aluminium preparations
|
|
|
|
|
|
C05AX02
|
Bismuth preparations, combinations
|
|
|
|
|
|
C05AX03
|
Other preparations, combinations
|
|
|
|
|
|
C05AX04
|
Zinc preparations
|
|
|
|
|
|
C05AX05
|
Tribenoside
|
|
|
|
C05B
|
|
|
Antivaricose therapy
|
|
|
|
|
C05BA
|
|
Heparins or heparinoids for topical use
|
|
|
|
|
|
C05BA01
|
Organo-heparinoid
|
|
|
|
|
|
C05BA02
|
Sodium apolate
|
|
|
|
|
|
C05BA03
|
Heparin
|
|
|
|
|
|
C05BA04
|
Pentosan polysulfate sodium
|
|
|
|
|
|
C05BA51
|
Heparinoid, combinations
|
|
|
|
|
|
C05BA53
|
Heparin, combinations
|
|
|
|
|
C05BB
|
|
Sclerosing agents for local injection
|
|
|
|
|
|
C05BB01
|
Monoethanolamine oleate
|
|
|
|
|
|
C05BB02
|
Polidocanol
|
|
|
|
|
|
C05BB03
|
Invert sugar
|
|
|
|
|
|
C05BB04
|
Sodium tetradecyl sulfate
|
|
|
|
|
|
C05BB05
|
Phenol
|
|
|
|
|
|
C05BB56
|
Glucose, combinations
|
|
|
|
|
C05BX
|
|
Other sclerosing agents
|
|
|
|
|
|
C05BX01
|
Calcium dobesilate
|
|
|
|
|
|
C05BX51
|
Calcium dobesilate, combinations
|
|
|
|
C05C
|
|
|
Capillary stabilising agents
|
|
|
|
|
C05CA
|
|
Bioflavonoids
|
|
|
|
|
|
C05CA01
|
Rutoside
|
|
|
|
|
|
C05CA02
|
Monoxerutin
|
|
|
|
|
|
C05CA03
|
Diosmin
|
|
|
|
|
|
C05CA04
|
Troxerutin
|
|
|
|
|
|
C05CA05
|
Hidrosmin
|
|
|
|
|
|
C05CA51
|
Rutoside, combinations
|
|
|
|
|
|
C05CA53
|
Diosmin, combinations
|
|
|
|
|
|
C05CA54
|
Troxerutin, combinations
|
|
|
|
|
C05CX
|
|
Other capillary stabilising agents
|
|
|
|
|
|
C05CX01
|
Tribenoside
|
|
|
|
|
|
C05CX02
|
Naftazone
|
|
|
|
|
|
C05CX03
|
Hippocastani semen
|
|
|
C07
|
|
|
|
Beta blocking agents
|
|
|
|
C07A
|
|
|
Beta blocking agents
|
|
|
|
|
C07AA
|
|
Beta blocking agents, non-selective
|
|
|
|
|
|
C07AA01
|
Alprenolol
|
|
|
|
|
|
C07AA02
|
Oxprenolol
|
|
|
|
|
|
C07AA03
|
Pindolol
|
|
|
|
|
|
C07AA05
|
Propranolol
|
|
|
|
|
|
C07AA06
|
Timolol
|
|
|
|
|
|
C07AA07
|
Sotalol
|
|
|
|
|
|
C07AA12
|
Nadolol
|
|
|
|
|
|
C07AA14
|
Mepindolol
|
|
|
|
|
|
C07AA15
|
Carteolol
|
|
|
|
|
|
C07AA16
|
Tertatolol
|
|
|
|
|
|
C07AA17
|
Bopindolol
|
|
|
|
|
|
C07AA19
|
Bupranolol
|
|
|
|
|
|
C07AA23
|
Penbutolol
|
|
|
|
|
|
C07AA27
|
Cloranolol
|
|
|
|
|
|
C07AA57
|
Sotalol, combinations
|
|
|
|
|
C07AB
|
|
Beta blocking agents, selective
|
|
|
|
|
|
C07AB01
|
Practolol
|
|
|
|
|
|
C07AB02
|
Metoprolol
|
|
|
|
|
|
C07AB03
|
Atenolol
|
|
|
|
|
|
C07AB04
|
Acebutolol
|
|
|
|
|
|
C07AB05
|
Betaxolol
|
|
|
|
|
|
C07AB06
|
Bevantolol
|
|
|
|
|
|
C07AB07
|
Bisoprolol
|
|
|
|
|
|
C07AB08
|
Celiprolol
|
|
|
|
|
|
C07AB09
|
Esmolol
|
|
|
|
|
|
C07AB10
|
Epanolol
|
|
|
|
|
|
C07AB11
|
S-atenolol
|
|
|
|
|
|
C07AB12
|
Nebivolol
|
|
|
|
|
|
C07AB13
|
Talinolol
|
|
|
|
|
|
C07AB52
|
Metoprolol, combinations
|
|
|
|
|
|
C07AB57
|
Bisoprolol, combinations
|
|
|
|
|
C07AG
|
|
Alpha and beta blocking agents
|
|
|
|
|
|
C07AG01
|
Labetalol
|
|
|
|
|
|
C07AG02
|
Carvedilol
|
|
|
|
C07B
|
|
|
Beta blocking agents and thiazides
|
|
|
|
|
C07BA
|
|
Beta blocking agents, non-selective, and thiazides
|
|
|
|
|
|
C07BA02
|
Oxprenolol and thiazides
|
|
|
|
|
|
C07BA05
|
Propranolol and thiazides
|
|
|
|
|
|
C07BA06
|
Timolol and thiazides
|
|
|
|
|
|
C07BA07
|
Sotalol and thiazides
|
|
|
|
|
|
C07BA12
|
Nadolol and thiazides
|
|
|
|
|
|
C07BA68
|
Metipranolol and thiazides, combinations
|
|
|
|
|
C07BB
|
|
Beta blocking agents, selective, and thiazides
|
|
|
|
|
|
C07BB02
|
Metoprolol and thiazides
|
|
|
|
|
|
C07BB03
|
Atenolol and thiazides
|
|
|
|
|
|
C07BB04
|
Acebutolol and thiazides
|
|
|
|
|
|
C07BB06
|
Bevantolol and thiazides
|
|
|
|
|
|
C07BB07
|
Bisoprolol and thiazides
|
|
|
|
|
|
C07BB12
|
Nebivolol and thiazides
|
|
|
|
|
|
C07BB52
|
Metoprolol and thiazides, combinations
|
|
|
|
|
C07BG
|
|
Alpha and beta blocking agents and thiazides
|
|
|
|
|
|
C07BG01
|
Labetalol and thiazides
|
|
|
|
C07C
|
|
|
Beta blocking agents and other diuretics
|
|
|
|
|
C07CA
|
|
Beta blocking agents, non-selective, and other diuretics
|
|
|
|
|
|
C07CA02
|
Oxprenolol and other diuretics
|
|
|
|
|
|
C07CA03
|
Pindolol and other diuretics
|
|
|
|
|
|
C07CA17
|
Bopindolol and other diuretics
|
|
|
|
|
|
C07CA23
|
Penbutolol and other diuretics
|
|
|
|
|
C07CB
|
|
Beta blocking agents, selective, and other diuretics
|
|
|
|
|
|
C07CB02
|
Metoprolol and other diuretics
|
|
|
|
|
|
C07CB03
|
Atenolol and other diuretics
|
|
|
|
|
|
C07CB53
|
Atenolol and other diuretics, combinations
|
|
|
|
|
C07CG
|
|
Alpha and beta blocking agents and other diuretics
|
|
|
|
|
|
C07CG01
|
Labetalol and other diuretics
|
|
|
|
C07D
|
|
|
Beta blocking agents, thiazides and other diuretics
|
|
|
|
|
C07DA
|
|
Beta blocking agents, non-selective, thiazides and other diuretics
|
|
|
|
|
|
C07DA06
|
Timolol, thiazides and other diuretics
|
|
|
|
|
C07DB
|
|
Beta blocking agents, selective, thiazides and other diuretics
|
|
|
|
|
|
C07DB01
|
Atenolol, thiazides and other diuretics
|
|
|
|
C07E
|
|
|
Beta blocking agents and vasodilators
|
|
|
|
|
C07EA
|
|
Beta blocking agents, non-selective, and vasodilators
|
|
|
|
|
|
|
empty
|
|
|
|
|
C07EB
|
|
Beta blocking agents, selective, and vasodilators
|
|
|
|
|
|
|
empty
|
|
|
|
C07F
|
|
|
Beta blocking agents and other antihypertensives
|
|
|
|
|
C07FA
|
|
Beta blocking agents, non-selective, and other antihypertensives
|
|
|
|
|
|
C07FA05
|
Propranolol and other antihypertensives
|
|
|
|
|
C07FB
|
|
Beta blocking agents, selective, and other antihypertensives
|
|
|
|
|
|
C07FB02
|
Metoprolol and other antihypertensives
|
|
|
|
|
|
C07FB03
|
Atenolol and other antihypertensives
|
|
|
|
|
|
C07FB07
|
Bisoprolol and other antihypertensives
|
|
|
C08
|
|
|
|
Calcium channel blockers
|
|
|
|
C08C
|
|
|
Selective calcium channel blockers with mainly vascular effects
|
|
|
|
|
C08CA
|
|
Dihydropyridine derivatives
|
|
|
|
|
|
C08CA01
|
Amlodipine
|
|
|
|
|
|
C08CA02
|
Felodipine
|
|
|
|
|
|
C08CA03
|
Isradipine
|
|
|
|
|
|
C08CA04
|
Nicardipine
|
|
|
|
|
|
C08CA05
|
Nifedipine
|
|
|
|
|
|
C08CA06
|
Nimodipine
|
|
|
|
|
|
C08CA07
|
Nisoldipine
|
|
|
|
|
|
C08CA08
|
Nitrendipine
|
|
|
|
|
|
C08CA09
|
Lacidipine
|
|
|
|
|
|
C08CA10
|
Nilvadipine
|
|
|
|
|
|
C08CA11
|
Manidipine
|
|
|
|
|
|
C08CA12
|
Barnidipine
|
|
|
|
|
|
C08CA13
|
Lercanidipine
|
|
|
|
|
|
C08CA14
|
Cilnidipine
|
|
|
|
|
|
C08CA15
|
Benidipine
|
|
|
|
|
|
C08CA16
|
Clevidipine
|
|
|
|
|
|
C08CA55
|
Nifedipine, combinations
|
|
|
|
|
C08CX
|
|
Other selective calcium channel blockers with mainly vascular effects
|
|
|
|
|
|
C08CX01
|
Mibefradil
|
|
|
|
C08D
|
|
|
Selective calcium channel blockers with direct cardiac effects
|
|
|
|
|
C08DA
|
|
Phenylalkylamine derivatives
|
|
|
|
|
|
C08DA01
|
Verapamil
|
|
|
|
|
|
C08DA02
|
Gallopamil
|
|
|
|
|
|
C08DA51
|
Verapamil, combinations
|
|
|
|
|
C08DB
|
|
Benzothiazepine derivatives
|
|
|
|
|
|
C08DB01
|
Diltiazem
|
|
|
|
C08E
|
|
|
Non-selective calcium channel blockers
|
|
|
|
|
C08EA
|
|
Phenylalkylamine derivatives
|
|
|
|
|
|
C08EA01
|
Fendiline
|
|
|
|
|
|
C08EA02
|
Bepridil
|
|
|
|
|
C08EX
|
|
Other non-selective calcium channel blockers
|
|
|
|
|
|
C08EX01
|
Lidoflazine
|
|
|
|
|
|
C08EX02
|
Perhexiline
|
|
|
|
C08G
|
|
|
Calcium channel blockers and diuretics
|
|
|
|
|
C08GA
|
|
Calcium channel blockers and diuretics
|
|
|
|
|
|
C08GA01
|
Nifedipine and diuretics
|
|
|
C09
|
|
|
|
Agents acting on the renin-angiotensin system
|
|
|
|
C09A
|
|
|
ACE inhibitors, plain
|
|
|
|
|
C09AA
|
|
ACE inhibitors, plain
|
|
|
|
|
|
C09AA01
|
Captopril
|
|
|
|
|
|
C09AA02
|
Enalapril
|
|
|
|
|
|
C09AA03
|
Lisinopril
|
|
|
|
|
|
C09AA04
|
Perindopril
|
|
|
|
|
|
C09AA05
|
Ramipril
|
|
|
|
|
|
C09AA06
|
Quinaprl
|
|
|
|
|
|
C09AA07
|
Benazepril
|
|
|
|
|
|
C09AA08
|
Cilazapril
|
|
|
|
|
|
C09AA09
|
Fosinopril
|
|
|
|
|
|
C09AA10
|
Trandolapril
|
|
|
|
|
|
C09AA11
|
Spirapril
|
|
|
|
|
|
C09AA12
|
Delapril
|
|
|
|
|
|
C09AA13
|
Moexipril
|
|
|
|
|
|
C09AA14
|
Temocapril
|
|
|
|
|
|
C09AA15
|
Zofenopril
|
|
|
|
|
|
C09AA16
|
Imidapril
|
|
|
|
C09B
|
|
|
ACE inhibitors, combinations
|
|
|
|
|
C09BA
|
|
ACE inhibitors and diuretics
|
|
|
|
|
|
C09BA01
|
Captopril and diuretics
|
|
|
|
|
|
C09BA02
|
Enalapril and diuretics
|
|
|
|
|
|
C09BA03
|
Lisinopril and diuretics
|
|
|
|
|
|
C09BA04
|
Perindopril and diuretics
|
|
|
|
|
|
C09BA05
|
Ramipril and diuretics
|
|
|
|
|
|
C09BA06
|
Quinapril and diuretics
|
|
|
|
|
|
C09BA07
|
Benazepril and diuretics
|
|
|
|
|
|
C09BA08
|
Cilazapril and diuretics
|
|
|
|
|
|
C09BA09
|
Fosinopril and diuretics
|
|
|
|
|
|
C09BA12
|
Delapril and diuretics
|
|
|
|
|
|
C09BA13
|
Moexipril and diuretics
|
|
|
|
|
|
C09BA15
|
Zofenopril and diuretics
|
|
|
|
|
C09BB
|
|
ACE inhibitors and calcium channel blockers
|
|
|
|
|
|
C09BB02
|
Enalapril and lercanidipine
|
|
|
|
|
|
C09BB03
|
Lisinopril and amlodipine
|
|
|
|
|
|
C09BB04
|
Perindopril and amlodipine
|
|
|
|
|
|
C09BB05
|
Ramipril and felodipine
|
|
|
|
|
|
C09BB06
|
Enalapril and nitrendipine
|
|
|
|
|
|
C09BB07
|
Ramipril and amlodipine
|
|
|
|
|
|
C09BB10
|
Trandolapril and verapamil
|
|
|
|
|
|
C09BB12
|
Delapril and manidipine
|
|
|
|
C09C
|
|
|
Angiotensin II antagonists, plain
|
|
|
|
|
C09CA
|
|
Angiotensin II antagonists, plain
|
|
|
|
|
|
C09CA01
|
Losartan
|
|
|
|
|
|
C09CA02
|
Eprosartan
|
|
|
|
|
|
C09CA03
|
Valsartan
|
|
|
|
|
|
C09CA04
|
Irbesartan
|
|
|
|
|
|
C09CA05
|
Tasosartan
|
|
|
|
|
|
C09CA06
|
Candesartan
|
|
|
|
|
|
C09CA07
|
Telmisartan
|
|
|
|
|
|
C09CA08
|
Olmesartan medoxomil
|
|
|
|
|
|
C09CA09
|
Azilsartan medoxomil
|
|
|
|
C09D
|
|
|
Angiotensin II antagonists, combinations
|
|
|
|
|
C09DA
|
|
Angiotensin II antagonists and diuretics
|
|
|
|
|
|
C09DA01
|
Losartan and diuretics
|
|
|
|
|
|
C09DA02
|
Eprosartan and diuretics
|
|
|
|
|
|
C09DA03
|
Valsartan and diuretics
|
|
|
|
|
|
C09DA04
|
Irbesartan and diuretics
|
|
|
|
|
|
C09DA06
|
Candesartan and diuretics
|
|
|
|
|
|
C09DA07
|
Telmisartan and diuretics
|
|
|
|
|
|
C09DA08
|
Olmesartan medoxomil and diuretics
|
|
|
|
|
C09DB
|
|
Angiotensin II antagonists and calcium channel blockers
|
|
|
|
|
|
C09DB01
|
Valsartan and amlodipine
|
|
|
|
|
|
C09DB02
|
Olmesartan medoxomil and amlodipine
|
|
|
|
|
|
C09DB04
|
Telmisartan and amlodipine
|
|
|
|
|
|
C09DB05
|
Irbesartan and amlodipine
|
|
|
|
|
|
C09DB06
|
Losartan and amlodipine
|
|
|
|
|
C09DX
|
|
Angiotensin II antagonists, other combinations
|
|
|
|
C09X
|
|
|
Other agents acting on the renin-angiotensin system
|
|
|
|
|
|
C09DX01
|
Valsartan, amlodipine and hydrochlorothiazide
|
|
|
|
|
|
C09DX02
|
Valsartan and aliskiren
|
|
|
|
|
|
C09DX03
|
Olmesartan medoxomil, amlodipine and hydrochlorothiazide
|
|
|
|
|
C09XA
|
|
Renin-inhibitors
|
|
|
|
|
|
C09XA01
|
Remikiren
|
|
|
|
|
|
C09XA02
|
Aliskiren
|
|
|
|
|
|
C09XA52
|
Aliskiren and hydrochlorothiazide
|
|
|
|
|
|
C09XA53
|
Aliskiren and amlodipine
|
|
|
|
|
|
C09XA54
|
Aliskiren, amlodipine and hydrochlorothiazide
|
|
|
C10
|
|
|
|
Lipid modifying agents
|
|
|
|
C10A
|
|
|
Lipid modifying agents, plain
|
|
|
|
|
C10AA
|
|
HMG CoA reductase inhibitors
|
|
|
|
|
|
C10AA01
|
Simvastatin
|
|
|
|
|
|
C10AA02
|
Lovastatin
|
|
|
|
|
|
C10AA03
|
Pravastatin
|
|
|
|
|
|
C10AA04
|
Fluvastatin
|
|
|
|
|
|
C10AA05
|
Atorvastatin
|
|
|
|
|
|
C10AA06
|
Cerivastatin
|
|
|
|
|
|
C10AA07
|
Rosuvastatin
|
|
|
|
|
|
C10AA08
|
Pitavastatin
|
|
|
|
|
C10AB
|
|
Fibrates
|
|
|
|
|
|
C10AB01
|
Clofibrate
|
|
|
|
|
|
C10AB02
|
Bezafibrate
|
|
|
|
|
|
C10AB03
|
Aluminium clofibrate
|
|
|
|
|
|
C10AB04
|
Gemfibrozil
|
|
|
|
|
|
C10AB05
|
Fenofibrate
|
|
|
|
|
|
C10AB06
|
Simfibrate
|
|
|
|
|
|
C10AB07
|
Ronifibrate
|
|
|
|
|
|
C10AB08
|
Ciprofibrate
|
|
|
|
|
|
C10AB09
|
Etofibrate
|
|
|
|
|
|
C10AB10
|
Clofibride
|
|
|
|
|
|
C10AB11
|
Choline fenofibrate
|
|
|
|
|
C10AC
|
|
Bile acid sequestrants
|
|
|
|
|
|
C10AC01
|
Colestyramine
|
|
|
|
|
|
C10AC02
|
Colestipol
|
|
|
|
|
|
C10AC03
|
Colextran
|
|
|
|
|
|
C10AC04
|
Colesevelam
|
|
|
|
|
C10AD
|
|
Nicotinic acid and derivatives
|
|
|
|
|
|
C10AD01
|
Niceritrol
|
|
|
|
|
|
C10AD02
|
Nicotinic acid
|
|
|
|
|
|
C10AD03
|
Nicofuranose
|
|
|
|
|
|
C10AD04
|
Aluminium nicotinate
|
|
|
|
|
|
C10AD05
|
Nicotinyl alcohol (pyridylcarbinol)
|
|
|
|
|
|
C10AD06
|
Acipimox
|
|
|
|
|
|
C10AD52
|
Nicotinic acid, combinations
|
|
|
|
|
C10AX
|
|
Other lipid modifying agents
|
|
|
|
|
|
C10AX01
|
Dextrothyroxine
|
|
|
|
|
|
C10AX02
|
Probucol
|
|
|
|
|
|
C10AX03
|
Tiadenol
|
|
|
|
|
|
C10AX05
|
Meglutol
|
|
|
|
|
|
C10AX06
|
Omega-3-triglycerides
|
|
|
|
|
|
C10AX07
|
Magnesium pyridoxal 5-phosphate glutamate
|
|
|
|
|
|
C10AX08
|
Policosanol
|
|
|
|
|
|
C10AX09
|
Ezetimibe
|
|
|
|
|
|
C10AX10
|
Alipogene tiparvovec
|
|
|
|
|
|
C10AX11
|
Mipomersen
|
|
|
|
|
|
C10AX12
|
Lomitapide
|
|
|
|
C10B
|
|
|
Lipid modifying agents, combinations
|
|
|
|
|
C10BA
|
|
HMG CoA reductase inhibitors in combination with other lipid modifying agents
|
|
|
|
|
|
C10BA01
|
Lovastatin and nicotinic acid
|
|
|
|
|
|
C10BA02
|
Simvastatin and ezetimibe
|
|
|
|
|
|
C10BA03
|
Pravastatin and fenofibrate
|
|
|
|
|
|
C10BA04
|
Simvastatin and fenofibrate
|
|
|
|
|
|
C10BA05
|
Atorvastatin and ezetimibe
|
|
|
|
|
C10BX
|
|
HMG CoA reductase inhibitors, other combinations
|
|
|
|
|
|
C10BX01
|
Simvastatin and acetylsalicylic acid
|
|
|
|
|
|
C10BX02
|
Pravastatin and acetylsalicylic acid
|
|
|
|
|
|
C10BX03
|
Atorvastatin and amlodipine
|
|
|
|
|
|
C10BX04
|
Simvastatin, acetylsalicylic acid and ramipril
|
| D
|
|
|
|
|
Dermatologicals
|
|
|
D01
|
|
|
|
Antifungals for dermatological use
|
|
|
|
D01A
|
|
|
Antifungals for topical use
|
|
|
|
|
D01AA
|
|
Antibiotics
|
|
|
|
|
|
D01AA01
|
Nystatin
|
|
|
|
|
|
D01AA02
|
Natamycin
|
|
|
|
|
|
D01AA03
|
Hachimycin
|
|
|
|
|
|
D01AA04
|
Pecilocin
|
|
|
|
|
|
D01AA06
|
Mepartricin
|
|
|
|
|
|
D01AA07
|
Pyrrolnitrin
|
|
|
|
|
|
D01AA08
|
Griseofulvin
|
|
|
|
|
|
D01AA20
|
Combinations
|
|
|
|
|
D01AC
|
|
Imidazole and triazole derivatives
|
|
|
|
|
|
D01AC01
|
Clotrimazole
|
|
|
|
|
|
D01AC02
|
Miconazole
|
|
|
|
|
|
D01AC03
|
Econazole
|
|
|
|
|
|
D01AC04
|
Clomidazole
|
|
|
|
|
|
D01AC05
|
Isoconazole
|
|
|
|
|
|
D01AC06
|
Tiabendazole
|
|
|
|
|
|
D01AC07
|
Tioconazole
|
|
|
|
|
|
D01AC08
|
Ketoconazole
|
|
|
|
|
|
D01AC09
|
Sulconazole
|
|
|
|
|
|
D01AC10
|
Bifonazole
|
|
|
|
|
|
D01AC11
|
Oxiconazole
|
|
|
|
|
|
D01AC12
|
Fenticonazole
|
|
|
|
|
|
D01AC13
|
Omoconazole
|
|
|
|
|
|
D01AC14
|
Sertaconazole
|
|
|
|
|
|
D01AC15
|
Fluconazole
|
|
|
|
|
|
D01AC16
|
Flutrimazole
|
|
|
|
|
|
D01AC17
|
Eberconazole
|
|
|
|
|
|
D01AC20
|
Combinations
|
|
|
|
|
|
D01AC52
|
Miconazole, combinations
|
|
|
|
|
|
D01AC60
|
Bifonazole, combinations
|
|
|
|
|
D01AE
|
|
Other antifungals for topical use
|
|
|
|
|
|
D01AE01
|
Bromochlorosalicylanilide
|
|
|
|
|
|
D01AE02
|
Methylrosaniline
|
|
|
|
|
|
D01AE03
|
Tribromometacresol
|
|
|
|
|
|
D01AE04
|
Undecylenic acid
|
|
|
|
|
|
D01AE05
|
Polynoxylin
|
|
|
|
|
|
D01AE06
|
2-(4-chlorphenoxy)-ethanol
|
|
|
|
|
|
D01AE07
|
Chlorphenesin
|
|
|
|
|
|
D01AE08
|
Ticlatone
|
|
|
|
|
|
D01AE09
|
Sulbentine
|
|
|
|
|
|
D01AE10
|
Ethyl hydroxybenzoate
|
|
|
|
|
|
D01AE11
|
Haloprogin
|
|
|
|
|
|
D01AE12
|
Salicylic acid
|
|
|
|
|
|
D01AE13
|
Selenium sulfide
|
|
|
|
|
|
D01AE14
|
Ciclopirox
|
|
|
|
|
|
D01AE15
|
Terbinafine
|
|
|
|
|
|
D01AE16
|
Amorolfine
|
|
|
|
|
|
D01AE17
|
Dimazole
|
|
|
|
|
|
D01AE18
|
Tolnaftate
|
|
|
|
|
|
D01AE19
|
Tolciclate
|
|
|
|
|
|
D01AE20
|
Combinations
|
|
|
|
|
|
D01AE21
|
Flucytosine
|
|
|
|
|
|
D01AE22
|
Naftifine
|
|
|
|
|
|
D01AE23
|
Butenafine
|
|
|
|
|
|
D01AE54
|
Undecylenic acid, combinations
|
|
|
|
D01B
|
|
|
Antifungals for systemic use
|
|
|
|
|
D01BA
|
|
Antifungals for systemic use
|
|
|
|
|
|
D01BA01
|
Griseofulvin
|
|
|
|
|
|
D01BA02
|
Terbinafine
|
|
|
D02
|
|
|
|
Emollients and protectives
|
|
|
|
D02A
|
|
|
Emollients and protectives
|
|
|
|
|
D02AA
|
|
Silicone products
|
|
|
|
|
|
|
empty
|
|
|
|
|
D02AB
|
|
Zinc products
|
|
|
|
|
|
|
empty
|
|
|
|
|
D02AC
|
|
Soft paraffin and fat products
|
|
|
|
|
|
|
empty
|
|
|
|
|
D02AD
|
|
Liquid plasters
|
|
|
|
|
|
|
empty
|
|
|
|
|
D02AE
|
|
Carbamide products
|
|
|
|
|
|
D02AE01
|
Carbamide
|
|
|
|
|
|
D02AE51
|
Carbamide, combinations
|
|
|
|
|
D02AF
|
|
Salicylic acid preparations
|
|
|
|
|
|
|
empty
|
|
|
|
|
D02AX
|
|
Other emollients and protectives
|
|
|
|
|
|
|
empty
|
|
|
|
D02B
|
|
|
Protectives against UV-radiation
|
|
|
|
|
D02BA
|
|
Protectives against UV-radiation for topical use
|
|
|
|
|
|
D02BA01
|
Aminobenzoic acid
|
|
|
|
|
|
D02BA02
|
Octinoxate
|
|
|
|
|
D02BB
|
|
Protectives against UV-radiation for systemic use
|
|
|
|
|
|
D02BB01
|
Betacarotene
|
|
|
D03
|
|
|
|
Preparations for treatment of wounds and ulcers
|
|
|
|
D03A
|
|
|
Cicatrizants
|
|
|
|
|
D03AA
|
|
Cod-liver oil ointments
|
|
|
|
|
|
|
empty
|
|
|
|
|
D03AX
|
|
Other cicatrizants
|
|
|
|
|
|
D03AX01
|
Cadexomer iodine
|
|
|
|
|
|
D03AX02
|
Dextranomer
|
|
|
|
|
|
D03AX03
|
Dexpanthenol
|
|
|
|
|
|
D03AX04
|
Calcium pantothenate
|
|
|
|
|
|
D03AX05
|
Hyaluronic acid
|
|
|
|
|
|
D03AX06
|
Becaplermin
|
|
|
|
|
|
D03AX09
|
Crilanomer
|
|
|
|
|
|
D03AX10
|
Enoxolone
|
|
|
|
|
|
D03AX11
|
Sodium chlorite (tetrachlorodecaoxide)
|
|
|
|
D03B
|
|
|
Enzymes
|
|
|
|
|
D03BA
|
|
Proteolytic enzymes
|
|
|
|
|
|
D03BA01
|
Trypsin
|
|
|
|
|
|
D03BA02
|
Clostridiopeptidase
|
|
|
|
|
|
D03BA52
|
Clostridiopeptidase, combinations
|
|
|
D04
|
|
|
|
Antipruritics, including antihistamines, anesthetics, etc
|
|
|
|
D04A
|
|
|
Antipruritics, including antihistamines, anesthetics, etc.
|
|
|
|
|
D04AA
|
|
Antihistamines for topical use
|
|
|
|
|
|
D04AA01
|
Thonzylamine
|
|
|
|
|
|
D04AA02
|
Mepyramine
|
|
|
|
|
|
D04AA03
|
Thenalidine
|
|
|
|
|
|
D04AA04
|
Tripelennamine
|
|
|
|
|
|
D04AA09
|
Chloropyramine
|
|
|
|
|
|
D04AA10
|
Promethazine
|
|
|
|
|
|
D04AA12
|
Tolpropamine
|
|
|
|
|
|
D04AA13
|
Dimetindene
|
|
|
|
|
|
D04AA14
|
Clemastine
|
|
|
|
|
|
D04AA15
|
Bamipine
|
|
|
|
|
|
D04AA22
|
Isothipendyl
|
|
|
|
|
|
D04AA32
|
Diphenhydramine
|
|
|
|
|
|
D04AA33
|
Diphenhydramine methylbromide
|
|
|
|
|
|
D04AA34
|
Chlorphenoxamine
|
|
|
|
|
D04AB
|
|
Anesthetics for topical use
|
|
|
|
|
|
D04AB01
|
Lidocaine
|
|
|
|
|
|
D04AB02
|
Cinchocaine
|
|
|
|
|
|
D04AB03
|
Oxybuprocaine
|
|
|
|
|
|
D04AB04
|
Benzocaine
|
|
|
|
|
|
D04AB05
|
Quinisocaine
|
|
|
|
|
|
D04AB06
|
Tetracaine
|
|
|
|
|
|
D04AB07
|
Pramocaine
|
|
|
|
|
D04AX
|
|
Other antipruritics
|
|
|
|
|
|
|
empty
|
|
|
D05
|
|
|
|
Antipsoriatics
|
|
|
|
D05A
|
|
|
Antipsoriatics for topical use
|
|
|
|
|
D05AA
|
|
Tars
|
|
|
|
|
|
|
empty
|
|
|
|
|
D05AC
|
|
Antracen derivatives
|
|
|
|
|
|
D05AC01
|
Dithranol
|
|
|
|
|
|
D05AC51
|
Dithranol, combinations
|
|
|
|
|
D05AD
|
|
Psoralens for topical use
|
|
|
|
|
|
D05AD01
|
Trioxysalen
|
|
|
|
|
|
D05AD02
|
Methoxsalen
|
|
|
|
|
D05AX
|
|
Other antipsoriatics for topical use
|
|
|
|
|
|
D05AX01
|
Fumaric acid
|
|
|
|
|
|
D05AX02
|
Calcipotriol
|
|
|
|
|
|
D05AX03
|
Calcitriol
|
|
|
|
|
|
D05AX04
|
Tacalcitol
|
|
|
|
|
|
D05AX05
|
Tazarotene
|
|
|
|
|
|
D05AX52
|
Calcipotriol, combinations
|
|
|
|
D05B
|
|
|
Antipsoriatics for systemic use
|
|
|
|
|
D05BA
|
|
Psoralens for systemic use
|
|
|
|
|
|
D05BA01
|
Trioxysalen
|
|
|
|
|
|
D05BA02
|
Methoxsalen
|
|
|
|
|
|
D05BA03
|
Bergapten
|
|
|
|
|
D05BB
|
|
Retinoids for treatment of psoriasis
|
|
|
|
|
|
D05BB01
|
Etretinate
|
|
|
|
|
|
D05BB02
|
Acitretin
|
|
|
|
|
D05BX
|
|
Other antipsoriatics for systemic use
|
|
|
|
|
|
D05BX51
|
Fumaric acid derivatives, combinations
|
|
|
D06
|
|
|
|
Antibiotics and chemotherapeutics for dermatological use
|
|
|
|
D06A
|
|
|
Antibiotics for topical use
|
|
|
|
|
D06AA
|
|
Tetracycline and derivatives
|
|
|
|
|
|
D06AA01
|
Demeclocycline
|
|
|
|
|
|
D06AA02
|
Chlortetracycline
|
|
|
|
|
|
D06AA03
|
Oxytetracycline
|
|
|
|
|
|
D06AA04
|
Tetracycline
|
|
|
|
|
D06AX
|
|
Other antibiotics for topical use
|
|
|
|
|
|
D06AX01
|
Fusidic acid
|
|
|
|
|
|
D06AX02
|
Chloramphenicol
|
|
|
|
|
|
D06AX04
|
Neomycin
|
|
|
|
|
|
D06AX05
|
Bacitracin
|
|
|
|
|
|
D06AX07
|
Gentamicin
|
|
|
|
|
|
D06AX08
|
Tyrothricin
|
|
|
|
|
|
D06AX09
|
Mupirocin
|
|
|
|
|
|
D06AX10
|
Virginiamycin
|
|
|
|
|
|
D06AX11
|
Rifaximin
|
|
|
|
|
|
D06AX12
|
Amikacin
|
|
|
|
|
|
D06AX13
|
Retapamulin
|
|
|
|
D06B
|
|
|
Chemotherapeutics for topical use
|
|
|
|
|
D06BA
|
|
Sulfonamides
|
|
|
|
|
|
D06BA01
|
Silver sulfadiazine
|
|
|
|
|
|
D06BA02
|
Sulfathiazole
|
|
|
|
|
|
D06BA03
|
Mafenide
|
|
|
|
|
|
D06BA04
|
Sulfamethizole
|
|
|
|
|
|
D06BA05
|
Sulfanilamide
|
|
|
|
|
|
D06BA06
|
Sulfamerazine
|
|
|
|
|
D06BB
|
|
Antivirals
|
|
|
|
|
|
D06BB01
|
Idoxuridine
|
|
|
|
|
|
D06BB02
|
Tromantadine
|
|
|
|
|
|
D06BB03
|
Aciclovir
|
|
|
|
|
|
D06BB04
|
Podophyllotoxin
|
|
|
|
|
|
D06BB05
|
Inosine
|
|
|
|
|
|
D06BB06
|
Penciclovir
|
|
|
|
|
|
D06BB07
|
Lysozyme
|
|
|
|
|
|
D06BB08
|
Ibacitabine
|
|
|
|
|
|
D06BB09
|
Edoxudine
|
|
|
|
|
|
D06BB10
|
Imiquimod
|
|
|
|
|
|
D06BB11
|
Docosanol
|
|
|
|
|
|
D06BB12
|
Sinecatechins
|
|
|
|
|
|
D06BB53
|
Aciclovir, combinations
|
|
|
|
|
D06BX
|
|
Other chemotherapeutics
|
|
|
|
|
|
D06BX01
|
Metronidazole
|
|
|
|
|
|
D06BX02
|
Ingenol mebutate
|
|
|
|
D06C
|
|
|
Antibiotics and chemotherapeutics, combinations
|
|
|
|
|
|
|
empty
|
|
|
D07
|
|
|
|
Corticosteroids, dermatological preparations
|
|
|
|
D07A
|
|
|
Corticosteroids, plain
|
|
|
|
|
D07AA
|
|
Corticosteroids, weak (group I)
|
|
|
|
|
|
D07AA01
|
Methylprednisolone
|
|
|
|
|
|
D07AA02
|
Hydrocortisone
|
|
|
|
|
|
D07AA03
|
Prednisolone
|
|
|
|
|
D07AB
|
|
Corticosteroids, moderately potent (group II)
|
|
|
|
|
|
D07AB01
|
Clobetasone
|
|
|
|
|
|
D07AB02
|
Hydrocortisone butyrate
|
|
|
|
|
|
D07AB03
|
Flumetasone
|
|
|
|
|
|
D07AB04
|
Fluocortin
|
|
|
|
|
|
D07AB05
|
Fluperolone
|
|
|
|
|
|
D07AB06
|
Fluorometholone
|
|
|
|
|
|
D07AB07
|
Fluprednidene
|
|
|
|
|
|
D07AB08
|
Desonide
|
|
|
|
|
|
D07AB09
|
Triamcinolone
|
|
|
|
|
|
D07AB10
|
Alclometasone
|
|
|
|
|
|
D07AB11
|
Hydrocortisone buteprate
|
|
|
|
|
|
D07AB19
|
Dexamethasone
|
|
|
|
|
|
D07AB21
|
Clocortolone
|
|
|
|
|
|
D07AB30
|
Combinations of corticosteroids
|
|
|
|
|
D07AC
|
|
Corticosteroids, potent (group III)
|
|
|
|
|
|
D07AC01
|
Betamethasone
|
|
|
|
|
|
D07AC02
|
Fluclorolone
|
|
|
|
|
|
D07AC03
|
Desoximetasone
|
|
|
|
|
|
D07AC04
|
Fluocinolone acetonide
|
|
|
|
|
|
D07AC05
|
Fluocortolone
|
|
|
|
|
|
D07AC06
|
Diflucortolone
|
|
|
|
|
|
D07AC07
|
Fludroxycortide
|
|
|
|
|
|
D07AC08
|
Fluocinonide
|
|
|
|
|
|
D07AC09
|
Budesonide
|
|
|
|
|
|
D07AC10
|
Diflorasone
|
|
|
|
|
|
D07AC11
|
Amcinonide
|
|
|
|
|
|
D07AC12
|
Halometasone
|
|
|
|
|
|
D07AC13
|
Mometasone furoate
|
|
|
|
|
|
D07AC14
|
Methylprednisolone aceponate
|
|
|
|
|
|
D07AC15
|
Beclometasone
|
|
|
|
|
|
D07AC16
|
Hydrocortisone aceponate
|
|
|
|
|
|
D07AC17
|
Fluticasone
|
|
|
|
|
|
D07AC18
|
Prednicarbate
|
|
|
|
|
|
D07AC19
|
Difluprednate
|
|
|
|
|
|
D07AC21
|
Ulobetasol
|
|
|
|
|
D07AD
|
|
Corticosteroids, very potent (group IV)
|
|
|
|
|
|
D07AD01
|
Clobetasol
|
|
|
|
|
|
D07AD02
|
Halcinonide
|
|
|
|
D07B
|
|
|
Corticosteroids, combinations with antiseptics
|
|
|
|
|
D07BA
|
|
Corticosteroids, weak, combinations with antiseptics
|
|
|
|
|
|
D07BA01
|
Prednisolone and antiseptics
|
|
|
|
|
|
D07BA04
|
Hydrocortisone and antiseptics
|
|
|
|
|
D07BB
|
|
Corticosteroids, moderately potent, combinations with antiseptics
|
|
|
|
|
|
D07BB01
|
Flumetasone and antiseptics
|
|
|
|
|
|
D07BB02
|
Desonide and antiseptics
|
|
|
|
|
|
D07BB03
|
Triamcinolone and antiseptics
|
|
|
|
|
|
D07BB04
|
Hydrocortisone butyrate and antiseptics
|
|
|
|
|
D07BC
|
|
Corticosteroids, potent, combinations with antiseptics
|
|
|
|
|
|
D07BC01
|
Betamethasone and antiseptics
|
|
|
|
|
|
D07BC02
|
Fluocinolone acetonide and antiseptics
|
|
|
|
|
|
D07BC03
|
Fluocortolone and antiseptics
|
|
|
|
|
|
D07BC04
|
Diflucortolone and antiseptics
|
|
|
|
|
D07BD
|
|
Corticosteroids, very potent, combinations with antiseptics
|
|
|
|
|
|
|
empty
|
|
|
|
D07C
|
|
|
Corticosteroids, combinations with antibiotics
|
|
|
|
|
D07CA
|
|
Corticosteroids, weak, combinations with antibiotics
|
|
|
|
|
|
D07CA01
|
Hydrocortisone and antibiotics
|
|
|
|
|
|
D07CA02
|
Methylprednisolone and antibiotics
|
|
|
|
|
|
D07CA03
|
Prednisolone and antibiotics
|
|
|
|
|
D07CB
|
|
Corticosteroids, moderately potent, combinations with antibiotics
|
|
|
|
|
|
D07CB01
|
Triamcinolone and antibiotics
|
|
|
|
|
|
D07CB02
|
Fluprednidene and antibiotics
|
|
|
|
|
|
D07CB03
|
Fluorometholone and antibiotics
|
|
|
|
|
|
D07CB04
|
Dexamethasone and antibiotics
|
|
|
|
|
|
D07CB05
|
Flumetasone and antibiotics
|
|
|
|
|
D07CC
|
|
Corticosteroids, potent, combinations with antibiotics
|
|
|
|
|
|
D07CC01
|
Betamethasone and antibiotics
|
|
|
|
|
|
D07CC02
|
Fluocinolone acetonide and antibiotics
|
|
|
|
|
|
D07CC03
|
Fludroxycortide and antibiotics
|
|
|
|
|
|
D07CC04
|
Beclometasone and antibiotics
|
|
|
|
|
|
D07CC05
|
Fluocinonide and antibiotics
|
|
|
|
|
|
D07CC06
|
Fluocortolone and antibiotics
|
|
|
|
|
D07CD
|
|
Corticosteroids, very potent, combinations with antibiotics
|
|
|
|
|
|
D07CD01
|
Clobetasol and antibiotics
|
|
|
|
D07X
|
|
|
Corticosteroids, other combinations
|
|
|
|
|
D07XA
|
|
Corticosteroids, weak, other combinations
|
|
|
|
|
|
D07XA01
|
Hydrocortisone
|
|
|
|
|
|
D07XA02
|
Prednisolone
|
|
|
|
|
D07XB
|
|
Corticosteroids, moderately potent, other combinations
|
|
|
|
|
|
D07XB01
|
Flumetasone
|
|
|
|
|
|
D07XB02
|
Triamcinolone
|
|
|
|
|
|
D07XB03
|
Fluprednidene
|
|
|
|
|
|
D07XB04
|
Fluorometholone
|
|
|
|
|
|
D07XB05
|
Dexamethasone
|
|
|
|
|
|
D07XB30
|
Combinations of corticosteroids
|
|
|
|
|
D07XC
|
|
Corticosteroids, potent, other combinations
|
|
|
|
|
|
D07XC01
|
Betamethasone
|
|
|
|
|
|
D07XC02
|
Desoximetasone
|
|
|
|
|
|
D07XC03
|
Mometasone
|
|
|
|
|
|
D07XC04
|
Diflucortolone
|
|
|
|
|
D07XD
|
|
Corticosteroids, very potent, other combinations
|
|
|
|
|
|
|
empty
|
|
|
D08
|
|
|
|
Antiseptics and disinfectants
|
|
|
|
D08A
|
|
|
Antiseptics and disinfectants
|
|
|
|
|
D08AA
|
|
Acridine derivatives
|
|
|
|
|
|
D08AA01
|
Ethacridine lactate
|
|
|
|
|
|
D08AA02
|
Aminoacridine
|
|
|
|
|
|
D08AA03
|
Euflavine
|
|
|
|
|
D08AB
|
|
Aluminium agents
|
|
|
|
|
|
|
empty
|
|
|
|
|
D08AC
|
|
Biguanides and amidines
|
|
|
|
|
|
D08AC01
|
Dibrompropamidine
|
|
|
|
|
|
D08AC02
|
Chlorhexidine
|
|
|
|
|
|
D08AC03
|
Propamidine
|
|
|
|
|
|
D08AC04
|
Hexamidine
|
|
|
|
|
|
D08AC05
|
Polihexanide
|
|
|
|
|
|
D08AC52
|
Chlorhexidine, combinations
|
|
|
|
|
D08AD
|
|
Boric acid products
|
|
|
|
|
|
|
empty
|
|
|
|
|
D08AE
|
|
Phenol and derivatives
|
|
|
|
|
|
D08AE01
|
Hexachlorophene
|
|
|
|
|
|
D08AE02
|
Policresulen
|
|
|
|
|
|
D08AE03
|
Phenol
|
|
|
|
|
|
D08AE04
|
Triclosan
|
|
|
|
|
|
D08AE05
|
Chloroxylenol
|
|
|
|
|
|
D08AE06
|
Biphenylol
|
|
|
|
|
D08AF
|
|
Nitrofuran derivatives
|
|
|
|
|
|
D08AF01
|
Nitrofural
|
|
|
|
|
D08AG
|
|
Iodine products
|
|
|
|
|
|
D08AG01
|
Iodine/octylphenoxypolyglycolether
|
|
|
|
|
|
D08AG02
|
Povidone-iodine
|
|
|
|
|
|
D08AG03
|
Iodine
|
|
|
|
|
|
D08AG04
|
Diiodohydroxypropane
|
|
|
|
|
D08AH
|
|
Quinoline derivatives
|
|
|
|
|
|
D08AH01
|
Dequalinium
|
|
|
|
|
|
D08AH02
|
Chlorquinaldol
|
|
|
|
|
|
D08AH03
|
Oxyquinoline
|
|
|
|
|
|
D08AH30
|
Clioquinol
|
|
|
|
|
D08AJ
|
|
Quaternary ammonium compounds
|
|
|
|
|
|
D08AJ01
|
Benzalkonium
|
|
|
|
|
|
D08AJ02
|
Cetrimonium
|
|
|
|
|
|
D08AJ03
|
Cetylpyridinium
|
|
|
|
|
|
D08AJ04
|
Cetrimide
|
|
|
|
|
|
D08AJ05
|
Benzoxonium chloride
|
|
|
|
|
|
D08AJ06
|
Didecyldimethylammonium chloride
|
|
|
|
|
|
D08AJ08
|
Benzethonium chloride
|
|
|
|
|
|
D08AJ57
|
Octenidine, combinations
|
|
|
|
|
|
D08AJ58
|
Benzethonium chloride, combinations
|
|
|
|
|
|
D08AJ59
|
Dodeclonium bromide, combinations
|
|
|
|
|
D08AK
|
|
Mercurial products
|
|
|
|
|
|
D08AK01
|
Mercuric amidochloride
|
|
|
|
|
|
D08AK02
|
Phenylmercuric borate
|
|
|
|
|
|
D08AK03
|
Mercuric chloride
|
|
|
|
|
|
D08AK04
|
Mercurochrome
|
|
|
|
|
|
D08AK05
|
Mercury, metallic
|
|
|
|
|
|
D08AK06
|
Thiomersal
|
|
|
|
|
|
D08AK30
|
Mercuric iodide
|
|
|
|
|
D08AL
|
|
Silver compounds
|
|
|
|
|
|
D08AL01
|
Silver nitrate
|
|
|
|
|
|
D08AL30
|
Silver
|
|
|
|
|
D08AX
|
|
Other antiseptics and disinfectants
|
|
|
|
|
|
D08AX01
|
Hydrogen peroxide
|
|
|
|
|
|
D08AX02
|
Eosin
|
|
|
|
|
|
D08AX03
|
Propanol
|
|
|
|
|
|
D08AX04
|
Tosylchloramide sodium
|
|
|
|
|
|
D08AX05
|
Isopropanol
|
|
|
|
|
|
D08AX06
|
Potassium permanganate
|
|
|
|
|
|
D08AX07
|
Sodium hypochlorite
|
|
|
|
|
|
D08AX08
|
Ethanol
|
|
|
|
|
|
D08AX53
|
Propanol, combinations
|
|
|
D09
|
|
|
|
Medicated dressings
|
|
|
|
D09A
|
|
|
Medicated dressings
|
|
|
|
|
D09AA
|
|
Medicated dressings with antiinfectives
|
|
|
|
|
|
D09AA01
|
Framycetin
|
|
|
|
|
|
D09AA02
|
Fusidic acid
|
|
|
|
|
|
D09AA03
|
Nitrofural
|
|
|
|
|
|
D09AA04
|
Phenylmercuric nitrate
|
|
|
|
|
|
D09AA05
|
Benzododecinium
|
|
|
|
|
|
D09AA06
|
Triclosan
|
|
|
|
|
|
D09AA07
|
Cetylpyridinium
|
|
|
|
|
|
D09AA08
|
Aluminium chlorohydrate
|
|
|
|
|
|
D09AA09
|
Povidone-iodine
|
|
|
|
|
|
D09AA10
|
Clioquinol
|
|
|
|
|
|
D09AA11
|
Benzalkonium
|
|
|
|
|
|
D09AA12
|
Chlorhexidine
|
|
|
|
|
|
D09AA13
|
Iodoform
|
|
|
|
|
D09AB
|
|
Zinc bandages
|
|
|
|
|
|
D09AB01
|
Zinc bandage without supplements
|
|
|
|
|
|
D09AB02
|
Zinc bandage with supplements
|
|
|
|
|
D09AX
|
|
Soft paraffin dressings
|
|
|
|
|
|
|
empty
|
|
|
D10
|
|
|
|
Anti-acne preparations
|
|
|
|
D10A
|
|
|
Anti-acne preparations for topical use
|
|
|
|
|
D10AA
|
|
Corticosteroids, combinations for treatment of acne
|
|
|
|
|
|
D10AA01
|
Fluorometholone
|
|
|
|
|
|
D10AA02
|
Methylprednisolone
|
|
|
|
|
|
D10AA03
|
Dexamethasone
|
|
|
|
|
D10AB
|
|
Preparations containing sulfur
|
|
|
|
|
|
D10AB01
|
Bithionol
|
|
|
|
|
|
D10AB02
|
Sulfur
|
|
|
|
|
|
D10AB03
|
Tioxolone
|
|
|
|
|
|
D10AB05
|
Mesulfen
|
|
|
|
|
D10AD
|
|
Retinoids for topical use in acne
|
|
|
|
|
|
D10AD01
|
Tretinoin
|
|
|
|
|
|
D10AD02
|
Retinol
|
|
|
|
|
|
D10AD03
|
Adapalene
|
|
|
|
|
|
D10AD04
|
Isotretinoin
|
|
|
|
|
|
D10AD05
|
Motretinide
|
|
|
|
|
|
D10AD51
|
Tretinoin, combinations
|
|
|
|
|
|
D10AD53
|
Adapalene, combinations
|
|
|
|
|
|
D10AD54
|
Isotretinoin, combinations
|
|
|
|
|
D10AE
|
|
Peroxides
|
|
|
|
|
|
D10AE01
|
Benzoyl peroxide
|
|
|
|
|
|
D10AE51
|
Benzoyl peroxide, combinations
|
|
|
|
|
D10AF
|
|
Anti-infectives for treatment of acne
|
|
|
|
|
|
D10AF01
|
Clindamycin
|
|
|
|
|
|
D10AF02
|
Erythromycin
|
|
|
|
|
|
D10AF03
|
Chloramphenicol
|
|
|
|
|
|
D10AF04
|
Meclocycline
|
|
|
|
|
|
D10AF51
|
Clindamycin, combinations
|
|
|
|
|
|
D10AF52
|
Erythromycin, combinations
|
|
|
|
|
D10AX
|
|
Other anti-acne preparations for topical use
|
|
|
|
|
|
D10AX01
|
Aluminium chloride
|
|
|
|
|
|
D10AX02
|
Resorcinol
|
|
|
|
|
|
D10AX03
|
Azelaic acid
|
|
|
|
|
|
D10AX04
|
Aluminium oxide
|
|
|
|
|
|
D10AX05
|
Dapsone
|
|
|
|
|
|
D10AX30
|
Various combinations
|
|
|
|
D10B
|
|
|
Anti-acne preparations for systemic use
|
|
|
|
|
D10BA
|
|
Retinoids for treatment of acne
|
|
|
|
|
|
D10BA01
|
Isotretinoin
|
|
|
|
|
D10BX
|
|
Other anti-acne preparations for systemic use
|
|
|
|
|
|
D10BX01
|
Ichtasol
|
|
|
D11
|
|
|
|
Other dermatological preparations
|
|
|
|
D11A
|
|
|
Other dermatological preparations
|
|
|
|
|
D11AA
|
|
Antihidrotics
|
|
|
|
|
|
|
empty
|
|
|
|
|
D11AC
|
|
Medicated shampoos
|
|
|
|
|
|
D11AC01
|
Cetrimide
|
|
|
|
|
|
D11AC02
|
Cadmium compounds
|
|
|
|
|
|
D11AC03
|
Selenium compounds
|
|
|
|
|
|
D11AC06
|
Povidone-iodine
|
|
|
|
|
|
D11AC08
|
Sulfur compounds
|
|
|
|
|
|
D11AC09
|
Xenysalate
|
|
|
|
|
|
D11AC30
|
Others
|
|
|
|
|
D11AE
|
|
Androgens for topical use
|
|
|
|
|
|
D11AE01
|
Metandienone
|
|
|
|
|
D11AF
|
|
Wart and anti-corn preparations
|
|
|
|
|
|
|
empty
|
|
|
|
|
D11AH
|
|
Agents for dermatitis, excluding corticosteroids
|
|
|
|
|
|
D11AH01
|
Tacrolimus
|
|
|
|
|
|
D11AH02
|
Pimecrolimus
|
|
|
|
|
|
D11AH03
|
Cromoglicic acid
|
|
|
|
|
|
D11AH04
|
Alitretinoin
|
|
|
|
|
D11AX
|
|
Other dermatologicals
|
|
|
|
|
|
D11AX01
|
Minoxidil
|
|
|
|
|
|
D11AX02
|
Gamolenic acid
|
|
|
|
|
|
D11AX03
|
Calcium gluconate
|
|
|
|
|
|
D11AX04
|
Lithium succinate
|
|
|
|
|
|
D11AX05
|
Magnesium sulfate
|
|
|
|
|
|
D11AX06
|
Mequinol
|
|
|
|
|
|
D11AX08
|
Tiratricol
|
|
|
|
|
|
D11AX09
|
Oxaceprol
|
|
|
|
|
|
D11AX10
|
Finasteride
|
|
|
|
|
|
D11AX11
|
Hydroquinone
|
|
|
|
|
|
D11AX12
|
Pyrithione zinc
|
|
|
|
|
|
D11AX13
|
Monobenzone
|
|
|
|
|
|
D11AX16
|
Eflornithine
|
|
|
|
|
|
D11AX18
|
Diclofenac
|
|
|
|
|
|
D11AX52
|
Gamolenic acid, combinations
|
|
|
|
|
|
D11AX57
|
Collagen, combinations
|
| G
|
|
|
|
|
Genito-urinary system and sex hormones
|
|
|
G01
|
|
|
|
Gynecological antiinfectives and antiseptics
|
|
|
|
G01A
|
|
|
Antiinfectives and antiseptics, excluding combinations with corticosteroids
|
|
|
|
|
G01AA
|
|
Antibiotics
|
|
|
|
|
|
G01AA01
|
Nystatin
|
|
|
|
|
|
G01AA02
|
Natamycin
|
|
|
|
|
|
G01AA03
|
Amphotericin B
|
|
|
|
|
|
G01AA04
|
Candicidin
|
|
|
|
|
|
G01AA05
|
Chloramphenicol
|
|
|
|
|
|
G01AA06
|
Hachimycin
|
|
|
|
|
|
G01AA07
|
Oxytetracycline
|
|
|
|
|
|
G01AA08
|
Carfecillin
|
|
|
|
|
|
G01AA09
|
Mepartricin
|
|
|
|
|
|
G01AA10
|
Clindamycin
|
|
|
|
|
|
G01AA11
|
Pentamycin
|
|
|
|
|
|
G01AA51
|
Nystatin, combinations
|
|
|
|
|
G01AB
|
|
Arsenic compounds
|
|
|
|
|
|
G01AB01
|
Acetarsol
|
|
|
|
|
G01AC
|
|
Quinoline derivatives
|
|
|
|
|
|
G01AC01
|
Diiodohydroxyquinoline
|
|
|
|
|
|
G01AC02
|
Clioquinol
|
|
|
|
|
|
G01AC03
|
Chlorquinaldol
|
|
|
|
|
|
G01AC05
|
Dequalinium
|
|
|
|
|
|
G01AC06
|
Broxyquinoline
|
|
|
|
|
|
G01AC30
|
Oxyquinoline
|
|
|
|
|
G01AD
|
|
Organic acids
|
|
|
|
|
|
G01AD01
|
Lactic acid
|
|
|
|
|
|
G01AD02
|
Acetic acid
|
|
|
|
|
|
G01AD03
|
Ascorbic acid
|
|
|
|
|
G01AE
|
|
Sulfonamides
|
|
|
|
|
|
G01AE01
|
Sulfatolamide
|
|
|
|
|
|
G01AE10
|
Combinations of sulfonamides
|
|
|
|
|
G01AF
|
|
Imidazole derivatives
|
|
|
|
|
|
G01AF01
|
Metronidazole
|
|
|
|
|
|
G01AF02
|
Clotrimazole
|
|
|
|
|
|
G01AF04
|
Miconazole
|
|
|
|
|
|
G01AF05
|
Econazole
|
|
|
|
|
|
G01AF06
|
Ornidazole
|
|
|
|
|
|
G01AF07
|
Isoconazole
|
|
|
|
|
|
G01AF08
|
Tioconazole
|
|
|
|
|
|
G01AF11
|
Ketoconazole
|
|
|
|
|
|
G01AF12
|
Fenticonazole
|
|
|
|
|
|
G01AF13
|
Azanidazole
|
|
|
|
|
|
G01AF14
|
Propenidazole
|
|
|
|
|
|
G01AF15
|
Butoconazole
|
|
|
|
|
|
G01AF16
|
Omoconazole
|
|
|
|
|
|
G01AF17
|
Oxiconazole
|
|
|
|
|
|
G01AF18
|
Flutrimazole
|
|
|
|
|
|
G01AF20
|
Combinations of imidazole derivatives
|
|
|
|
|
G01AG
|
|
Triazole derivatives
|
|
|
|
|
|
G01AG02
|
Terconazole
|
|
|
|
|
G01AX
|
|
Other anti-infectives and antiseptics
|
|
|
|
|
|
G01AX01
|
Clodantoin
|
|
|
|
|
|
G01AX02
|
Inosine
|
|
|
|
|
|
G01AX03
|
Policresulen
|
|
|
|
|
|
G01AX05
|
Nifuratel
|
|
|
|
|
|
G01AX06
|
Furazolidone
|
|
|
|
|
|
G01AX09
|
Methylrosaniline
|
|
|
|
|
|
G01AX11
|
Povidone-iodine
|
|
|
|
|
|
G01AX12
|
Ciclopirox
|
|
|
|
|
|
G01AX13
|
Protiofate
|
|
|
|
|
|
G01AX14
|
Lactobacillus fermentum
|
|
|
|
|
|
G01AX15
|
Copper usnate
|
|
|
|
|
|
G01AX66
|
Octenidine, combinations
|
|
|
|
G01B
|
|
|
Antiinfectives/antiseptics in combination with corticosteroids
|
|
|
|
|
G01BA
|
|
Antibiotics and corticosteroids
|
|
|
|
|
|
|
empty
|
|
|
|
|
G01BC
|
|
Quinoline derivatives and corticosteroids
|
|
|
|
|
|
|
empty
|
|
|
|
|
G01BD
|
|
Antiseptics and corticosteroids
|
|
|
|
|
|
|
empty
|
|
|
|
|
G01BE
|
|
Sulfonamides and corticosteroids
|
|
|
|
|
|
|
empty
|
|
|
|
|
G01BF
|
|
Imidazole derivatives and corticosteroids
|
|
|
|
|
|
|
empty
|
|
|
G02
|
|
|
|
Other gynecologicals
|
|
|
|
G02A
|
|
|
Oxytocics
|
|
|
|
|
G02AB
|
|
Ergot alkaloids
|
|
|
|
|
|
G02AB01
|
Methylergometrine
|
|
|
|
|
|
G02AB02
|
Ergot alkaloids
|
|
|
|
|
|
G02AB03
|
Ergometrine
|
|
|
|
|
G02AC
|
|
Ergot alkaloids and oxytocin including analogues, in combination
|
|
|
|
|
|
G02AC01
|
Methylergometrine and oxytocin
|
|
|
|
|
G02AD
|
|
Prostaglandins
|
|
|
|
|
|
G02AD01
|
Dinoprost
|
|
|
|
|
|
G02AD02
|
Dinoprostone
|
|
|
|
|
|
G02AD03
|
Gemeprost
|
|
|
|
|
|
G02AD04
|
Carboprost
|
|
|
|
|
|
G02AD05
|
Sulprostone
|
|
|
|
|
|
G02AD06
|
Misoprostol
|
|
|
|
|
G02AX
|
|
Other oxytocics
|
|
|
|
|
|
|
empty
|
|
|
|
G02B
|
|
|
Contraceptives for topical use
|
|
|
|
|
G02BA
|
|
Intrauterine contraceptives
|
|
|
|
|
|
G02BA01
|
Plastic IUD
|
|
|
|
|
|
G02BA02
|
Plastic IUD with copper
|
|
|
|
|
|
G02BA03
|
Plastic IUD with progestogen
|
|
|
|
|
G02BB
|
|
Intravaginal contraceptives
|
|
|
|
|
|
G02BB01
|
Vaginal ring with progestogen and estrogen
|
|
|
|
G02C
|
|
|
Other gynecologicals
|
|
|
|
|
G02CA
|
|
Sympathomimetics, labour repressants
|
|
|
|
|
|
G02CA01
|
Ritodrine
|
|
|
|
|
|
G02CA02
|
Buphenine
|
|
|
|
|
|
G02CA03
|
Fenoterol
|
|
|
|
|
G02CB
|
|
Prolactin inhibitors
|
|
|
|
|
|
G02CB01
|
Bromocriptine
|
|
|
|
|
|
G02CB02
|
Lisuride
|
|
|
|
|
|
G02CB03
|
Cabergoline
|
|
|
|
|
|
G02CB04
|
Quinagolide
|
|
|
|
|
|
G02CB05
|
Metergoline
|
|
|
|
|
|
G02CB06
|
Terguride
|
|
|
|
|
G02CC
|
|
Anti-inflammatory products for vaginal administration
|
|
|
|
|
|
G02CC01
|
Ibuprofen
|
|
|
|
|
|
G02CC02
|
Naproxen
|
|
|
|
|
|
G02CC03
|
Benzydamine
|
|
|
|
|
|
G02CC04
|
Flunoxaprofen
|
|
|
|
|
G02CX
|
|
Other gynecologicals
|
|
|
|
|
|
G02CX01
|
Atosiban
|
|
|
|
|
|
G02CX03
|
Agni casti fructus
|
|
|
|
|
|
G02CX04
|
Cimicifugae rhizoma
|
|
|
G03
|
|
|
|
Sex hormones and modulators of the genital system
|
|
|
|
G03A
|
|
|
Hormonal contraceptives for systemic use
|
|
|
|
|
G03AA
|
|
Progestogens and estrogens, fixed combinations
|
|
|
|
|
|
G03AA01
|
Etynodiol and ethinylestradiol
|
|
|
|
|
|
G03AA02
|
Quingestanol and ethinylestradiol
|
|
|
|
|
|
G03AA03
|
Lynestrenol and ethinylestradiol
|
|
|
|
|
|
G03AA04
|
Megestrol and ethinylestradiol
|
|
|
|
|
|
G03AA05
|
Norethisterone and ethinylestradiol
|
|
|
|
|
|
G03AA06
|
Norgestrel and ethinylestradiol
|
|
|
|
|
|
G03AA07
|
Levonorgestrel and ethinylestradiol
|
|
|
|
|
|
G03AA08
|
Medroxyprogesterone and ethinylestradiol
|
|
|
|
|
|
G03AA09
|
Desogestrel and ethinylestradiol
|
|
|
|
|
|
G03AA10
|
Gestodene and ethinylestradiol
|
|
|
|
|
|
G03AA11
|
Norgestimate and ethinylestradiol
|
|
|
|
|
|
G03AA12
|
Drospirenone and ethinylestradiol
|
|
|
|
|
|
G03AA13
|
Norelgestromin and ethinylestradiol
|
|
|
|
|
|
G03AA14
|
Nomegestrol and estradiol
|
|
|
|
|
|
G03AA15
|
Chlormadinone and ethinylestradiol
|
|
|
|
|
G03AB
|
|
Progestogens and estrogens, sequential preparations
|
|
|
|
|
|
G03AB01
|
Megestrol and ethinylestradiol
|
|
|
|
|
|
G03AB02
|
Lynestrenol and ethinylestradiol
|
|
|
|
|
|
G03AB03
|
Levonorgestrel and ethinylestradiol
|
|
|
|
|
|
G03AB04
|
Norethisterone and ethinylestradiol
|
|
|
|
|
|
G03AB05
|
Desogestrel and ethinylestradiol
|
|
|
|
|
|
G03AB06
|
Gestodene and ethinylestradiol
|
|
|
|
|
|
G03AB07
|
Chlormadinone and ethinylestradiol
|
|
|
|
|
|
G03AB08
|
Dienogest and estradiol
|
|
|
|
|
G03AC
|
|
Progestogens
|
|
|
|
|
|
G03AC01
|
Norethisterone
|
|
|
|
|
|
G03AC02
|
Lynestrenol
|
|
|
|
|
|
G03AC03
|
Levonorgestrel
|
|
|
|
|
|
G03AC04
|
Quingestanol
|
|
|
|
|
|
G03AC05
|
Megestrol
|
|
|
|
|
|
G03AC06
|
Medroxyprogesterone
|
|
|
|
|
|
G03AC07
|
Norgestrienone
|
|
|
|
|
|
G03AC08
|
Etonogestrel
|
|
|
|
|
|
G03AC09
|
Desogestrel
|
|
|
|
|
G03AD
|
|
Emergency contraceptives
|
|
|
|
|
|
G03AD01
|
Levonorgestrel
|
|
|
|
|
|
G03AD02
|
Ulipristal
|
|
|
|
G03B
|
|
|
Androgens
|
|
|
|
|
G03BA
|
|
3-oxoandrosten-(4) derivatives
|
|
|
|
|
|
G03BA01
|
Fluoxymesterone
|
|
|
|
|
|
G03BA02
|
Methyltestosterone
|
|
|
|
|
|
G03BA03
|
Testosterone
|
|
|
|
|
G03BB
|
|
5-androstanon-(3) derivatives
|
|
|
|
|
|
G03BB01
|
Mesterolone
|
|
|
|
|
|
G03BB02
|
Androstanolone
|
|
|
|
G03C
|
|
|
Estrogens
|
|
|
|
|
G03CA
|
|
Natural and semisynthetic estrogens, plain
|
|
|
|
|
|
G03CA01
|
Ethinylestradiol
|
|
|
|
|
|
G03CA03
|
Estradiol
|
|
|
|
|
|
G03CA04
|
Estriol
|
|
|
|
|
|
G03CA06
|
Chlorotrianisene
|
|
|
|
|
|
G03CA07
|
Estrone
|
|
|
|
|
|
G03CA09
|
Promestriene
|
|
|
|
|
|
G03CA53
|
Estradiol, combinations
|
|
|
|
|
|
G03CA57
|
Conjugated estrogens
|
|
|
|
|
G03CB
|
|
Synthetic estrogens, plain
|
|
|
|
|
|
G03CB01
|
Dienestrol
|
|
|
|
|
|
G03CB02
|
Diethylstilbestrol
|
|
|
|
|
|
G03CB03
|
Methallenestril
|
|
|
|
|
|
G03CB04
|
Moxestrol
|
|
|
|
|
G03CC
|
|
Estrogens, combinations with other drugs
|
|
|
|
|
|
G03CC02
|
Dienestrol
|
|
|
|
|
|
G03CC03
|
Methallenestril
|
|
|
|
|
|
G03CC04
|
Estrone
|
|
|
|
|
|
G03CC05
|
Diethylstilbestrol
|
|
|
|
|
|
G03CC06
|
Estriol
|
|
|
|
|
G03CX
|
|
Other estrogens
|
|
|
|
|
|
G03CX01
|
Tibolone
|
|
|
|
G03D
|
|
|
Progestogens
|
|
|
|
|
G03DA
|
|
Pregnen-(4) derivatives
|
|
|
|
|
|
G03DA01
|
Gestonorone
|
|
|
|
|
|
G03DA02
|
Medroxyprogesterone
|
|
|
|
|
|
G03DA03
|
Hydroxyprogesterone
|
|
|
|
|
|
G03DA04
|
Progesterone
|
|
|
|
|
G03DB
|
|
Pregnadien derivatives
|
|
|
|
|
|
G03DB01
|
Dydrogesterone
|
|
|
|
|
|
G03DB02
|
Megestrol
|
|
|
|
|
|
G03DB03
|
Medrogestone
|
|
|
|
|
|
G03DB04
|
Nomegestrol
|
|
|
|
|
|
G03DB05
|
Demegestone
|
|
|
|
|
|
G03DB06
|
Chlormadinone
|
|
|
|
|
|
G03DB07
|
Promegestone
|
|
|
|
|
|
G03DB08
|
Dienogest
|
|
|
|
|
G03DC
|
|
Estren derivatives
|
|
|
|
|
|
G03DC01
|
Allylestrenol
|
|
|
|
|
|
G03DC02
|
Norethisterone
|
|
|
|
|
|
G03DC03
|
Lynestrenol
|
|
|
|
|
|
G03DC04
|
Ethisterone
|
|
|
|
|
|
G03DC05
|
Tibolone
|
|
|
|
|
|
G03DC06
|
Etynodiol
|
|
|
|
|
|
G03DC31
|
Methylestrenolone
|
|
|
|
G03E
|
|
|
Androgens and female sex hormones in combination
|
|
|
|
|
G03EA
|
|
Androgens and estrogens
|
|
|
|
|
|
G03EA01
|
Methyltestosterone and estrogen
|
|
|
|
|
|
G03EA02
|
Testosterone and estrogen
|
|
|
|
|
|
G03EA03
|
Prasterone and estrogen
|
|
|
|
|
G03EB
|
|
Androgen, progestogen and estrogen in combination
|
|
|
|
|
|
|
empty
|
|
|
|
|
G03EK
|
|
Androgens and female sex hormones in combination with other drugs
|
|
|
|
|
|
G03EK01
|
Methyltestosterone
|
|
|
|
G03F
|
|
|
Progestogens and estrogens in combination
|
|
|
|
|
G03FA
|
|
Progestogens and estrogens, fixed combinations
|
|
|
|
|
|
G03FA01
|
Norethisterone and estrogen
|
|
|
|
|
|
G03FA02
|
Hydroxyprogesterone and estrogen
|
|
|
|
|
|
G03FA03
|
Ethisterone and estrogen
|
|
|
|
|
|
G03FA04
|
Progesterone and estrogen
|
|
|
|
|
|
G03FA05
|
Methylnortestosterone and estrogen
|
|
|
|
|
|
G03FA06
|
Etynodiol and estrogen
|
|
|
|
|
|
G03FA07
|
Lynestrenol and estrogen
|
|
|
|
|
|
G03FA08
|
Megestrol and estrogen
|
|
|
|
|
|
G03FA09
|
Noretynodrel and estrogen
|
|
|
|
|
|
G03FA10
|
Norgestrel and estrogen
|
|
|
|
|
|
G03FA11
|
Levonorgestrel and estrogen
|
|
|
|
|
|
G03FA12
|
Medroxyprogesterone and estrogen
|
|
|
|
|
|
G03FA13
|
Norgestimate and estrogen
|
|
|
|
|
|
G03FA14
|
Dydrogesterone and estrogen
|
|
|
|
|
|
G03FA15
|
Dienogest and estrogen
|
|
|
|
|
|
G03FA16
|
Trimegestone and estrogen
|
|
|
|
|
|
G03FA17
|
Drospirenone and estrogen
|
|
|
|
|
G03FB
|
|
Progestogens and estrogens, sequential preparations
|
|
|
|
|
|
G03FB01
|
Norgestrel and estrogen
|
|
|
|
|
|
G03FB02
|
Lynestrenol and estrogen
|
|
|
|
|
|
G03FB03
|
Chlormadinone and estrogen
|
|
|
|
|
|
G03FB04
|
Megestrol and estrogen
|
|
|
|
|
|
G03FB05
|
Norethisterone and estrogen
|
|
|
|
|
|
G03FB06
|
Medroxyprogesterone and estrogen
|
|
|
|
|
|
G03FB07
|
Medrogestone and estrogen
|
|
|
|
|
|
G03FB08
|
Dydrogesterone and estrogen
|
|
|
|
|
|
G03FB09
|
Levonorgestrel and estrogen
|
|
|
|
|
|
G03FB10
|
Desogestrel and estrogen
|
|
|
|
|
|
G03FB11
|
Trimegestone and estrogen
|
|
|
|
G03G
|
|
|
Gonadotropins and other ovulation stimulants
|
|
|
|
|
G03GA
|
|
Gonadotropins
|
|
|
|
|
|
G03GA01
|
Human chorionic gonadotropin
|
|
|
|
|
|
G03GA02
|
Human menopausal gonadotropin
|
|
|
|
|
|
G03GA03
|
Serum gonadotropin
|
|
|
|
|
|
G03GA04
|
Urofollitropin
|
|
|
|
|
|
G03GA05
|
Follitropin alfa
|
|
|
|
|
|
G03GA06
|
Follitropin beta
|
|
|
|
|
|
G03GA07
|
Lutropin alfa
|
|
|
|
|
|
G03GA08
|
Choriogonadotropin alfa
|
|
|
|
|
|
G03GA09
|
Corifollitropin alfa
|
|
|
|
|
|
G03GA30
|
Combinations
|
|
|
|
|
G03GB
|
|
Ovulation stimulants, synthetic
|
|
|
|
|
|
G03GB01
|
Cyclofenil
|
|
|
|
|
|
G03GB02
|
Clomifene
|
|
|
|
|
|
G03GB03
|
Epimestrol
|
|
|
|
G03H
|
|
|
Antiandrogens
|
|
|
|
|
G03HA
|
|
Antiandrogens, plain
|
|
|
|
|
|
G03HA01
|
Cyproterone
|
|
|
|
|
G03HB
|
|
Antiandrogens and estrogens
|
|
|
|
|
|
G03HB01
|
Cyproterone and estrogen
|
|
|
|
G03X
|
|
|
Other sex hormones and modulators of the genital system
|
|
|
|
|
G03XA
|
|
Antigonadotropins and similar agents
|
|
|
|
|
|
G03XA01
|
Danazol
|
|
|
|
|
|
G03XA02
|
Gestrinone
|
|
|
|
|
G03XB
|
|
Antiprogestogens
|
|
|
|
|
|
G03XB01
|
Mifepristone
|
|
|
|
|
G03XC
|
|
Selective estrogen receptor modulators
|
|
|
|
|
|
G03XC01
|
Raloxifene
|
|
|
|
|
|
G03XC02
|
Bazedoxifene
|
|
|
|
|
|
G03XC03
|
Lasofoxifene
|
|
|
|
|
|
G03XC04
|
Ormeloxifene
|
|
|
G04
|
|
|
|
Urologicals
|
|
|
|
G04B
|
|
|
Urologicals
|
|
|
|
|
G04BA
|
|
Acidifiers
|
|
|
|
|
|
G04BA01
|
Ammonium chloride
|
|
|
|
|
|
G04BA03
|
Calcium chloride
|
|
|
|
|
G04BC
|
|
Urinary concrement solvents
|
|
|
|
|
|
|
empty
|
|
|
|
|
G04BD
|
|
Drugs for urinary frequency and incontinence
|
|
|
|
|
|
G04BD01
|
Emepronium
|
|
|
|
|
|
G04BD02
|
Flavoxate
|
|
|
|
|
|
G04BD03
|
Meladrazine
|
|
|
|
|
|
G04BD04
|
Oxybutynin
|
|
|
|
|
|
G04BD05
|
Terodiline
|
|
|
|
|
|
G04BD06
|
Propiverine
|
|
|
|
|
|
G04BD07
|
Tolterodine
|
|
|
|
|
|
G04BD08
|
Solifenacin
|
|
|
|
|
|
G04BD09
|
Trospium
|
|
|
|
|
|
G04BD10
|
Darifenacin
|
|
|
|
|
|
G04BD11
|
Fesoterodine
|
|
|
|
|
|
G04BD12
|
Mirabegron
|
|
|
|
|
G04BE
|
|
Drugs used in erectile dysfunction
|
|
|
|
|
|
G04BE01
|
Alprostadil
|
|
|
|
|
|
G04BE02
|
Papaverine
|
|
|
|
|
|
G04BE03
|
Sildenafil
|
|
|
|
|
|
G04BE04
|
Yohimbin
|
|
|
|
|
|
G04BE06
|
Moxisylyte
|
|
|
|
|
|
G04BE07
|
Apomorphine
|
|
|
|
|
|
G04BE08
|
Tadalafil
|
|
|
|
|
|
G04BE09
|
Vardenafil
|
|
|
|
|
|
G04BE30
|
Combinations
|
|
|
|
|
|
G04BE52
|
Papaverine, combinations
|
|
|
|
|
G04BX
|
|
Other urologicals
|
|
|
|
|
|
G04BX01
|
Magnesium hydroxide
|
|
|
|
|
|
G04BX03
|
Acetohydroxamic acid
|
|
|
|
|
|
G04BX06
|
Phenazopyridine
|
|
|
|
|
|
G04BX10
|
Succinimide
|
|
|
|
|
|
G04BX11
|
Collagen
|
|
|
|
|
|
G04BX12
|
Phenyl salicylate
|
|
|
|
|
|
G04BX13
|
Dimethyl sulfoxide
|
|
|
|
|
|
G04BX14
|
Dapoxetine
|
|
|
|
|
|
G04BX15
|
Pentosan polysulfate sodium
|
|
|
|
G04C
|
|
|
Drugs used in benign prostatic hypertrophy
|
|
|
|
|
G04CA
|
|
Alpha-adrenoreceptor antagonists
|
|
|
|
|
|
G04CA01
|
Alfuzosin
|
|
|
|
|
|
G04CA02
|
Tamsulosin
|
|
|
|
|
|
G04CA03
|
Terazosin
|
|
|
|
|
|
G04CA04
|
Silodosin
|
|
|
|
|
|
G04CA51
|
Alfuzosin and finasteride
|
|
|
|
|
|
G04CA52
|
Tamsulosin and dutasteride
|
|
|
|
|
|
G04CA53
|
Tamsulosin and solifenacin
|
|
|
|
|
G04CB
|
|
Testosterone-5-alpha reductase inhibitors
|
|
|
|
|
|
G04CB01
|
Finasteride
|
|
|
|
|
|
G04CB02
|
Dutasteride
|
|
|
|
|
G04CX
|
|
Other drugs used in benign prostatic hypertrophy
|
|
|
|
|
|
G04CX01
|
Prunus africanae cortex
|
|
|
|
|
|
G04CX02
|
Sabalis serrulatae fructus
|
|
|
|
|
|
G04CX03
|
Mepartricin
|
| H
|
|
|
|
|
Systemic hormonal preparations, excluding sex hormones and insulins
|
|
|
H01
|
|
|
|
Pituitary and hypothalamic hormones and analogues
|
|
|
|
H01A
|
|
|
Anterior pituitary lobe hormones and analogues
|
|
|
|
|
H01AA
|
|
Adrenocorticotropic hormone
|
|
|
|
|
|
H01AA01
|
Corticotropin
|
|
|
|
|
|
H01AA02
|
Tetracosactide
|
|
|
|
|
H01AB
|
|
Thyrotropin
|
|
|
|
|
|
H01AB01
|
Thyrotropin
|
|
|
|
|
H01AC
|
|
Somatropin and somatropin agonists
|
|
|
|
|
|
H01AC01
|
Somatropin
|
|
|
|
|
|
H01AC02
|
Somatrem
|
|
|
|
|
|
H01AC03
|
Mecasermin
|
|
|
|
|
|
H01AC04
|
Sermorelin
|
|
|
|
|
|
H01AC05
|
Mecasermin rinfabate
|
|
|
|
|
|
H01AC06
|
Tesamorelin
|
|
|
|
|
H01AX
|
|
Other anterior pituitary lobe hormones and analogues
|
|
|
|
|
|
H01AX01
|
Pegvisomant
|
|
|
|
H01B
|
|
|
Posterior pituitary lobe hormones
|
|
|
|
|
H01BA
|
|
Vasopressin and analogues
|
|
|
|
|
|
H01BA01
|
Vasopressin
|
|
|
|
|
|
H01BA02
|
Desmopressin
|
|
|
|
|
|
H01BA03
|
Lypressin
|
|
|
|
|
|
H01BA04
|
Terlipressin
|
|
|
|
|
|
H01BA05
|
Ornipressin
|
|
|
|
|
|
H01BA06
|
Argipressin
|
|
|
|
|
H01BB
|
|
Oxytocin and analogues
|
|
|
|
|
|
H01BB01
|
Demoxytocin
|
|
|
|
|
|
H01BB02
|
Oxytocin
|
|
|
|
|
|
H01BB03
|
Carbetocin
|
|
|
|
H01C
|
|
|
Hypothalamic hormones
|
|
|
|
|
H01CA
|
|
Gonadotropin-releasing hormones
|
|
|
|
|
|
H01CA01
|
Gonadorelin
|
|
|
|
|
|
H01CA02
|
Nafarelin
|
|
|
|
|
H01CB
|
|
Somatostatin and analogues
|
|
|
|
|
|
H01CB01
|
Somatostatin
|
|
|
|
|
|
H01CB02
|
Octreotide
|
|
|
|
|
|
H01CB03
|
Lanreotide
|
|
|
|
|
|
H01CB04
|
Vapreotide
|
|
|
|
|
|
H01CB05
|
Pasireotide
|
|
|
|
|
H01CC
|
|
Anti-gonadotropin-releasing hormones
|
|
|
|
|
|
H01CC01
|
Ganirelix
|
|
|
|
|
|
H01CC02
|
Cetrorelix
|
|
|
H02
|
|
|
|
Corticosteroids for systemic use
|
|
|
|
H02A
|
|
|
Corticosteroids for systemic use, plain
|
|
|
|
|
H02AA
|
|
Mineralocorticoids
|
|
|
|
|
|
H02AA01
|
Aldosterone
|
|
|
|
|
|
H02AA02
|
Fludrocortisone
|
|
|
|
|
|
H02AA03
|
Desoxycortone
|
|
|
|
|
H02AB
|
|
Glucocorticoids
|
|
|
|
|
|
H02AB01
|
Betamethasone
|
|
|
|
|
|
H02AB02
|
Dexamethasone
|
|
|
|
|
|
H02AB03
|
Fluocortolone
|
|
|
|
|
|
H02AB04
|
Methylprednisolone
|
|
|
|
|
|
H02AB05
|
Paramethasone
|
|
|
|
|
|
H02AB06
|
Prednisolone
|
|
|
|
|
|
H02AB07
|
Prednisone
|
|
|
|
|
|
H02AB08
|
Triamcinolone
|
|
|
|
|
|
H02AB09
|
Hydrocortisone
|
|
|
|
|
|
H02AB10
|
Cortisone
|
|
|
|
|
|
H02AB11
|
Prednylidene
|
|
|
|
|
|
H02AB12
|
Rimexolone
|
|
|
|
|
|
H02AB13
|
Deflazacort
|
|
|
|
|
|
H02AB14
|
Cloprednol
|
|
|
|
|
|
H02AB15
|
Meprednisone
|
|
|
|
|
|
H02AB17
|
Cortivazol
|
|
|
|
H02B
|
|
|
Corticosteroids for systemic use, combinations
|
|
|
|
|
H02BX
|
|
Corticosteroids for systemic use, combinations
|
|
|
|
|
|
H02BX01
|
Methylprednisolone, combinations
|
|
|
|
H02C
|
|
|
Antiadrenal preparations
|
|
|
|
|
H02CA
|
|
Anticorticosteroids
|
|
|
|
|
|
H02CA01
|
Trilostane
|
|
|
H03
|
|
|
|
Thyroid therapy
|
|
|
|
H03A
|
|
|
Thyroid preparations
|
|
|
|
|
H03AA
|
|
Thyroid hormones
|
|
|
|
|
|
H03AA01
|
Levothyroxine sodium
|
|
|
|
|
|
H03AA02
|
Liothyronine sodium
|
|
|
|
|
|
H03AA03
|
Combinations of levothyroxine and liothyronine
|
|
|
|
|
|
H03AA04
|
Tiratricol
|
|
|
|
|
|
H03AA05
|
Thyroid gland preparations
|
|
|
|
H03B
|
|
|
Antithyroid preparations
|
|
|
|
|
H03BA
|
|
Thiouracils
|
|
|
|
|
|
H03BA01
|
Methylthiouracil
|
|
|
|
|
|
H03BA02
|
Propylthiouracil
|
|
|
|
|
|
H03BA03
|
Benzylthiouracil
|
|
|
|
|
H03BB
|
|
Sulphur-containing imidazole derivatives
|
|
|
|
|
|
H03BB01
|
Carbimazole
|
|
|
|
|
|
H03BB02
|
Thiamazole
|
|
|
|
|
|
H03BB52
|
Thiamazole, combinations
|
|
|
|
|
H03BC
|
|
Perchlorates
|
|
|
|
|
|
H03BC01
|
Potassium perchlorate
|
|
|
|
|
H03BX
|
|
Other antithyroid preparations
|
|
|
|
|
|
H03BX01
|
Diiodotyrosine
|
|
|
|
|
|
H03BX02
|
Dibromotyrosine
|
|
|
|
H03C
|
|
|
Iodine therapy
|
|
|
|
|
H03CA
|
|
Iodine therapy
|
|
|
|
|
|
|
empty
|
|
|
H04
|
|
|
|
Pancreatic hormones
|
|
|
|
H04A
|
|
|
Glycogenolytic hormones
|
|
|
|
|
H04AA
|
|
Glycogenolytic hormones
|
|
|
|
|
|
H04AA01
|
Glucagon
|
|
|
H05
|
|
|
|
Calcium homeostasis
|
|
|
|
H05A
|
|
|
Parathyroid hormones and analogues
|
|
|
|
|
H05AA
|
|
Parathyroid hormones and analogues
|
|
|
|
|
|
H05AA01
|
Parathyroid gland extract
|
|
|
|
|
|
H05AA02
|
Teriparatide
|
|
|
|
|
|
H05AA03
|
Parathyroid hormone
|
|
|
|
H05B
|
|
|
Anti-parathyroid agents
|
|
|
|
|
H05BA
|
|
Calcitonin preparations
|
|
|
|
|
|
H05BA01
|
Calcitonin (salmon synthetic)
|
|
|
|
|
|
H05BA02
|
Calcitonin (pork natural)
|
|
|
|
|
|
H05BA03
|
Calcitonin (human synthetic)
|
|
|
|
|
|
H05BA04
|
Elcatonin
|
|
|
|
|
H05BX
|
|
Other anti-parathyroid agents
|
|
|
|
|
|
H05BX01
|
Cinacalcet
|
|
|
|
|
|
H05BX02
|
Paricalcitol
|
|
|
|
|
|
H05BX03
|
Doxercalciferol
|
| J
|
|
|
|
|
Antiinfectives for systemic use
|
|
|
J01
|
|
|
|
Antibacterials for systemic use
|
|
|
|
J01A
|
|
|
Tetracyclines
|
|
|
|
|
J01AA
|
|
Tetracyclines
|
|
|
|
|
|
J01AA01
|
Demeclocycline
|
|
|
|
|
|
J01AA02
|
Doxycycline
|
|
|
|
|
|
J01AA03
|
Chlortetracycline
|
|
|
|
|
|
J01AA04
|
Lymecycline
|
|
|
|
|
|
J01AA05
|
Metacycline
|
|
|
|
|
|
J01AA06
|
Oxytetracycline
|
|
|
|
|
|
J01AA07
|
Tetracycline
|
|
|
|
|
|
J01AA08
|
Minocycline
|
|
|
|
|
|
J01AA09
|
Rolitetracycline
|
|
|
|
|
|
J01AA10
|
Penimepicycline
|
|
|
|
|
|
J01AA11
|
Clomocycline
|
|
|
|
|
|
J01AA12
|
Tigecycline
|
|
|
|
|
|
J01AA20
|
Combinations of tetracyclines
|
|
|
|
|
|
J01AA56
|
Oxytetracycline, combinations
|
|
|
|
J01B
|
|
|
Amphenicols
|
|
|
|
|
J01BA
|
|
Amphenicols
|
|
|
|
|
|
J01BA01
|
Chloramphenicol
|
|
|
|
|
|
J01BA02
|
Thiamphenicol
|
|
|
|
|
|
J01BA52
|
Thiamphenicol, combinations
|
|
|
|
J01C
|
|
|
Beta-lactam antibacterials, penicillins
|
|
|
|
|
J01CA
|
|
Penicillins with extended spectrum
|
|
|
|
|
|
J01CA01
|
Ampicillin
|
|
|
|
|
|
J01CA02
|
Pivampicillin
|
|
|
|
|
|
J01CA03
|
Carbenicillin
|
|
|
|
|
|
J01CA04
|
Amoxicillin
|
|
|
|
|
|
J01CA05
|
Carindacillin
|
|
|
|
|
|
J01CA06
|
Bacampicillin
|
|
|
|
|
|
J01CA07
|
Epicillin
|
|
|
|
|
|
J01CA08
|
Pivmecillinam
|
|
|
|
|
|
J01CA09
|
Azlocillin
|
|
|
|
|
|
J01CA10
|
Mezlocillin
|
|
|
|
|
|
J01CA11
|
Mecillinam
|
|
|
|
|
|
J01CA12
|
Piperacillin
|
|
|
|
|
|
J01CA13
|
Ticarcillin
|
|
|
|
|
|
J01CA14
|
Metampicillin
|
|
|
|
|
|
J01CA15
|
Talampicillin
|
|
|
|
|
|
J01CA16
|
Sulbenicillin
|
|
|
|
|
|
J01CA17
|
Temocillin
|
|
|
|
|
|
J01CA18
|
Hetacillin
|
|
|
|
|
|
J01CA19
|
Aspoxicillin
|
|
|
|
|
|
J01CA20
|
Combinations
|
|
|
|
|
|
J01CA51
|
Ampicillin, combinations
|
|
|
|
|
J01CE
|
|
Beta-lactamase-sensitive penicillins
|
|
|
|
|
|
J01CE01
|
Benzylpenicillin
|
|
|
|
|
|
J01CE02
|
Phenoxymethylpenicillin
|
|
|
|
|
|
J01CE03
|
Propicillin
|
|
|
|
|
|
J01CE04
|
Azidocillin
|
|
|
|
|
|
J01CE05
|
Pheneticillin
|
|
|
|
|
|
J01CE06
|
Penamecillin
|
|
|
|
|
|
J01CE07
|
Clometocillin
|
|
|
|
|
|
J01CE08
|
Benzathine benzylpenicillin
|
|
|
|
|
|
J01CE09
|
Procaine benzylpenicillin
|
|
|
|
|
|
J01CE10
|
Benzathine phenoxymethylpenicillin
|
|
|
|
|
|
J01CE30
|
Combinations
|
|
|
|
|
J01CF
|
|
Beta-lactamase-resistant penicillins
|
|
|
|
|
|
J01CF01
|
Dicloxacillin
|
|
|
|
|
|
J01CF02
|
Cloxacillin
|
|
|
|
|
|
J01CF03
|
Methicillin
|
|
|
|
|
|
J01CF04
|
Oxacillin
|
|
|
|
|
|
J01CF05
|
Flucloxacillin
|
|
|
|
|
|
J01CF06
|
Nafcillin
|
|
|
|
|
J01CG
|
|
Beta-lactamase inhibitors
|
|
|
|
|
|
J01CG01
|
Sulbactam
|
|
|
|
|
|
J01CG02
|
Tazobactam
|
|
|
|
|
J01CR
|
|
Combinations of penicillins, including beta-lactamase inhibitors
|
|
|
|
|
|
J01CR01
|
Ampicillin and enzyme inhibitor
|
|
|
|
|
|
J01CR02
|
Amoxicillin and enzyme inhibitor
|
|
|
|
|
|
J01CR03
|
Ticarcillin and enzyme inhibitor
|
|
|
|
|
|
J01CR04
|
Sultamicillin
|
|
|
|
|
|
J01CR05
|
Piperacillin and enzyme inhibitor
|
|
|
|
|
|
J01CR50
|
Combinations of penicillins
|
|
|
|
J01D
|
|
|
Other beta-lactam antibacterials
|
|
|
|
|
J01DB
|
|
First-generation cephalosporins
|
|
|
|
|
|
J01DB01
|
Cefalexin
|
|
|
|
|
|
J01DB02
|
Cefaloridine
|
|
|
|
|
|
J01DB03
|
Cefalotin
|
|
|
|
|
|
J01DB04
|
Cefazolin
|
|
|
|
|
|
J01DB05
|
Cefadroxil
|
|
|
|
|
|
J01DB06
|
Cefazedone
|
|
|
|
|
|
J01DB07
|
Cefatrizine
|
|
|
|
|
|
J01DB08
|
Cefapirin
|
|
|
|
|
|
J01DB09
|
Cefradine
|
|
|
|
|
|
J01DB10
|
Cefacetrile
|
|
|
|
|
|
J01DB11
|
Cefroxadine
|
|
|
|
|
|
J01DB12
|
Ceftezole
|
|
|
|
|
J01DC
|
|
Second-generation cephalosporins
|
|
|
|
|
|
J01DC01
|
Cefoxitin
|
|
|
|
|
|
J01DC02
|
Cefuroxime
|
|
|
|
|
|
J01DC03
|
Cefamandole
|
|
|
|
|
|
J01DC04
|
Cefaclor
|
|
|
|
|
|
J01DC05
|
Cefotetan
|
|
|
|
|
|
J01DC06
|
Cefonicide
|
|
|
|
|
|
J01DC07
|
Cefotiam
|
|
|
|
|
|
J01DC08
|
Loracarbef
|
|
|
|
|
|
J01DC09
|
Cefmetazole
|
|
|
|
|
|
J01DC10
|
Cefprozil
|
|
|
|
|
|
J01DC11
|
Ceforanide
|
|
|
|
|
|
J01DC12
|
Cefminox
|
|
|
|
|
|
J01DC13
|
Cefbuperazone
|
|
|
|
|
|
J01DC14
|
Flomoxef
|
|
|
|
|
J01DD
|
|
Third-generation cephalosporins
|
|
|
|
|
|
J01DD01
|
Cefotaxime
|
|
|
|
|
|
J01DD02
|
Ceftazidime
|
|
|
|
|
|
J01DD03
|
Cefsulodin
|
|
|
|
|
|
J01DD04
|
Ceftriaxone
|
|
|
|
|
|
J01DD05
|
Cefmenoxime
|
|
|
|
|
|
J01DD06
|
Latamoxef
|
|
|
|
|
|
J01DD07
|
Ceftizoxime
|
|
|
|
|
|
J01DD08
|
Cefixime
|
|
|
|
|
|
J01DD09
|
Cefodizime
|
|
|
|
|
|
J01DD10
|
Cefetamet
|
|
|
|
|
|
J01DD11
|
Cefpiramide
|
|
|
|
|
|
J01DD12
|
Cefoperazone
|
|
|
|
|
|
J01DD13
|
Cefpodoxime
|
|
|
|
|
|
J01DD14
|
Ceftibuten
|
|
|
|
|
|
J01DD15
|
Cefdinir
|
|
|
|
|
|
J01DD16
|
Cefditoren
|
|
|
|
|
|
J01DD17
|
Cefcapene
|
|
|
|
|
|
J01DD54
|
Ceftriaxone, combinations
|
|
|
|
|
|
J01DD62
|
Cefoperazone, combinations
|
|
|
|
|
J01DE
|
|
Fourth-generation cephalosporins
|
|
|
|
|
|
J01DE01
|
Cefepime
|
|
|
|
|
|
J01DE02
|
Cefpirome
|
|
|
|
|
|
J01DE03
|
Cefozopran
|
|
|
|
|
J01DF
|
|
Monobactams
|
|
|
|
|
|
J01DF01
|
Aztreonam
|
|
|
|
|
|
J01DF02
|
Carumonam
|
|
|
|
|
J01DH
|
|
Carbapenems
|
|
|
|
|
|
J01DH02
|
Meropenem
|
|
|
|
|
|
J01DH03
|
Ertapenem
|
|
|
|
|
|
J01DH04
|
Doripenem
|
|
|
|
|
|
J01DH05
|
Biapenem
|
|
|
|
|
|
J01DH51
|
Imipenem and enzyme inhibitor
|
|
|
|
|
|
J01DH55
|
Panipenem and betamipron
|
|
|
|
|
J01DI
|
|
Other cephalosporins and penems
|
|
|
|
|
|
J01DI01
|
Ceftobiprole medocaril
|
|
|
|
|
|
J01DI02
|
Ceftaroline fosamil
|
|
|
|
|
|
J01DI03
|
Faropenem
|
|
|
|
J01E
|
|
|
Sulfonamides and trimethoprim
|
|
|
|
|
J01EA
|
|
Trimethoprim and derivatives
|
|
|
|
|
|
J01EA01
|
Trimethoprim
|
|
|
|
|
|
J01EA02
|
Brodimoprim
|
|
|
|
|
|
J01EA03
|
Iclaprim
|
|
|
|
|
J01EB
|
|
Short-acting sulfonamides
|
|
|
|
|
|
J01EB01
|
Sulfaisodimidine
|
|
|
|
|
|
J01EB02
|
Sulfamethizole
|
|
|
|
|
|
J01EB03
|
Sulfadimidine
|
|
|
|
|
|
J01EB04
|
Sulfapyridine
|
|
|
|
|
|
J01EB05
|
Sulfafurazole
|
|
|
|
|
|
J01EB06
|
Sulfanilamide
|
|
|
|
|
|
J01EB07
|
Sulfathiazole
|
|
|
|
|
|
J01EB08
|
Sulfathiourea
|
|
|
|
|
|
J01EB20
|
Combinations
|
|
|
|
|
J01EC
|
|
Intermediate-acting sulfonamides
|
|
|
|
|
|
J01EC01
|
Sulfamethoxazole
|
|
|
|
|
|
J01EC02
|
Sulfadiazine
|
|
|
|
|
|
J01EC03
|
Sulfamoxole
|
|
|
|
|
|
J01EC20
|
Combinations
|
|
|
|
|
J01ED
|
|
Long-acting sulfonamides
|
|
|
|
|
|
J01ED01
|
Sulfadimethoxine
|
|
|
|
|
|
J01ED02
|
Sulfalene
|
|
|
|
|
|
J01ED03
|
Sulfametomidine
|
|
|
|
|
|
J01ED04
|
Sulfametoxydiazine
|
|
|
|
|
|
J01ED05
|
Sulfamethoxypyridazine
|
|
|
|
|
|
J01ED06
|
Sulfaperin
|
|
|
|
|
|
J01ED07
|
Sulfamerazine
|
|
|
|
|
|
J01ED08
|
Sulfaphenazole
|
|
|
|
|
|
J01ED09
|
Sulfamazon
|
|
|
|
|
|
J01ED20
|
Combinations
|
|
|
|
|
J01EE
|
|
Combinations of sulfonamides and trimethoprim, including derivatives
|
|
|
|
|
|
J01EE01
|
Sulfamethoxazole and trimethoprim
|
|
|
|
|
|
J01EE02
|
Sulfadiazine and trimethoprim
|
|
|
|
|
|
J01EE03
|
Sulfametrole and trimethoprim
|
|
|
|
|
|
J01EE04
|
Sulfamoxole and trimethoprim
|
|
|
|
|
|
J01EE05
|
Sulfadimidine and trimethoprim
|
|
|
|
|
|
J01EE06
|
Sulfadiazine and tetroxoprim
|
|
|
|
|
|
J01EE07
|
Sulfamerazine and trimethoprim
|
|
|
|
J01F
|
|
|
Macrolides, lincosamides and streptogramins
|
|
|
|
|
J01FA
|
|
Macrolides
|
|
|
|
|
|
J01FA01
|
Erythromycin
|
|
|
|
|
|
J01FA02
|
Spiramycin
|
|
|
|
|
|
J01FA03
|
Midecamycin
|
|
|
|
|
|
J01FA05
|
Oleandomycin
|
|
|
|
|
|
J01FA06
|
Roxithromycin
|
|
|
|
|
|
J01FA07
|
Josamycin
|
|
|
|
|
|
J01FA08
|
Troleandomycin
|
|
|
|
|
|
J01FA09
|
Clarithromycin
|
|
|
|
|
|
J01FA10
|
Azithromycin
|
|
|
|
|
|
J01FA11
|
Miocamycin
|
|
|
|
|
|
J01FA12
|
Rokitamycin
|
|
|
|
|
|
J01FA13
|
Dirithromycin
|
|
|
|
|
|
J01FA14
|
Flurithromycin
|
|
|
|
|
|
J01FA15
|
Telithromycin
|
|
|
|
|
J01FF
|
|
Lincosamides
|
|
|
|
|
|
J01FF01
|
Clindamycin
|
|
|
|
|
|
J01FF02
|
Lincomycin
|
|
|
|
|
J01FG
|
|
Streptogramins
|
|
|
|
|
|
J01FG01
|
Pristinamycin
|
|
|
|
|
|
J01FG02
|
Quinupristin/dalfopristin
|
|
|
|
J01G
|
|
|
Aminoglycoside antibacterials
|
|
|
|
|
J01GA
|
|
Streptomycins
|
|
|
|
|
|
J01GA01
|
Streptomycin
|
|
|
|
|
|
J01GA02
|
Streptoduocin
|
|
|
|
|
J01GB
|
|
Other aminoglycosides
|
|
|
|
|
|
J01GB01
|
Tobramycin
|
|
|
|
|
|
J01GB03
|
Gentamicin
|
|
|
|
|
|
J01GB04
|
Kanamycin
|
|
|
|
|
|
J01GB05
|
Neomycin
|
|
|
|
|
|
J01GB06
|
Amikacin
|
|
|
|
|
|
J01GB07
|
Netilmicin
|
|
|
|
|
|
J01GB08
|
Sisomicin
|
|
|
|
|
|
J01GB09
|
Dibekacin
|
|
|
|
|
|
J01GB10
|
Ribostamycin
|
|
|
|
|
|
J01GB11
|
Isepamicin
|
|
|
|
|
|
J01GB12
|
Arbekacin
|
|
|
|
|
|
J01GB13
|
Bekanamycin
|
|
|
|
J01M
|
|
|
Quinolone antibacterials
|
|
|
|
|
J01MA
|
|
Fluoroquinolones
|
|
|
|
|
|
J01MA01
|
Ofloxacin
|
|
|
|
|
|
J01MA02
|
Ciprofloxacin
|
|
|
|
|
|
J01MA03
|
Pefloxacin
|
|
|
|
|
|
J01MA04
|
Enoxacin
|
|
|
|
|
|
J01MA05
|
Temafloxacin
|
|
|
|
|
|
J01MA06
|
Norfloxacin
|
|
|
|
|
|
J01MA07
|
Lomefloxacin
|
|
|
|
|
|
J01MA08
|
Fleroxacin
|
|
|
|
|
|
J01MA09
|
Sparfloxacin
|
|
|
|
|
|
J01MA10
|
Rufloxacin
|
|
|
|
|
|
J01MA11
|
Grepafloxacin
|
|
|
|
|
|
J01MA12
|
Levofloxacin
|
|
|
|
|
|
J01MA13
|
Trovafloxacin
|
|
|
|
|
|
J01MA14
|
Moxifloxacin
|
|
|
|
|
|
J01MA15
|
Gemifloxacin
|
|
|
|
|
|
J01MA16
|
Gatifloxacin
|
|
|
|
|
|
J01MA17
|
Prulifloxacin
|
|
|
|
|
|
J01MA18
|
Pazufloxacin
|
|
|
|
|
|
J01MA19
|
Garenoxacin
|
|
|
|
|
|
J01MA21
|
Sitafloxacin
|
|
|
|
|
J01MB
|
|
Other quinolones
|
|
|
|
|
|
J01MB01
|
Rosoxacin
|
|
|
|
|
|
J01MB02
|
Nalidixic acid
|
|
|
|
|
|
J01MB03
|
Piromidic acid
|
|
|
|
|
|
J01MB04
|
Pipemidic acid
|
|
|
|
|
|
J01MB05
|
Oxolinic acid
|
|
|
|
|
|
J01MB06
|
Cinoxacin
|
|
|
|
|
|
J01MB07
|
Flumequine
|
|
|
|
J01R
|
|
|
Combinations of antibacterials
|
|
|
|
|
J01RA
|
|
Combinations of antbacterials
|
|
|
|
|
|
J01RA01
|
Penicillins, combinations with other antibacterials
|
|
|
|
|
|
J01RA02
|
Sulfonamides, combinations with other antibacterials (excluding trimethoprim)
|
|
|
|
|
|
J01RA03
|
Cefuroxime, combinations with other antibacterials
|
|
|
|
|
|
J01RA04
|
Spiramycin, combinations with other antibacterials
|
|
|
|
J01X
|
|
|
Other antibacterials
|
|
|
|
|
J01XA
|
|
Glycopeptide antibacterials
|
|
|
|
|
|
J01XA01
|
Vancomycin
|
|
|
|
|
|
J01XA02
|
Teicoplanin
|
|
|
|
|
|
J01XA03
|
Telavancin
|
|
|
|
|
|
J01XA04
|
Dalbavancin
|
|
|
|
|
|
J01XA05
|
Oritavancin
|
|
|
|
|
J01XB
|
|
Polymyxins
|
|
|
|
|
|
J01XB01
|
Colistin
|
|
|
|
|
|
J01XB02
|
Polymyxin B
|
|
|
|
|
J01XC
|
|
Steroid antibacterials
|
|
|
|
|
|
J01XC01
|
Fusidic acid
|
|
|
|
|
J01XD
|
|
Imidazole derivatives
|
|
|
|
|
|
J01XD01
|
Metronidazole
|
|
|
|
|
|
J01XD02
|
Tinidazole
|
|
|
|
|
|
J01XD03
|
Ornidazole
|
|
|
|
|
J01XE
|
|
Nitrofuran derivatives
|
|
|
|
|
|
J01XE01
|
Nitrofurantoin
|
|
|
|
|
|
J01XE02
|
Nifurtoinol
|
|
|
|
|
J01XX
|
|
Other antibacterials
|
|
|
|
|
|
J01XX01
|
Fosfomycin
|
|
|
|
|
|
J01XX02
|
Xibornol
|
|
|
|
|
|
J01XX03
|
Clofoctol
|
|
|
|
|
|
J01XX04
|
Spectinomycin
|
|
|
|
|
|
J01XX05
|
Methenamine
|
|
|
|
|
|
J01XX06
|
Mandelic acid
|
|
|
|
|
|
J01XX07
|
Nitroxoline
|
|
|
|
|
|
J01XX08
|
Linezolid
|
|
|
|
|
|
J01XX09
|
Daptomycin
|
|
|
|
|
|
J01XX10
|
Bacitracin
|
|
|
J02
|
|
|
|
Antimycotics for systemic use
|
|
|
|
J02A
|
|
|
Antimycotics for systemic use
|
|
|
|
|
J02AA
|
|
Antibiotics
|
|
|
|
|
|
J02AA01
|
Amphotericin B
|
|
|
|
|
|
J02AA02
|
Hachimycin
|
|
|
|
|
J02AB
|
|
Imidazole derivatives
|
|
|
|
|
|
J02AB01
|
Miconazole
|
|
|
|
|
|
J02AB02
|
Ketoconazole
|
|
|
|
|
J02AC
|
|
Triazole derivatives
|
|
|
|
|
|
J02AC01
|
Fluconazole
|
|
|
|
|
|
J02AC02
|
Itraconazole
|
|
|
|
|
|
J02AC03
|
Voriconazole
|
|
|
|
|
|
J02AC04
|
Posaconazole
|
|
|
|
|
J02AX
|
|
Other antimycotics for systemic use
|
|
|
|
|
|
J02AX01
|
Flucytosine
|
|
|
|
|
|
J02AX04
|
Caspofungin
|
|
|
|
|
|
J02AX05
|
Micafungin
|
|
|
|
|
|
J02AX06
|
Anidulafungin
|
|
|
J04
|
|
|
|
Antimycobacterials
|
|
|
|
J04A
|
|
|
Drugs for treatment of tuberculosis
|
|
|
|
|
J04AA
|
|
Aminosalicylic acid and derivatives
|
|
|
|
|
|
J04AA01
|
Aminosalicylic acid
|
|
|
|
|
|
J04AA02
|
Sodium aminosalicylate
|
|
|
|
|
|
J04AA03
|
Calcium aminosalicylate
|
|
|
|
|
J04AB
|
|
Antibiotics
|
|
|
|
|
|
J04AB01
|
Cycloserine
|
|
|
|
|
|
J04AB02
|
Rifampicin
|
|
|
|
|
|
J04AB03
|
Rifamycin
|
|
|
|
|
|
J04AB04
|
Rifabutin
|
|
|
|
|
|
J04AB05
|
Rifapentin
|
|
|
|
|
|
J04AB30
|
Capreomycin
|
|
|
|
|
J04AC
|
|
Hydrazides
|
|
|
|
|
|
J04AC01
|
Isoniazid
|
|
|
|
|
|
J04AC51
|
Isoniazid, combinations
|
|
|
|
|
J04AD
|
|
Thiocarbamide derivatives
|
|
|
|
|
|
J04AD01
|
Protionamide
|
|
|
|
|
|
J04AD02
|
Tiocarlide
|
|
|
|
|
|
J04AD03
|
Ethionamide
|
|
|
|
|
J04AK
|
|
Other drugs for treatment of tuberculosis
|
|
|
|
|
|
J04AK01
|
Pyrazinamide
|
|
|
|
|
|
J04AK02
|
Ethambutol
|
|
|
|
|
|
J04AK03
|
Terizidone
|
|
|
|
|
|
J04AK04
|
Morinamide
|
|
|
|
|
J04AM
|
|
Combinations of drugs for treatment of tuberculosis
|
|
|
|
|
|
J04AM01
|
Streptomycin and isoniazid
|
|
|
|
|
|
J04AM02
|
Rifampicin and isoniazid
|
|
|
|
|
|
J04AM03
|
Ethambutol and isoniazid
|
|
|
|
|
|
J04AM04
|
Thioacetazone and isoniazid
|
|
|
|
|
|
J04AM05
|
Rifampicin, pyrazinamide and isoniazid
|
|
|
|
|
|
J04AM06
|
Rifampicin, pyrazinamide, ethambutol and isoniazid
|
|
|
|
J04B
|
|
|
Drugs for treatment of lepra
|
|
|
|
|
J04BA
|
|
Drugs for treatment of lepra
|
|
|
|
|
|
J04BA01
|
Clofazimine
|
|
|
|
|
|
J04BA02
|
Dapsone
|
|
|
|
|
|
J04BA03
|
Aldesulfone sodium
|
|
|
J05
|
|
|
|
Antivirals for systemic use
|
|
|
|
J05A
|
|
|
Direct acting antiviral drugs
|
|
|
|
|
J05AA
|
|
Thiosemicarbazones
|
|
|
|
|
|
J05AA01
|
Metisazone
|
|
|
|
|
J05AB
|
|
Nucleosides and nucleotides excluding reverse transcriptase inhibitors
|
|
|
|
|
|
J05AB01
|
Aciclovir
|
|
|
|
|
|
J05AB02
|
Idoxuridine
|
|
|
|
|
|
J05AB03
|
Vidarabine
|
|
|
|
|
|
J05AB04
|
Ribavirin
|
|
|
|
|
|
J05AB06
|
Ganciclovir
|
|
|
|
|
|
J05AB09
|
Famciclovir
|
|
|
|
|
|
J05AB11
|
Valaciclovir
|
|
|
|
|
|
J05AB12
|
Cidofovir
|
|
|
|
|
|
J05AB13
|
Penciclovir
|
|
|
|
|
|
J05AB14
|
Valganciclovir
|
|
|
|
|
|
J05AB15
|
Brivudine
|
|
|
|
|
|
J05AB54
|
Ribavirin, combinations
|
|
|
|
|
J05AC
|
|
Cyclic amines
|
|
|
|
|
|
J05AC02
|
Rimantadine
|
|
|
|
|
|
J05AC03
|
Tromantadine
|
|
|
|
|
J05AD
|
|
Phosphonic acid derivatives
|
|
|
|
|
|
J05AD01
|
Foscarnet
|
|
|
|
|
|
J05AD02
|
Fosfonet
|
|
|
|
|
J05AE
|
|
Protease inhibitors
|
|
|
|
|
|
J05AE01
|
Saquinavir
|
|
|
|
|
|
J05AE02
|
Indinavir
|
|
|
|
|
|
J05AE03
|
Ritonavir
|
|
|
|
|
|
J05AE04
|
Nelfinavir
|
|
|
|
|
|
J05AE05
|
Amprenavir
|
|
|
|
|
|
J05AE07
|
Fosamprenavir
|
|
|
|
|
|
J05AE08
|
Atazanavir
|
|
|
|
|
|
J05AE09
|
Tipranavir
|
|
|
|
|
|
J05AE10
|
Darunavir
|
|
|
|
|
|
J05AE11
|
Telaprevir
|
|
|
|
|
|
J05AE12
|
Boceprevir
|
|
|
|
|
J05AF
|
|
Nucleoside and nucleotide reverse transcriptase inhibitors
|
|
|
|
|
|
J05AF01
|
Zidovudine
|
|
|
|
|
|
J05AF02
|
Didanosine
|
|
|
|
|
|
J05AF03
|
Zalcitabine
|
|
|
|
|
|
J05AF04
|
Stavudine
|
|
|
|
|
|
J05AF05
|
Lamivudine
|
|
|
|
|
|
J05AF06
|
Abacavir
|
|
|
|
|
|
J05AF07
|
Tenofovir disoproxil
|
|
|
|
|
|
J05AF08
|
Adefovir dipivoxil
|
|
|
|
|
|
J05AF09
|
Emtricitabine
|
|
|
|
|
|
J05AF10
|
Entecavir
|
|
|
|
|
|
J05AF11
|
Telbivudine
|
|
|
|
|
|
J05AF12
|
Clevudine
|
|
|
|
|
J05AG
|
|
Non-nucleoside reverse transcriptase inhibitors
|
|
|
|
|
|
J05AG01
|
Nevirapine
|
|
|
|
|
|
J05AG02
|
Delavirdine
|
|
|
|
|
|
J05AG03
|
Efavirenz
|
|
|
|
|
|
J05AG04
|
Etravirine
|
|
|
|
|
|
J05AG05
|
Rilpivirine
|
|
|
|
|
J05AH
|
|
Neuraminidase inhibitors
|
|
|
|
|
|
J05AH01
|
Zanamivir
|
|
|
|
|
|
J05AH02
|
Oseltamivir
|
|
|
|
|
J05AR
|
|
Antivirals for treatment of HIV infections, combinations
|
|
|
|
|
|
J05AR01
|
Zidovudine and lamivudine
|
|
|
|
|
|
J05AR02
|
Lamivudine and abacavir
|
|
|
|
|
|
J05AR03
|
Tenofovir disoproxil and emtricitabine
|
|
|
|
|
|
J05AR04
|
Zidovudine, lamivudine and abacavir
|
|
|
|
|
|
J05AR05
|
Zidovudine, lamivudine and nevirapine
|
|
|
|
|
|
J05AR06
|
Emtricitabine, tenofovir disoproxil and efavirenz
|
|
|
|
|
|
J05AR07
|
Stavudine, lamivudine and nevirapine
|
|
|
|
|
|
J05AR08
|
Emtricitabine, tenofovir disoproxil and rilpivirine
|
|
|
|
|
|
J05AR09
|
Emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat
|
|
|
|
|
|
J05AR10
|
Lopinavir and ritonavir
|
|
|
|
|
J05AX
|
|
Other antivirals
|
|
|
|
|
|
J05AX01
|
Moroxydine
|
|
|
|
|
|
J05AX02
|
Lysozyme
|
|
|
|
|
|
J05AX05
|
Inosine pranobex
|
|
|
|
|
|
J05AX06
|
Pleconaril
|
|
|
|
|
|
J05AX07
|
Enfuvirtide
|
|
|
|
|
|
J05AX08
|
Raltegravir
|
|
|
|
|
|
J05AX09
|
Maraviroc
|
|
|
|
|
|
J05AX10
|
Maribavir
|
|
|
|
|
|
J05AX11
|
Elvitegravir
|
|
|
J06
|
|
|
|
Immune sera and immunoglobulins
|
|
|
|
J06A
|
|
|
Immune sera
|
|
|
|
|
J06AA
|
|
Immune sera
|
|
|
|
|
|
J06AA01
|
Diphtheria antitoxin
|
|
|
|
|
|
J06AA02
|
Tetanus antitoxin
|
|
|
|
|
|
J06AA03
|
Snake venom antiserum
|
|
|
|
|
|
J06AA04
|
Botulinum antitoxin
|
|
|
|
|
|
J06AA05
|
Gas-gangrene sera
|
|
|
|
|
|
J06AA06
|
Rabies serum
|
|
|
|
J06B
|
|
|
Immunoglobulins
|
|
|
|
|
J06BA
|
|
Immunoglobulins, normal human
|
|
|
|
|
|
J06BA01
|
Immunoglobulins, normal human, for extravascular administration
|
|
|
|
|
|
J06BA02
|
Immunoglobulins, normal human, for intravascular administration
|
|
|
|
|
J06BB
|
|
Specific immunoglobulins
|
|
|
|
|
|
J06BB01
|
Anti-D (rh) immunoglobulin
|
|
|
|
|
|
J06BB02
|
Tetanus immunoglobulin
|
|
|
|
|
|
J06BB03
|
Varicella/zoster immunoglobulin
|
|
|
|
|
|
J06BB04
|
Hepatitis B immunoglobulin
|
|
|
|
|
|
J06BB05
|
Rabies immunoglobulin
|
|
|
|
|
|
J06BB06
|
Rubella immunoglobulin
|
|
|
|
|
|
J06BB07
|
Vaccinia immunoglobulin
|
|
|
|
|
|
J06BB08
|
Staphylococcus immunoglobulin
|
|
|
|
|
|
J06BB09
|
Cytomegalovirus immunoglobulin
|
|
|
|
|
|
J06BB10
|
Diphtheria immunoglobulin
|
|
|
|
|
|
J06BB11
|
Hepatitis A immunoglobulin
|
|
|
|
|
|
J06BB12
|
Encephalitis, tick borne immunoglobulin
|
|
|
|
|
|
J06BB13
|
Pertussis immunoglobulin
|
|
|
|
|
|
J06BB14
|
Morbilli immunoglobulin
|
|
|
|
|
|
J06BB15
|
Parotitis immunoglobulin
|
|
|
|
|
|
J06BB16
|
Palivizumab
|
|
|
|
|
|
J06BB17
|
Motavizumab
|
|
|
|
|
|
J06BB30
|
Combinations
|
|
|
|
|
J06BC
|
|
Other immunoglobulins
|
|
|
|
|
|
J06BC01
|
Nebacumab
|
| L
|
|
|
|
|
Antineoplastic and immunomodulating agents
|
|
|
L01
|
|
|
|
Antineoplastic agents
|
|
|
|
L01A
|
|
|
Alkylating agents
|
|
|
|
|
L01AA
|
|
Nitrogen mustard analogues
|
|
|
|
|
|
L01AA01
|
Cyclophosphamide
|
|
|
|
|
|
L01AA02
|
Chlorambucil
|
|
|
|
|
|
L01AA03
|
Melphalan
|
|
|
|
|
|
L01AA05
|
Chlormethine
|
|
|
|
|
|
L01AA06
|
Ifosfamide
|
|
|
|
|
|
L01AA07
|
Trofosfamide
|
|
|
|
|
|
L01AA08
|
Prednimustine
|
|
|
|
|
|
L01AA09
|
Bendamustine
|
|
|
|
|
L01AB
|
|
Alkyl sulfonates
|
|
|
|
|
|
L01AB01
|
Busulfan
|
|
|
|
|
|
L01AB02
|
Treosulfan
|
|
|
|
|
|
L01AB03
|
Mannosulfan
|
|
|
|
|
L01AC
|
|
Ethylene imines
|
|
|
|
|
|
L01AC01
|
Thiotepa
|
|
|
|
|
|
L01AC02
|
Triaziquone
|
|
|
|
|
|
L01AC03
|
Carboquone
|
|
|
|
|
L01AD
|
|
Nitrosoureas
|
|
|
|
|
|
L01AD01
|
Carmustine
|
|
|
|
|
|
L01AD02
|
Lomustine
|
|
|
|
|
|
L01AD03
|
Semustine
|
|
|
|
|
|
L01AD04
|
Streptozocin
|
|
|
|
|
|
L01AD05
|
Fotemustine
|
|
|
|
|
|
L01AD06
|
Nimustine
|
|
|
|
|
|
L01AD07
|
Ranimustine
|
|
|
|
|
L01AG
|
|
Epoxides
|
|
|
|
|
|
L01AG01
|
Etoglucid
|
|
|
|
|
L01AX
|
|
Other alkylating agents
|
|
|
|
|
|
L01AX01
|
Mitobronitol
|
|
|
|
|
|
L01AX02
|
Pipobroman
|
|
|
|
|
|
L01AX03
|
Temozolomide
|
|
|
|
|
|
L01AX04
|
Dacarbazine
|
|
|
|
L01B
|
|
|
Antimetabolites
|
|
|
|
|
L01BA
|
|
Folic acid analogues
|
|
|
|
|
|
L01BA01
|
Methotrexate
|
|
|
|
|
|
L01BA03
|
Raltitrexed
|
|
|
|
|
|
L01BA04
|
Pemetrexed
|
|
|
|
|
|
L01BA05
|
Pralatrexate
|
|
|
|
|
L01BB
|
|
Purine analogues
|
|
|
|
|
|
L01BB02
|
Mercaptopurine
|
|
|
|
|
|
L01BB03
|
Tioguanine
|
|
|
|
|
|
L01BB04
|
Cladribine
|
|
|
|
|
|
L01BB05
|
Fludarabine
|
|
|
|
|
|
L01BB06
|
Clofarabine
|
|
|
|
|
|
L01BB07
|
Nelarabine
|
|
|
|
|
L01BC
|
|
Pyrimidine analogues
|
|
|
|
|
|
L01BC01
|
Cytarabine
|
|
|
|
|
|
L01BC02
|
Fluorouracil
|
|
|
|
|
|
L01BC03
|
Tegafur
|
|
|
|
|
|
L01BC04
|
Carmofur
|
|
|
|
|
|
L01BC05
|
Gemcitabine
|
|
|
|
|
|
L01BC06
|
Capecitabine
|
|
|
|
|
|
L01BC07
|
Azacitidine
|
|
|
|
|
|
L01BC08
|
Decitabine
|
|
|
|
|
|
L01BC52
|
Fluorouracil, combinations
|
|
|
|
|
|
L01BC53
|
Tegafur, combinations
|
|
|
|
L01C
|
|
|
Plant alkaloids and other natural products
|
|
|
|
|
L01CA
|
|
Vinca alkaloids and analogues
|
|
|
|
|
|
L01CA01
|
Vinblastine
|
|
|
|
|
|
L01CA02
|
Vincristine
|
|
|
|
|
|
L01CA03
|
Vindesine
|
|
|
|
|
|
L01CA04
|
Vinorelbine
|
|
|
|
|
|
L01CA05
|
Vinflunine
|
|
|
|
|
L01CB
|
|
Podophyllotoxin derivatives
|
|
|
|
|
|
L01CB01
|
Etoposide
|
|
|
|
|
|
L01CB02
|
Teniposide
|
|
|
|
|
L01CC
|
|
Colchicine derivatives
|
|
|
|
|
|
L01CC01
|
Demecolcine
|
|
|
|
|
L01CD
|
|
Taxanes
|
|
|
|
|
|
L01CD01
|
Paclitaxel
|
|
|
|
|
|
L01CD02
|
Docetaxel
|
|
|
|
|
|
L01CD03
|
Paclitaxel poliglumex
|
|
|
|
|
|
L01CD04
|
Cabazitaxel
|
|
|
|
|
L01CX
|
|
Other plant alkaloids and natural products
|
|
|
|
|
|
L01CX01
|
Trabectedin
|
|
|
|
L01D
|
|
|
Cytotoxic antibiotics and related substances
|
|
|
|
|
L01DA
|
|
Actinomycines
|
|
|
|
|
|
L01DA01
|
Dactinomycin
|
|
|
|
|
L01DB
|
|
Anthracyclines and related substances
|
|
|
|
|
|
L01DB01
|
Doxorubicin
|
|
|
|
|
|
L01DB02
|
Daunorubicin
|
|
|
|
|
|
L01DB03
|
Epirubicin
|
|
|
|
|
|
L01DB04
|
Aclarubicin
|
|
|
|
|
|
L01DB05
|
Zorubicin
|
|
|
|
|
|
L01DB06
|
Idarubicin
|
|
|
|
|
|
L01DB07
|
Mitoxantrone
|
|
|
|
|
|
L01DB08
|
Pirarubicin
|
|
|
|
|
|
L01DB09
|
Valrubicin
|
|
|
|
|
|
L01DB10
|
Amrubicin
|
|
|
|
|
|
L01DB11
|
Pixantrone
|
|
|
|
|
L01DC
|
|
Other cytotoxic antibiotics
|
|
|
|
|
|
L01DC01
|
Bleomycin
|
|
|
|
|
|
L01DC02
|
Plicamycin
|
|
|
|
|
|
L01DC03
|
Mitomycin
|
|
|
|
|
|
L01DC04
|
Ixabepilone
|
|
|
|
L01X
|
|
|
Other antineoplastic agents
|
|
|
|
|
L01XA
|
|
Platinum compounds
|
|
|
|
|
|
L01XA01
|
Cisplatin
|
|
|
|
|
|
L01XA02
|
Carboplatin
|
|
|
|
|
|
L01XA03
|
Oxaliplatin
|
|
|
|
|
|
L01XA04
|
Satraplatin
|
|
|
|
|
|
L01XA05
|
Polyplatillen
|
|
|
|
|
L01XB
|
|
Methylhydrazines
|
|
|
|
|
|
L01XB01
|
Procarbazine
|
|
|
|
|
L01XC
|
|
Monoclonal antibodies
|
|
|
|
|
|
L01XC01
|
Edrecolomab
|
|
|
|
|
|
L01XC02
|
Rituximab
|
|
|
|
|
|
L01XC03
|
Trastuzumab
|
|
|
|
|
|
L01XC04
|
Alemtuzumab
|
|
|
|
|
|
L01XC05
|
Gemtuzumab
|
|
|
|
|
|
L01XC06
|
Cetuximab
|
|
|
|
|
|
L01XC07
|
Bevacizumab
|
|
|
|
|
|
L01XC08
|
Panitumumab
|
|
|
|
|
|
L01XC09
|
Catumaxomab
|
|
|
|
|
|
L01XC10
|
Ofatumumab
|
|
|
|
|
|
L01XC11
|
Ipilimumab
|
|
|
|
|
|
L01XC12
|
Brentuximab vedotin
|
|
|
|
|
|
L01XC13
|
Pertuzumab
|
|
|
|
|
L01XD
|
|
Sensitizers used in photodynamic/radiation therapy
|
|
|
|
|
|
L01XD01
|
Porfimer sodium
|
|
|
|
|
|
L01XD03
|
Methyl aminolevulinate
|
|
|
|
|
|
L01XD04
|
Aminolevulinic acid
|
|
|
|
|
|
L01XD05
|
Temoporfin
|
|
|
|
|
|
L01XD06
|
Efaproxiral
|
|
|
|
|
L01XE
|
|
Protein kinase inhibitors
|
|
|
|
|
|
L01XE01
|
Imatinib
|
|
|
|
|
|
L01XE02
|
Gefitinib
|
|
|
|
|
|
L01XE03
|
Erlotinib
|
|
|
|
|
|
L01XE04
|
Sunitinib
|
|
|
|
|
|
L01XE05
|
Sorafenib
|
|
|
|
|
|
L01XE06
|
Dasatinib
|
|
|
|
|
|
L01XE07
|
Lapatinib
|
|
|
|
|
|
L01XE08
|
Nilotinib
|
|
|
|
|
|
L01XE09
|
Temsirolimus
|
|
|
|
|
|
L01XE10
|
Everolimus
|
|
|
|
|
|
L01XE11
|
Pazopanib
|
|
|
|
|
|
L01XE12
|
Vandetanib
|
|
|
|
|
|
L01XE13
|
Afatinib
|
|
|
|
|
|
L01XE14
|
Bosutinib
|
|
|
|
|
|
L01XE15
|
Vemurafenib
|
|
|
|
|
|
L01XE16
|
Crizotinib
|
|
|
|
|
|
L01XE17
|
Axitinib
|
|
|
|
|
|
L01XE18
|
Ruxolitinib
|
|
|
|
|
|
L01XE19
|
Ridaforolimus
|
|
|
|
|
|
L01XE21
|
Regorafenib
|
|
|
|
|
|
L01XE22
|
Masitinib
|
|
|
|
|
L01XX
|
|
Other antineoplastic agents
|
|
|
|
|
|
L01XX01
|
Amsacrine
|
|
|
|
|
|
L01XX02
|
Asparaginase
|
|
|
|
|
|
L01XX03
|
Altretamine
|
|
|
|
|
|
L01XX05
|
Hydroxycarbamide
|
|
|
|
|
|
L01XX07
|
Lonidamine
|
|
|
|
|
|
L01XX08
|
Pentostatin
|
|
|
|
|
|
L01XX09
|
Miltefosine
|
|
|
|
|
|
L01XX10
|
Masoprocol
|
|
|
|
|
|
L01XX11
|
Estramustine
|
|
|
|
|
|
L01XX14
|
Tretinoin
|
|
|
|
|
|
L01XX16
|
Mitoguazone
|
|
|
|
|
|
L01XX17
|
Topotecan
|
|
|
|
|
|
L01XX18
|
Tiazofurine
|
|
|
|
|
|
L01XX19
|
Irinotecan
|
|
|
|
|
|
L01XX22
|
Alitretinoin
|
|
|
|
|
|
L01XX23
|
Mitotane
|
|
|
|
|
|
L01XX24
|
Pegaspargase
|
|
|
|
|
|
L01XX25
|
Bexarotene
|
|
|
|
|
|
L01XX27
|
Arsenic trioxide
|
|
|
|
|
|
L01XX29
|
Denileukin diftitox
|
|
|
|
|
|
L01XX32
|
Bortezomib
|
|
|
|
|
|
L01XX33
|
Celecoxib
|
|
|
|
|
|
L01XX35
|
Anagrelide
|
|
|
|
|
|
L01XX36
|
Oblimersen
|
|
|
|
|
|
L01XX37
|
Sitimagene ceradenovec
|
|
|
|
|
|
L01XX38
|
Vorinostat
|
|
|
|
|
|
L01XX39
|
Romidepsin
|
|
|
|
|
|
L01XX40
|
Omacetaxine mepesuccinate
|
|
|
|
|
|
L01XX41
|
Eribulin
|
|
|
|
|
|
L01XX42
|
Panobinostat
|
|
|
|
|
|
L01XX43
|
Vismodegib
|
|
|
|
|
L01XY
|
|
Combinations of antineoplastic agents
|
|
|
|
|
|
|
Empty
|
|
|
L02
|
|
|
|
Endocrine therapy
|
|
|
|
L02A
|
|
|
Hormones and related agents
|
|
|
|
|
L02AA
|
|
Estrogens
|
|
|
|
|
|
L02AA01
|
Diethylstilbestrol
|
|
|
|
|
|
L02AA02
|
Polyestradiol phosphate
|
|
|
|
|
|
L02AA03
|
Ethinylestradiol
|
|
|
|
|
|
L02AA04
|
Fosfestrol
|
|
|
|
|
L02AB
|
|
Progestogens
|
|
|
|
|
|
L02AB01
|
Megestrol
|
|
|
|
|
|
L02AB02
|
Medroxyprogesterone
|
|
|
|
|
|
L02AB03
|
Gestonorone
|
|
|
|
|
L02AE
|
|
Gonadotropin-releasing hormone analogues
|
|
|
|
|
|
L02AE01
|
Buserelin
|
|
|
|
|
|
L02AE02
|
Leuprorelin
|
|
|
|
|
|
L02AE03
|
Goserelin
|
|
|
|
|
|
L02AE04
|
Triptorelin
|
|
|
|
|
|
L02AE05
|
Histrelin
|
|
|
|
|
L02AX
|
|
Other hormones
|
|
|
|
|
|
|
empty
|
|
|
|
L02B
|
|
|
Hormone antagonists and related agents
|
|
|
|
|
L02BA
|
|
Anti-estrogens
|
|
|
|
|
|
L02BA01
|
Tamoxifen
|
|
|
|
|
|
L02BA02
|
Toremifene
|
|
|
|
|
|
L02BA03
|
Fulvestrant
|
|
|
|
|
L02BB
|
|
Anti-androgens
|
|
|
|
|
|
L02BB01
|
Flutamide
|
|
|
|
|
|
L02BB02
|
Nilutamide
|
|
|
|
|
|
L02BB03
|
Bicalutamide
|
|
|
|
|
L02BG
|
|
Aromatase inhibitors
|
|
|
|
|
|
L02BG01
|
Aminogluthetimide
|
|
|
|
|
|
L02BG02
|
Formestane
|
|
|
|
|
|
L02BG03
|
Anastrozole
|
|
|
|
|
|
L02BG04
|
Letrozole
|
|
|
|
|
|
L02BG05
|
Vorozole
|
|
|
|
|
|
L02BG06
|
Exemestane
|
|
|
|
|
L02BX
|
|
Other hormone antagonists and related agents
|
|
|
|
|
|
L02BX01
|
Abarelix
|
|
|
|
|
|
L02BX02
|
Degarelix
|
|
|
|
|
|
L02BX03
|
Abiraterone
|
|
|
L03
|
|
|
|
Immunostimulants
|
|
|
|
L03A
|
|
|
Immunostimulants
|
|
|
|
|
L03AA
|
|
Colony stimulating factors
|
|
|
|
|
|
L03AA02
|
Filgrastim
|
|
|
|
|
|
L03AA03
|
Molgramostim
|
|
|
|
|
|
L03AA09
|
Sargramostim
|
|
|
|
|
|
L03AA10
|
Lenograstim
|
|
|
|
|
|
L03AA12
|
Ancestim
|
|
|
|
|
|
L03AA13
|
Pegfilgrastim
|
|
|
|
|
|
L03AA14
|
Lipegfilgrastim
|
|
|
|
|
L03AB
|
|
Interferons
|
|
|
|
|
|
L03AB01
|
Interferon alfa natural
|
|
|
|
|
|
L03AB02
|
Interferon beta natural
|
|
|
|
|
|
L03AB03
|
Interferon gamma
|
|
|
|
|
|
L03AB04
|
Interferon alfa-2a
|
|
|
|
|
|
L03AB05
|
Interferon alfa-2b
|
|
|
|
|
|
L03AB06
|
Interferon alfa-n1
|
|
|
|
|
|
L03AB07
|
Interferon beta-1a
|
|
|
|
|
|
L03AB08
|
Interferon beta-1b
|
|
|
|
|
|
L03AB09
|
Interferon alfacon-1
|
|
|
|
|
|
L03AB10
|
Peginterferon alfa-2b
|
|
|
|
|
|
L03AB11
|
Peginterferon alfa-2a
|
|
|
|
|
|
L03AB12
|
Albinterferon alfa-2b
|
|
|
|
|
|
L03AB60
|
Peginterferon alfa-2b, combinations
|
|
|
|
|
|
L03AB61
|
Peginterferon alfa-2a, combinations
|
|
|
|
|
L03AC
|
|
Interleukins
|
|
|
|
|
|
L03AC01
|
Aldesleukin
|
|
|
|
|
|
L03AC02
|
Oprelvekin
|
|
|
|
|
L03AX
|
|
Other immunostimulants
|
|
|
|
|
|
L03AX01
|
Lentinan
|
|
|
|
|
|
L03AX02
|
Roquinimex
|
|
|
|
|
|
L03AX03
|
BCG vaccine
|
|
|
|
|
|
L03AX04
|
Pegademase
|
|
|
|
|
|
L03AX05
|
Pidotimod
|
|
|
|
|
|
L03AX07
|
Poly I:C
|
|
|
|
|
|
L03AX08
|
Poly ICLC
|
|
|
|
|
|
L03AX09
|
Thymopentin
|
|
|
|
|
|
L03AX10
|
Immunocyanin
|
|
|
|
|
|
L03AX11
|
Tasonermin
|
|
|
|
|
|
L03AX12
|
Melanoma vaccine
|
|
|
|
|
|
L03AX13
|
Glatiramer acetate
|
|
|
|
|
|
L03AX14
|
Histamine dihydrochloride
|
|
|
|
|
|
L03AX15
|
Mifamurtide
|
|
|
|
|
|
L03AX16
|
Plerixafor
|
|
|
|
|
|
L03AX17
|
Sipuleucel-T
|
|
|
L04
|
|
|
|
Immunosuppressants
|
|
|
|
L04A
|
|
|
Immunosuppressants
|
|
|
|
|
L04AA
|
|
Selective immunosuppressants
|
|
|
|
|
|
L04AA02
|
Muromonab-CD3
|
|
|
|
|
|
L04AA03
|
Antilymphocyte immunoglobulin (horse)
|
|
|
|
|
|
L04AA04
|
Antithymocyte immunoglobulin (rabbit)
|
|
|
|
|
|
L04AA06
|
Mycophenolic acid
|
|
|
|
|
|
L04AA10
|
Sirolimus
|
|
|
|
|
|
L04AA13
|
Leflunomide
|
|
|
|
|
|
L04AA15
|
Alefacept
|
|
|
|
|
|
L04AA18
|
Everolimus
|
|
|
|
|
|
L04AA19
|
Gusperimus
|
|
|
|
|
|
L04AA21
|
Efalizumab
|
|
|
|
|
|
L04AA22
|
Abetimus
|
|
|
|
|
|
L04AA23
|
Natalizumab
|
|
|
|
|
|
L04AA24
|
Abatacept
|
|
|
|
|
|
L04AA25
|
Eculizumab
|
|
|
|
|
|
L04AA26
|
Belimumab
|
|
|
|
|
|
L04AA27
|
Fingolimod
|
|
|
|
|
|
L04AA28
|
Belatacept
|
|
|
|
|
|
L04AA29
|
Tofacitinib
|
|
|
|
|
L04AB
|
|
Tumor necrosis factor alpha (TNF-α) inhibitors
|
|
|
|
|
|
L04AB01
|
Etanercept
|
|
|
|
|
|
L04AB02
|
Infliximab
|
|
|
|
|
|
L04AB03
|
Afelimomab
|
|
|
|
|
|
L04AB04
|
Adalimumab
|
|
|
|
|
|
L04AB05
|
Certolizumab pegol
|
|
|
|
|
|
L04AB06
|
Golimumab
|
|
|
|
|
L04AC
|
|
Interleukin inhibitors
|
|
|
|
|
|
L04AC01
|
Daclizumab
|
|
|
|
|
|
L04AC02
|
Basiliximab
|
|
|
|
|
|
L04AC03
|
Anakinra
|
|
|
|
|
|
L04AC04
|
Rilonacept
|
|
|
|
|
|
L04AC05
|
Ustekinumab
|
|
|
|
|
|
L04AC06
|
Mepolizumab
|
|
|
|
|
|
L04AC07
|
Tocilizumab
|
|
|
|
|
|
L04AC08
|
Canakinumab
|
|
|
|
|
|
L04AC09
|
Briakinumab
|
|
|
|
|
|
L04AC10
|
Secukinumab
|
|
|
|
|
L04AD
|
|
Calcineurin inhibitors
|
|
|
|
|
|
L04AD01
|
Ciclosporin
|
|
|
|
|
|
L04AD02
|
Tacrolimus
|
|
|
|
|
|
L04AD03
|
Voclosporin
|
|
|
|
|
L04AX
|
|
Other immunosuppressants
|
|
|
|
|
|
L04AX01
|
Azathioprine
|
|
|
|
|
|
L04AX02
|
Thalidomide
|
|
|
|
|
|
L04AX03
|
Methotrexate
|
|
|
|
|
|
L04AX04
|
Lenalidomide
|
|
|
|
|
|
L04AX05
|
Pirfenidone
|
| M
|
|
|
|
|
Musculo-skeletal system
|
|
|
M01
|
|
|
|
Anti-inflammatory and antirheumatic products
|
|
|
|
M01A
|
|
|
Anti-inflammatory and antirheumatic products, non-steroids
|
|
|
|
|
M01AA
|
|
Butylpyrazolidines
|
|
|
|
|
|
M01AA01
|
Phenylbutazone
|
|
|
|
|
|
M01AA02
|
Mofebutazone
|
|
|
|
|
|
M01AA03
|
Oxyphenbutazone
|
|
|
|
|
|
M01AA05
|
Clofezone
|
|
|
|
|
|
M01AA06
|
Kebuzone
|
|
|
|
|
M01AB
|
|
Acetic acid derivatives and related substances
|
|
|
|
|
|
M01AB01
|
Indometacin
|
|
|
|
|
|
M01AB02
|
Sulindac
|
|
|
|
|
|
M01AB03
|
Tolmetin
|
|
|
|
|
|
M01AB04
|
Zomepirac
|
|
|
|
|
|
M01AB05
|
Diclofenac
|
|
|
|
|
|
M01AB06
|
Alclofenac
|
|
|
|
|
|
M01AB07
|
Bumadizone
|
|
|
|
|
|
M01AB08
|
Etodolac
|
|
|
|
|
|
M01AB09
|
Lonazolac
|
|
|
|
|
|
M01AB10
|
Fentiazac
|
|
|
|
|
|
M01AB11
|
Acemetacin
|
|
|
|
|
|
M01AB12
|
Difenpiramide
|
|
|
|
|
|
M01AB13
|
Oxametacin
|
|
|
|
|
|
M01AB14
|
Proglumetacin
|
|
|
|
|
|
M01AB15
|
Ketorolac
|
|
|
|
|
|
M01AB16
|
Aceclofenac
|
|
|
|
|
|
M01AB17
|
Bufexamac
|
|
|
|
|
|
M01AB51
|
Indometacin, combinations
|
|
|
|
|
|
M01AB55
|
Diclofenac, combinations
|
|
|
|
|
M01AC
|
|
Oxicams
|
|
|
|
|
|
M01AC01
|
Piroxicam
|
|
|
|
|
|
M01AC02
|
Tenoxicam
|
|
|
|
|
|
M01AC04
|
Droxicam
|
|
|
|
|
|
M01AC05
|
Lornoxicam
|
|
|
|
|
|
M01AC06
|
Meloxicam
|
|
|
|
|
|
M01AC56
|
Meloxicam, combinations
|
|
|
|
|
M01AE
|
|
Propionic acid derivatives
|
|
|
|
|
|
M01AE01
|
Ibuprofen
|
|
|
|
|
|
M01AE02
|
Naproxen
|
|
|
|
|
|
M01AE03
|
Ketoprofen
|
|
|
|
|
|
M01AE04
|
Fenoprofen
|
|
|
|
|
|
M01AE05
|
Fenbufen
|
|
|
|
|
|
M01AE06
|
Benoxaprofen
|
|
|
|
|
|
M01AE07
|
Suprofen
|
|
|
|
|
|
M01AE08
|
Pirprofen
|
|
|
|
|
|
M01AE09
|
Flurbiprofen
|
|
|
|
|
|
M01AE10
|
Indoprofen
|
|
|
|
|
|
M01AE11
|
Tiaprofenic acid
|
|
|
|
|
|
M01AE12
|
Oxaprozin
|
|
|
|
|
|
M01AE13
|
Ibuproxam
|
|
|
|
|
|
M01AE14
|
Dexibuprofen
|
|
|
|
|
|
M01AE15
|
Flunoxaprofen
|
|
|
|
|
|
M01AE16
|
Alminoprofen
|
|
|
|
|
|
M01AE17
|
Dexketoprofen
|
|
|
|
|
|
M01AE18
|
Naproxcinod
|
|
|
|
|
|
M01AE51
|
Ibuprofen, combinations
|
|
|
|
|
|
M01AE52
|
Naproxen and esomeprazole
|
|
|
|
|
|
M01AE53
|
Ketoprofen, combinations
|
|
|
|
|
|
M01AE56
|
Naproxen and misoprostol
|
|
|
|
|
M01AG
|
|
Fenamates
|
|
|
|
|
|
M01AG01
|
Mefenamic acid
|
|
|
|
|
|
M01AG02
|
Tolfenamic acid
|
|
|
|
|
|
M01AG03
|
Flufenamic acid
|
|
|
|
|
|
M01AG04
|
Meclofenamic acid
|
|
|
|
|
M01AH
|
|
Coxibs
|
|
|
|
|
|
M01AH01
|
Celecoxib
|
|
|
|
|
|
M01AH02
|
Rofecoxib
|
|
|
|
|
|
M01AH03
|
Valdecoxib
|
|
|
|
|
|
M01AH04
|
Parecoxib
|
|
|
|
|
|
M01AH05
|
Etoricoxib
|
|
|
|
|
|
M01AH06
|
Lumiracoxib
|
|
|
|
|
M01AX
|
|
Other anti-inflammatory and antirheumatic agents, non-steroids
|
|
|
|
|
|
M01AX01
|
Nabumetone
|
|
|
|
|
|
M01AX02
|
Niflumic acid
|
|
|
|
|
|
M01AX04
|
Azapropazone
|
|
|
|
|
|
M01AX05
|
Glucosamine
|
|
|
|
|
|
M01AX07
|
Benzydamine
|
|
|
|
|
|
M01AX12
|
Glucosaminoglycan polysulfate
|
|
|
|
|
|
M01AX13
|
Proquazone
|
|
|
|
|
|
M01AX14
|
Orgotein
|
|
|
|
|
|
M01AX17
|
Nimesulide
|
|
|
|
|
|
M01AX18
|
Feprazone
|
|
|
|
|
|
M01AX21
|
Diacerein
|
|
|
|
|
|
M01AX22
|
Morniflumate
|
|
|
|
|
|
M01AX23
|
Tenidap
|
|
|
|
|
|
M01AX24
|
Oxaceprol
|
|
|
|
|
|
M01AX25
|
Chondroitin sulfate
|
|
|
|
|
|
M01AX26
|
Avocado and soyabean oil, unsaponifiables
|
|
|
|
|
|
M01AX68
|
Feprazone, combinations
|
|
|
|
M01B
|
|
|
Anti-inflammatory/antirheumatic agents in combination
|
|
|
|
|
M01BA
|
|
Anti-inflammatory/antirheumatic agents in combination with corticosteroids
|
|
|
|
|
|
M01BA01
|
Phenylbutazone and corticosteroids
|
|
|
|
|
|
M01BA02
|
Dipyrocetyl and corticosteroids
|
|
|
|
|
|
M01BA03
|
Acetylsalicylic acid and corticosteroids
|
|
|
|
|
M01BX
|
|
Other anti-inflammatory/antirheumatic agents in combination with other drugs
|
|
|
|
|
|
|
empty
|
|
|
|
M01C
|
|
|
Specific antirheumatic agents
|
|
|
|
|
M01CA
|
|
Quinolines
|
|
|
|
|
|
M01CA03
|
Oxycinchophen
|
|
|
|
|
M01CB
|
|
Gold preparations
|
|
|
|
|
|
M01CB01
|
Sodium aurothiomalate
|
|
|
|
|
|
M01CB02
|
Sodium aurothiosulfate
|
|
|
|
|
|
M01CB03
|
Auranofin
|
|
|
|
|
|
M01CB04
|
Aurothioglucose
|
|
|
|
|
|
M01CB05
|
Aurotioprol
|
|
|
|
|
M01CC
|
|
Penicillamine and similar agents
|
|
|
|
|
|
M01CC01
|
Penicillamine
|
|
|
|
|
|
M01CC02
|
Bucillamine
|
|
|
|
|
M01CX
|
|
Other specific antirheumatic agents
|
|
|
|
|
|
|
empty
|
|
|
M02
|
|
|
|
Topical products for joint and muscular pain
|
|
|
|
M02A
|
|
|
Topical products for joint and muscular pain
|
|
|
|
|
M02AA
|
|
Anti-inflammatory preparations, non-steroids for topical use
|
|
|
|
|
|
M02AA01
|
Phenylbutazone
|
|
|
|
|
|
M02AA02
|
Mofebutazone
|
|
|
|
|
|
M02AA03
|
Clofezone
|
|
|
|
|
|
M02AA04
|
Oxyphenbutazone
|
|
|
|
|
|
M02AA05
|
Benzydamine
|
|
|
|
|
|
M02AA06
|
Etofenamate
|
|
|
|
|
|
M02AA07
|
Piroxicam
|
|
|
|
|
|
M02AA08
|
Felbinac
|
|
|
|
|
|
M02AA09
|
Bufexamac
|
|
|
|
|
|
M02AA10
|
Ketoprofen
|
|
|
|
|
|
M02AA11
|
Bendazac
|
|
|
|
|
|
M02AA12
|
Naproxen
|
|
|
|
|
|
M02AA13
|
Ibuprofen
|
|
|
|
|
|
M02AA14
|
Fentiazac
|
|
|
|
|
|
M02AA15
|
Diclofenac
|
|
|
|
|
|
M02AA16
|
Feprazone
|
|
|
|
|
|
M02AA17
|
Niflumic acid
|
|
|
|
|
|
M02AA18
|
Meclofenamic acid
|
|
|
|
|
|
M02AA19
|
Flurbiprofen
|
|
|
|
|
|
M02AA21
|
Tolmetin
|
|
|
|
|
|
M02AA22
|
Suxibuzone
|
|
|
|
|
|
M02AA23
|
Indometacin
|
|
|
|
|
|
M02AA24
|
Nifenazone
|
|
|
|
|
|
M02AA25
|
Aceclofenac
|
|
|
|
|
|
M02AA26
|
Nimesulide
|
|
|
|
|
M02AB
|
|
Capsaicin and similar agents
|
|
|
|
|
|
M02AB01
|
Capsaicin
|
|
|
|
|
|
M02AB02
|
Zucapsaicin
|
|
|
|
|
M02AC
|
|
Preparations with salicylic acid derivatives
|
|
|
|
|
|
|
empty
|
|
|
|
|
M02AX
|
|
Other topical products for joint and muscular pain
|
|
|
|
|
|
M02AX02
|
Tolazoline
|
|
|
|
|
|
M02AX03
|
Dimethyl sulfoxide
|
|
|
|
|
|
M02AX05
|
Idrocilamide
|
|
|
|
|
|
M02AX10
|
Various
|
|
|
M03
|
|
|
|
Muscle relaxants
|
|
|
|
M03A
|
|
|
Muscle relaxants, peripherally acting agents
|
|
|
|
|
M03AA
|
|
Curare alkaloids
|
|
|
|
|
|
M03AA01
|
Alcuronium
|
|
|
|
|
|
M03AA02
|
Tubocurarine
|
|
|
|
|
|
M03AA04
|
Dimethyltubocurarine
|
|
|
|
|
M03AB
|
|
Choline derivatives
|
|
|
|
|
|
M03AB01
|
Suxamethonium
|
|
|
|
|
M03AC
|
|
Other quaternary ammonium compounds
|
|
|
|
|
|
M03AC01
|
Pancuronium
|
|
|
|
|
|
M03AC02
|
Gallamine
|
|
|
|
|
|
M03AC03
|
Vecuronium
|
|
|
|
|
|
M03AC04
|
Atracurium
|
|
|
|
|
|
M03AC05
|
Hexafluronium
|
|
|
|
|
|
M03AC06
|
Pipecuronium bromide
|
|
|
|
|
|
M03AC07
|
Doxacurium chloride
|
|
|
|
|
|
M03AC08
|
Fazadinium bromide
|
|
|
|
|
|
M03AC09
|
Rocuronium bromide
|
|
|
|
|
|
M03AC10
|
Mivacurium chloride
|
|
|
|
|
|
M03AC11
|
Cisatracurium
|
|
|
|
|
M03AX
|
|
Other muscle relaxants, peripherally acting agents
|
|
|
|
|
|
M03AX01
|
Botulinum toxin
|
|
|
|
M03B
|
|
|
Muscle relaxants, centrally acting agents
|
|
|
|
|
M03BA
|
|
Carbamic acid esters
|
|
|
|
|
|
M03BA01
|
Phenprobamate
|
|
|
|
|
|
M03BA02
|
Carisoprodol
|
|
|
|
|
|
M03BA03
|
Methocarbamol
|
|
|
|
|
|
M03BA04
|
Styramate
|
|
|
|
|
|
M03BA05
|
Febarbamate
|
|
|
|
|
|
M03BA51
|
Phenprobamate, combinations excluding psycholeptics
|
|
|
|
|
|
M03BA52
|
Carisoprodol, combinations excluding psycholeptics
|
|
|
|
|
|
M03BA53
|
Methocarbamol, combinations excluding psycholeptics
|
|
|
|
|
|
M03BA71
|
Phenprobamate, combinations with psycholeptics
|
|
|
|
|
|
M03BA72
|
Carisoprodol, combinations with psycholeptics
|
|
|
|
|
|
M03BA73
|
Methocarbamol, combinations with psycholeptics
|
|
|
|
|
M03BB
|
|
Oxazol, thiazine, and triazine derivatives
|
|
|
|
|
|
M03BB02
|
Chlormezanone
|
|
|
|
|
|
M03BB03
|
Chlorzoxazone
|
|
|
|
|
|
M03BB52
|
Chlormezanone, combinations excluding psycholeptics
|
|
|
|
|
|
M03BB53
|
Chlorzoxazone, combinations excluding psycholeptics
|
|
|
|
|
|
M03BB72
|
Chlormezanone, combinations with psycholeptics
|
|
|
|
|
|
M03BB73
|
Chlorzoxazone, combinations with psycholeptics
|
|
|
|
|
M03BC
|
|
Ethers, chemically close to antihistamines
|
|
|
|
|
|
M03BC01
|
Orphenadrine (citrate)
|
|
|
|
|
|
M03BC51
|
Orphenadrine, combinations
|
|
|
|
|
M03BX
|
|
Other centrally acting agents
|
|
|
|
|
|
M03BX01
|
Baclofen
|
|
|
|
|
|
M03BX02
|
Tizanidine
|
|
|
|
|
|
M03BX03
|
Pridinol
|
|
|
|
|
|
M03BX04
|
Tolperisone
|
|
|
|
|
|
M03BX05
|
Thiocolchicoside
|
|
|
|
|
|
M03BX06
|
Mephenesin
|
|
|
|
|
|
M03BX07
|
Tetrazepam
|
|
|
|
|
|
M03BX08
|
Cyclobenzaprine
|
|
|
|
|
|
M03BX09
|
Eperisone
|
|
|
|
|
|
M03BX30
|
Phenyramidol
|
|
|
|
M03C
|
|
|
Muscle relaxants, directly acting agents
|
|
|
|
|
M03CA
|
|
Dantrolene and derivatives
|
|
|
|
|
|
M03CA01
|
Dantrolene
|
|
|
M04
|
|
|
|
Antigout preparations
|
|
|
|
M04A
|
|
|
Antigout preparations
|
|
|
|
|
M04AA
|
|
Preparations inhibiting uric acid production
|
|
|
|
|
|
M04AA01
|
Allopurinol
|
|
|
|
|
|
M04AA02
|
Tisopurine
|
|
|
|
|
|
M04AA03
|
Febuxostat
|
|
|
|
|
|
M04AA51
|
Allopurinol, combinations
|
|
|
|
|
M04AB
|
|
Preparations increasing uric acid excretion
|
|
|
|
|
|
M04AB01
|
Probenecid
|
|
|
|
|
|
M04AB02
|
Sulfinpyrazone
|
|
|
|
|
|
M04AB03
|
Benzbromarone
|
|
|
|
|
|
M04AB04
|
Isobromindione
|
|
|
|
|
M04AC
|
|
Preparations with no effect on uric acid metabolism
|
|
|
|
|
|
M04AC01
|
Colchicine
|
|
|
|
|
|
M04AC02
|
Cinchophen
|
|
|
|
|
M04AX
|
|
Other antigout preparations
|
|
|
|
|
|
M04AX01
|
Urate oxidase
|
|
|
|
|
|
M04AX02
|
Pegloticase
|
|
|
M05
|
|
|
|
Drugs for treatment of bone diseases
|
|
|
|
M05B
|
|
|
Drugs affecting bone structure and mineralization
|
|
|
|
|
M05BA
|
|
Bisphosphonates
|
|
|
|
|
|
M05BA01
|
Etidronic acid
|
|
|
|
|
|
M05BA02
|
Clodronic acid
|
|
|
|
|
|
M05BA03
|
Pamidronic acid
|
|
|
|
|
|
M05BA04
|
Alendronic acid
|
|
|
|
|
|
M05BA05
|
Tiludronic acid
|
|
|
|
|
|
M05BA06
|
Ibandronic acid
|
|
|
|
|
|
M05BA07
|
Risedronic acid
|
|
|
|
|
|
M05BA08
|
Zoledronic acid
|
|
|
|
|
M05BB
|
|
Bisphosphonates, combinations
|
|
|
|
|
|
M05BB01
|
Etidronic acid and calcium, sequential
|
|
|
|
|
|
M05BB02
|
Risedronic acid and calcium, sequential
|
|
|
|
|
|
M05BB03
|
Alendronic acid and colecalciferol
|
|
|
|
|
|
M05BB04
|
Risedronic acid, calcium and colecalciferol, sequential
|
|
|
|
|
|
M05BB05
|
Alendronic acid, calcium and colecalciferol, sequential
|
|
|
|
|
|
M05BB06
|
Alendronic acid and alfacalcidol, sequential
|
|
|
|
|
M05BC
|
|
Bone morphogenetic proteins
|
|
|
|
|
|
M05BC01
|
Dibotermin alfa
|
|
|
|
|
|
M05BC02
|
Eptotermin alfa
|
|
|
|
|
M05BX
|
|
Other drugs affecting bone structure and mineralization
|
|
|
|
|
|
M05BX01
|
Ipriflavone
|
|
|
|
|
|
M05BX02
|
luminium chlorohydrate
|
|
|
|
|
|
M05BX03
|
Strontium ranelate
|
|
|
|
|
|
M05BX04
|
Denosumab
|
|
|
M09
|
|
|
|
Other drugs for disorders of the musculo-skeletal system
|
|
|
|
M09A
|
|
|
Other drugs for disorders of the musculo-skeletal system
|
|
|
|
|
M09AA
|
|
Quinine and derivatives
|
|
|
|
|
|
M09AA01
|
Hydroquinine
|
|
|
|
|
|
M09AA72
|
Quinine, combinations with psycholeptics
|
|
|
|
|
M09AB
|
|
Enzymes
|
|
|
|
|
|
M09AB01
|
Chymopapain
|
|
|
|
|
|
M09AB02
|
Collagenase clostridium histolyticum
|
|
|
|
|
|
M09AB52
|
Trypsin, combinations
|
|
|
|
|
M09AX
|
|
Other drugs for disorders of the musculo-skeletal system
|
|
|
|
|
|
M09AX01
|
Hyaluronic acid
|
|
|
|
|
|
M09AX02
|
Chondrocytes, autologous
|
| N
|
|
|
|
|
Nervous system
|
|
|
N01
|
|
|
|
Anesthetics
|
|
|
|
N01A
|
|
|
Anesthetics, general
|
|
|
|
|
N01AA
|
|
Ethers
|
|
|
|
|
|
N01AA01
|
Diethyl ether
|
|
|
|
|
|
N01AA02
|
Vinyl ether
|
|
|
|
|
N01AB
|
|
Halogenated hydrocarbons
|
|
|
|
|
|
N01AB01
|
Halothane
|
|
|
|
|
|
N01AB02
|
Chloroform
|
|
|
|
|
|
N01AB04
|
Enflurane
|
|
|
|
|
|
N01AB05
|
Trichloroethylene
|
|
|
|
|
|
N01AB06
|
Isoflurane
|
|
|
|
|
|
N01AB07
|
Desflurane
|
|
|
|
|
|
N01AB08
|
Sevoflurane
|
|
|
|
|
N01AF
|
|
Barbiturates, plain
|
|
|
|
|
|
N01AF01
|
Methohexital
|
|
|
|
|
|
N01AF02
|
Hexobarbital
|
|
|
|
|
|
N01AF03
|
Thiopental
|
|
|
|
|
N01AG
|
|
Barbiturates in combination with other drugs
|
|
|
|
|
|
N01AG01
|
Narcobarbital
|
|
|
|
|
N01AH
|
|
Opioid anesthetics
|
|
|
|
|
|
N01AH01
|
Fentanyl
|
|
|
|
|
|
N01AH02
|
Alfentanil
|
|
|
|
|
|
N01AH03
|
Sufentanil
|
|
|
|
|
|
N01AH04
|
Phenoperidine
|
|
|
|
|
|
N01AH05
|
Anileridine
|
|
|
|
|
|
N01AH06
|
Remifentanil
|
|
|
|
|
|
N01AH51
|
Fentanyl, combinations
|
|
|
|
|
N01AX
|
|
Other general anesthetics
|
|
|
|
|
|
N01AX03
|
Ketamine
|
|
|
|
|
|
N01AX04
|
Propanidid
|
|
|
|
|
|
N01AX05
|
Alfaxalone
|
|
|
|
|
|
N01AX07
|
Etomidate
|
|
|
|
|
|
N01AX10
|
Propofol
|
|
|
|
|
|
N01AX11
|
Sodium oxybate
|
|
|
|
|
|
N01AX13
|
Nitrous oxide
|
|
|
|
|
|
N01AX14
|
Esketamine
|
|
|
|
|
|
N01AX15
|
Xenon
|
|
|
|
|
|
N01AX63
|
Nitrous oxide, combinations
|
|
|
|
N01B
|
|
|
Anesthetics, local
|
|
|
|
|
N01BA
|
|
Esters of aminobenzoic acid
|
|
|
|
|
|
N01BA01
|
Metabutethamine
|
|
|
|
|
|
N01BA02
|
Procaine
|
|
|
|
|
|
N01BA03
|
Tetracaine
|
|
|
|
|
|
N01BA04
|
Chloroprocaine
|
|
|
|
|
|
N01BA05
|
Benzocaine
|
|
|
|
|
|
N01BA52
|
Procaine, combinations
|
|
|
|
|
N01BB
|
|
Amides
|
|
|
|
|
|
N01BB01
|
Bupivacaine
|
|
|
|
|
|
N01BB02
|
Lidocaine
|
|
|
|
|
|
N01BB03
|
Mepivacaine
|
|
|
|
|
|
N01BB04
|
Prilocaine
|
|
|
|
|
|
N01BB05
|
Butanilicaine
|
|
|
|
|
|
N01BB06
|
Cinchocaine
|
|
|
|
|
|
N01BB07
|
Etidocaine
|
|
|
|
|
|
N01BB08
|
Articaine
|
|
|
|
|
|
N01BB09
|
Ropivacaine
|
|
|
|
|
|
N01BB10
|
Levobupivacaine
|
|
|
|
|
|
N01BB20
|
Combinations
|
|
|
|
|
|
N01BB51
|
Bupivacaine, combinations
|
|
|
|
|
|
N01BB52
|
Lidocaine, combinations
|
|
|
|
|
|
N01BB53
|
Mepivacaine, combinations
|
|
|
|
|
|
N01BB54
|
Prilocaine, combinations
|
|
|
|
|
|
N01BB57
|
Etidocaine, combinations
|
|
|
|
|
|
N01BB58
|
Articaine, combinations
|
|
|
|
|
N01BC
|
|
Esters of benzoic acid
|
|
|
|
|
|
N01BC01
|
Cocaine
|
|
|
|
|
N01BX
|
|
Other local anesthetics
|
|
|
|
|
|
N01BX01
|
Ethyl chloride
|
|
|
|
|
|
N01BX02
|
Dyclonine
|
|
|
|
|
|
N01BX03
|
Phenol
|
|
|
|
|
|
N01BX04
|
Capsaicin
|
|
|
N02
|
|
|
|
Analgesics
|
|
|
|
N02A
|
|
|
Opioids
|
|
|
|
|
N02AA
|
|
Natural opium alkaloids
|
|
|
|
|
|
N02AA01
|
Morphine
|
|
|
|
|
|
N02AA02
|
Opium
|
|
|
|
|
|
N02AA03
|
Hydromorphone
|
|
|
|
|
|
N02AA04
|
Nicomorphine
|
|
|
|
|
|
N02AA05
|
Oxycodone
|
|
|
|
|
|
N02AA08
|
Dihydrocodeine
|
|
|
|
|
|
N02AA10
|
Papaveretum
|
|
|
|
|
|
N02AA51
|
Morphine, combinations
|
|
|
|
|
|
N02AA55
|
Oxycodone, combinations
|
|
|
|
|
|
N02AA58
|
Dihydrocodeine, combinations
|
|
|
|
|
|
N02AA59
|
Codeine, combinations excluding psycholeptics
|
|
|
|
|
|
N02AA79
|
Codeine, combinations with psycholeptics
|
|
|
|
|
N02AB
|
|
Phenylpiperidine derivatives
|
|
|
|
|
|
N02AB01
|
Ketobemidone
|
|
|
|
|
|
N02AB02
|
Pethidine
|
|
|
|
|
|
N02AB03
|
Fentanyl
|
|
|
|
|
|
N02AB52
|
Pethidine, combinations excluding psycholeptics
|
|
|
|
|
|
N02AB72
|
Pethidine, combinations with psycholeptics
|
|
|
|
|
N02AC
|
|
Diphenylpropylamine derivatives
|
|
|
|
|
|
N02AC01
|
Dextromoramide
|
|
|
|
|
|
N02AC03
|
Piritramide
|
|
|
|
|
|
N02AC04
|
Dextropropoxyphene
|
|
|
|
|
|
N02AC05
|
Bezitramide
|
|
|
|
|
|
N02AC52
|
Methadone, combinations excluding psycholeptics
|
|
|
|
|
|
N02AC54
|
Dextropropoxyphene, combinations excluding psycholeptics
|
|
|
|
|
|
N02AC74
|
Dextropropoxyphene, combinations with psycholeptics
|
|
|
|
|
N02AD
|
|
Benzomorphan derivatives
|
|
|
|
|
|
N02AD01
|
Pentazocine
|
|
|
|
|
|
N02AD02
|
Phenazocine
|
|
|
|
|
N02AE
|
|
Oripavine derivatives
|
|
|
|
|
|
N02AE01
|
Buprenorphine
|
|
|
|
|
N02AF
|
|
Morphinan derivatives
|
|
|
|
|
|
N02AF01
|
Butorphanol
|
|
|
|
|
|
N02AF02
|
Nalbuphine
|
|
|
|
|
N02AG
|
|
Opioids in combination with antispasmodics
|
|
|
|
|
|
N02AG01
|
Morphine and antispasmodics
|
|
|
|
|
|
N02AG02
|
Ketobemidone and antispasmodics
|
|
|
|
|
|
N02AG03
|
Pethidine and antispasmodics
|
|
|
|
|
|
N02AG04
|
Hydromorphone and antispasmodics
|
|
|
|
|
N02AX
|
|
Other opioids
|
|
|
|
|
|
N02AX01
|
Tilidine
|
|
|
|
|
|
N02AX02
|
Tramadol
|
|
|
|
|
|
N02AX03
|
Dezocine
|
|
|
|
|
|
N02AX05
|
Meptazinol
|
|
|
|
|
|
N02AX06
|
Tapentadol
|
|
|
|
|
|
N02AX52
|
Tramadol, combinations
|
|
|
|
N02B
|
|
|
Other analgesics and antipyretics
|
|
|
|
|
N02BA
|
|
Salicylic acid and derivatives
|
|
|
|
|
|
N02BA01
|
Acetylsalicylic acid
|
|
|
|
|
|
N02BA02
|
Aloxiprin
|
|
|
|
|
|
N02BA03
|
Choline salicylate
|
|
|
|
|
|
N02BA04
|
Sodium salicylate
|
|
|
|
|
|
N02BA05
|
Salicylamide
|
|
|
|
|
|
N02BA06
|
Salsalate
|
|
|
|
|
|
N02BA07
|
Ethenzamide
|
|
|
|
|
|
N02BA08
|
Morpholine salicylate
|
|
|
|
|
|
N02BA09
|
Dipyrocetyl
|
|
|
|
|
|
N02BA10
|
Benorilate
|
|
|
|
|
|
N02BA11
|
Diflunisal
|
|
|
|
|
|
N02BA12
|
Potassium salicylate
|
|
|
|
|
|
N02BA14
|
Guacetisal
|
|
|
|
|
|
N02BA15
|
Carbasalate calcium
|
|
|
|
|
|
N02BA16
|
Imidazole salicylate
|
|
|
|
|
|
N02BA51
|
Acetylsalicylic acid, combinations excluding psycholeptics
|
|
|
|
|
|
N02BA55
|
Salicylamide, combinations excluding psycholeptics
|
|
|
|
|
|
N02BA57
|
Ethenzamide, combinations excluding psycholeptics
|
|
|
|
|
|
N02BA59
|
Dipyrocetyl, combinations excluding psycholeptics
|
|
|
|
|
|
N02BA65
|
Carbasalate calcium combinations excluding psycholeptics
|
|
|
|
|
|
N02BA71
|
Acetylsalicylic acid, combinations with psycholeptics
|
|
|
|
|
|
N02BA75
|
Salicylamide, combinations with psycholeptics
|
|
|
|
|
|
N02BA77
|
Ethenzamide, combinations with psycholeptics
|
|
|
|
|
|
N02BA79
|
Dipyrocetyl, combinations with psycholeptics
|
|
|
|
|
N02BB
|
|
Pyrazolones
|
|
|
|
|
|
N02BB01
|
Phenazone
|
|
|
|
|
|
N02BB02
|
Metamizole
|
|
|
|
|
|
N02BB03
|
Aminophenazone
|
|
|
|
|
|
N02BB04
|
Propyphenazone
|
|
|
|
|
|
N02BB05
|
Nifenazone
|
|
|
|
|
|
N02BB51
|
Phenazone, combinations excluding psycholeptics
|
|
|
|
|
|
N02BB52
|
Metamizole sodium, combinations excluding psycholeptics
|
|
|
|
|
|
N02BB53
|
Aminophenazone, combinations excluding psycholeptics
|
|
|
|
|
|
N02BB54
|
Propyphenazone, combinations excluding psycholeptics
|
|
|
|
|
|
N02BB71
|
Phenazone, combinations with psycholeptics
|
|
|
|
|
|
N02BB72
|
Metamizole sodium, combinations with psycholeptics
|
|
|
|
|
|
N02BB73
|
Aminophenazone, combinations with psycholeptics
|
|
|
|
|
|
N02BB74
|
Propyphenazone, combinations with psycholeptics
|
|
|
|
|
N02BE
|
|
Anilides
|
|
|
|
|
|
N02BE01
|
Paracetamol
|
|
|
|
|
|
N02BE03
|
Phenacetin
|
|
|
|
|
|
N02BE04
|
Bucetin
|
|
|
|
|
|
N02BE05
|
Propacetamol
|
|
|
|
|
|
N02BE51
|
Paracetamol, combinations excluding psycholeptics
|
|
|
|
|
|
N02BE53
|
Phenacetin, combinations excluding psycholeptics
|
|
|
|
|
|
N02BE54
|
Bucetin, combinations excluding psycholeptics
|
|
|
|
|
|
N02BE71
|
Paracetamol, combinations with psycholeptics
|
|
|
|
|
|
N02BE73
|
Phenacetin, combinations with psycholeptics
|
|
|
|
|
|
N02BE74
|
Bucetin, combinations with psycholeptics
|
|
|
|
|
N02BG
|
|
Other analgesics and antipyretics
|
|
|
|
|
|
N02BG02
|
Rimazolium
|
|
|
|
|
|
N02BG03
|
Glafenine
|
|
|
|
|
|
N02BG04
|
Floctafenine
|
|
|
|
|
|
N02BG05
|
Viminol
|
|
|
|
|
|
N02BG06
|
Nefopam
|
|
|
|
|
|
N02BG07
|
Flupirtine
|
|
|
|
|
|
N02BG08
|
Ziconotide
|
|
|
|
|
|
N02BG09
|
Methoxyflurane
|
|
|
|
|
|
N02BG10
|
Nabiximols
|
|
|
|
N02C
|
|
|
Antimigraine preparations
|
|
|
|
|
N02CA
|
|
Ergot alkaloids
|
|
|
|
|
|
N02CA01
|
Dihydroergotamine
|
|
|
|
|
|
N02CA02
|
Ergotamine
|
|
|
|
|
|
N02CA04
|
Methysergide
|
|
|
|
|
|
N02CA07
|
Lisuride
|
|
|
|
|
|
N02CA51
|
Dihydroergotamine, combinations
|
|
|
|
|
|
N02CA52
|
Ergotamine, combinations excluding psycholeptics
|
|
|
|
|
|
N02CA72
|
Ergotamine, combinations with psycholeptics
|
|
|
|
|
N02CB
|
|
Corticosteroid derivatives
|
|
|
|
|
|
N02CB01
|
Flumedroxone
|
|
|
|
|
N02CC
|
|
Selective serotonin (5-HT1) agonists
|
|
|
|
|
|
N02CC01
|
Sumatriptan
|
|
|
|
|
|
N02CC02
|
Naratriptan
|
|
|
|
|
|
N02CC03
|
Zolmitriptan
|
|
|
|
|
|
N02CC04
|
Rizatriptan
|
|
|
|
|
|
N02CC05
|
Almotriptan
|
|
|
|
|
|
N02CC06
|
Eletriptan
|
|
|
|
|
|
N02CC07
|
Frovatriptan
|
|
|
|
|
N02CX
|
|
Other antimigraine preparations
|
|
|
|
|
|
N02CX01
|
Pizotifen
|
|
|
|
|
|
N02CX02
|
Clonidine
|
|
|
|
|
|
N02CX03
|
Iprazochrome
|
|
|
|
|
|
N02CX05
|
Dimetotiazine
|
|
|
|
|
|
N02CX06
|
Oxetorone
|
|
|
N03
|
|
|
|
Antiepileptics
|
|
|
|
N03A
|
|
|
Antiepileptics
|
|
|
|
|
N03AA
|
|
Barbiturates and derivatives
|
|
|
|
|
|
N03AA01
|
Methylphenobarbital
|
|
|
|
|
|
N03AA02
|
Phenobarbital
|
|
|
|
|
|
N03AA03
|
Primidone
|
|
|
|
|
|
N03AA04
|
Barbexaclone
|
|
|
|
|
|
N03AA30
|
Metharbital
|
|
|
|
|
N03AB
|
|
Hydantoin derivatives
|
|
|
|
|
|
N03AB01
|
Ethotoin
|
|
|
|
|
|
N03AB02
|
Phenytoin
|
|
|
|
|
|
03AB03
|
Amino(diphenylhydantoin) valeric acid
|
|
|
|
|
|
N03AB04
|
Mephenytoin
|
|
|
|
|
|
N03AB05
|
Fosphenytoin
|
|
|
|
|
|
N03AB52
|
Phenytoin, combinations
|
|
|
|
|
|
N03AB54
|
Mephenytoin, combinations
|
|
|
|
|
N03AC
|
|
Oxazolidine derivatives
|
|
|
|
|
|
N03AC01
|
Paramethadione
|
|
|
|
|
|
N03AC02
|
Trimethadione
|
|
|
|
|
|
N03AC03
|
Ethadione
|
|
|
|
|
N03AD
|
|
Succinimide derivatives
|
|
|
|
|
|
N03AD01
|
Ethosuximide
|
|
|
|
|
|
N03AD02
|
Phensuximide
|
|
|
|
|
|
N03AD03
|
Mesuximide
|
|
|
|
|
|
N03AD51
|
Ethosuximide, combinations
|
|
|
|
|
N03AE
|
|
Benzodiazepine derivatives
|
|
|
|
|
|
N03AE01
|
Clonazepam
|
|
|
|
|
N03AF
|
|
Carboxamide derivatives
|
|
|
|
|
|
N03AF01
|
Carbamazepine
|
|
|
|
|
|
N03AF02
|
Oxcarbazepine
|
|
|
|
|
|
N03AF03
|
Rufinamide
|
|
|
|
|
|
N03AF04
|
Eslicarbazepine
|
|
|
|
|
N03AG
|
|
Fatty acid derivatives
|
|
|
|
|
|
N03AG01
|
Valproic acid
|
|
|
|
|
|
N03AG02
|
Valpromide
|
|
|
|
|
|
N03AG03
|
Aminobutyric acid
|
|
|
|
|
|
N03AG04
|
Vigabatrin
|
|
|
|
|
|
N03AG05
|
Progabide
|
|
|
|
|
|
N03AG06
|
Tiagabine
|
|
|
|
|
N03AX
|
|
Other antiepileptics
|
|
|
|
|
|
N03AX03
|
Sultiame
|
|
|
|
|
|
N03AX07
|
Phenacemide
|
|
|
|
|
|
N03AX09
|
Lamotrigine
|
|
|
|
|
|
N03AX10
|
Felbamate
|
|
|
|
|
|
N03AX11
|
Topiramate
|
|
|
|
|
|
N03AX12
|
Gabapentin
|
|
|
|
|
|
N03AX13
|
Pheneturide
|
|
|
|
|
|
N03AX14
|
Levetiracetam
|
|
|
|
|
|
N03AX15
|
Zonisamide
|
|
|
|
|
|
N03AX16
|
Pregabalin
|
|
|
|
|
|
N03AX17
|
Stiripentol
|
|
|
|
|
|
N03AX18
|
Lacosamide
|
|
|
|
|
|
N03AX19
|
Carisbamate
|
|
|
|
|
|
N03AX21
|
Retigabine
|
|
|
|
|
|
N03AX22
|
Perampanel
|
|
|
|
|
|
N03AX30
|
Beclamide
|
|
|
N04
|
|
|
|
Anti-parkinson drugs
|
|
|
|
N04A
|
|
|
Anticholinergic agents
|
|
|
|
|
N04AA
|
|
Tertiary amines
|
|
|
|
|
|
N04AA01
|
Trihexyphenidyl
|
|
|
|
|
|
N04AA02
|
Biperiden
|
|
|
|
|
|
N04AA03
|
Metixene
|
|
|
|
|
|
N04AA04
|
Procyclidine
|
|
|
|
|
|
N04AA05
|
Profenamine
|
|
|
|
|
|
N04AA08
|
Dexetimide
|
|
|
|
|
|
N04AA09
|
Phenglutarimide
|
|
|
|
|
|
N04AA10
|
Mazaticol
|
|
|
|
|
|
N04AA11
|
Bornaprine
|
|
|
|
|
|
N04AA12
|
Tropatepine
|
|
|
|
|
N04AB
|
|
Ethers chemically close to antihistamines
|
|
|
|
|
|
N04AB01
|
Etanautine
|
|
|
|
|
|
N04AB02
|
Orphenadrine (chloride)
|
|
|
|
|
N04AC
|
|
Ethers of tropine or tropine derivatives
|
|
|
|
|
|
N04AC01
|
Benzatropine
|
|
|
|
|
|
N04AC30
|
Etybenzatropine
|
|
|
|
N04B
|
|
|
Dopaminergic agents
|
|
|
|
|
N04BA
|
|
Dopa and dopa derivatives
|
|
|
|
|
|
N04BA01
|
Levodopa
|
|
|
|
|
|
N04BA02
|
Levodopa and decarboxylase inhibitor
|
|
|
|
|
|
N04BA03
|
Levodopa, decarboxylase inhibitor and COMT inhibitor
|
|
|
|
|
|
N04BA04
|
Melevodopa
|
|
|
|
|
|
N04BA05
|
Melevodopa and decarboxylase inhibitor
|
|
|
|
|
|
N04BA06
|
Etilevodopa and decarboxylase inhibitor
|
|
|
|
|
N04BB
|
|
Adamantane derivatives
|
|
|
|
|
|
N04BB01
|
Amantadine
|
|
|
|
|
N04BC
|
|
Dopamine agonists
|
|
|
|
|
|
N04BC01
|
Bromocriptine
|
|
|
|
|
|
N04BC02
|
Pergolide
|
|
|
|
|
|
N04BC03
|
Dihydroergocryptine mesylate
|
|
|
|
|
|
N04BC04
|
Ropinirole
|
|
|
|
|
|
N04BC05
|
Pramipexole
|
|
|
|
|
|
N04BC06
|
Cabergoline
|
|
|
|
|
|
N04BC07
|
Apomorphine
|
|
|
|
|
|
N04BC08
|
Piribedil
|
|
|
|
|
|
N04BC09
|
Rotigotine
|
|
|
|
|
N04BD
|
|
Monoamine oxidase B inhibitors
|
|
|
|
|
|
N04BD01
|
Selegiline
|
|
|
|
|
|
N04BD02
|
Rasagiline
|
|
|
|
|
N04BX
|
|
Other dopaminergic agents
|
|
|
|
|
|
N04BX01
|
Tolcapone
|
|
|
|
|
|
N04BX02
|
Entacapone
|
|
|
|
|
|
N04BX03
|
Budipine
|
|
|
N05
|
|
|
|
Psycholeptics
|
|
|
|
N05A
|
|
|
Antipsychotics
|
|
|
|
|
N05AA
|
|
Phenothiazines with aliphatic side-chain
|
|
|
|
|
|
N05AA01
|
Chlorpromazine
|
|
|
|
|
|
N05AA02
|
Levomepromazine
|
|
|
|
|
|
N05AA03
|
Promazine
|
|
|
|
|
|
N05AA04
|
Acepromazine
|
|
|
|
|
|
N05AA05
|
Triflupromazine
|
|
|
|
|
|
N05AA06
|
Cyamemazine
|
|
|
|
|
|
N05AA07
|
Chlorproethazine
|
|
|
|
|
N05AB
|
|
Phenothiazines with piperazine structure
|
|
|
|
|
|
N05AB01
|
Dixyrazine
|
|
|
|
|
|
N05AB02
|
Fluphenazine
|
|
|
|
|
|
N05AB03
|
Perphenazine
|
|
|
|
|
|
N05AB04
|
Prochlorperazine
|
|
|
|
|
|
N05AB05
|
Thiopropazate
|
|
|
|
|
|
N05AB06
|
Trifluoperazine
|
|
|
|
|
|
N05AB07
|
Acetophenazine
|
|
|
|
|
|
N05AB08
|
Thioproperazine
|
|
|
|
|
|
N05AB09
|
Butaperazine
|
|
|
|
|
|
N05AB10
|
Perazine
|
|
|
|
|
N05AC
|
|
Phenothiazines with piperidine structure
|
|
|
|
|
|
N05AC01
|
Periciazine
|
|
|
|
|
|
N05AC02
|
Thioridazine
|
|
|
|
|
|
N05AC03
|
Mesoridazine
|
|
|
|
|
|
N05AC04
|
Pipotiazine
|
|
|
|
|
N05AD
|
|
Butyrophenone derivatives
|
|
|
|
|
|
N05AD01
|
Haloperidol
|
|
|
|
|
|
N05AD02
|
Trifluperidol
|
|
|
|
|
|
N05AD03
|
Melperone
|
|
|
|
|
|
N05AD04
|
Moperone
|
|
|
|
|
|
N05AD05
|
Pipamperone
|
|
|
|
|
|
N05AD06
|
Bromperidol
|
|
|
|
|
|
N05AD07
|
Benperidol
|
|
|
|
|
|
N05AD08
|
Droperidol
|
|
|
|
|
|
N05AD09
|
Fluanisone
|
|
|
|
|
N05AE
|
|
Indole derivatives
|
|
|
|
|
|
N05AE01
|
Oxypertine
|
|
|
|
|
|
N05AE02
|
Molindone
|
|
|
|
|
|
N05AE03
|
Sertindole
|
|
|
|
|
|
N05AE04
|
Ziprasidone
|
|
|
|
|
|
N05AE05
|
Lurasidone
|
|
|
|
|
N05AF
|
|
Thioxanthene derivative
|
|
|
|
|
|
N05AF01
|
Flupentixol
|
|
|
|
|
|
N05AF02
|
Clopenthixol
|
|
|
|
|
|
N05AF03
|
Chlorprothixene
|
|
|
|
|
|
N05AF04
|
Thiothixene
|
|
|
|
|
|
N05AF05
|
Zuclopenthixol
|
|
|
|
|
N05AG
|
|
Diphenylbutylpiperidine derivatives
|
|
|
|
|
|
N05AG01
|
Fluspirilene
|
|
|
|
|
|
N05AG02
|
Pimozide
|
|
|
|
|
|
N05AG03
|
Penfluridol
|
|
|
|
|
N05AH
|
|
Diazepines, oxazepines, thiazepines and oxepines
|
|
|
|
|
|
N05AH01
|
Loxapine
|
|
|
|
|
|
N05AH02
|
Clozapine
|
|
|
|
|
|
N05AH03
|
Olanzapine
|
|
|
|
|
|
N05AH04
|
Quetiapine
|
|
|
|
|
|
N05AH05
|
Asenapine
|
|
|
|
|
|
N05AH06
|
Clotiapine
|
|
|
|
|
N05AL
|
|
Benzamides
|
|
|
|
|
|
N05AL01
|
Sulpiride
|
|
|
|
|
|
N05AL02
|
Sultopride
|
|
|
|
|
|
N05AL03
|
Tiapride
|
|
|
|
|
|
N05AL04
|
Remoxipride
|
|
|
|
|
|
N05AL05
|
Amisulpride
|
|
|
|
|
|
N05AL06
|
Veralipride
|
|
|
|
|
|
N05AL07
|
Levosulpiride
|
|
|
|
|
N05AN
|
|
Lithium
|
|
|
|
|
|
N05AN01
|
Lithium
|
|
|
|
|
N05AX
|
|
Other antipsychotics
|
|
|
|
|
|
N05AX07
|
Prothipendyl
|
|
|
|
|
|
N05AX08
|
Risperidone
|
|
|
|
|
|
N05AX10
|
Mosapramine
|
|
|
|
|
|
N05AX11
|
Zotepine
|
|
|
|
|
|
N05AX12
|
Aripiprazole
|
|
|
|
|
|
N05AX13
|
Paliperidone
|
|
|
|
|
|
N05AX14
|
Iloperidone
|
|
|
|
N05B
|
|
|
Anxiolytics
|
|
|
|
|
N05BA
|
|
Benzodiazepine derivatives
|
|
|
|
|
|
N05BA01
|
Diazepam
|
|
|
|
|
|
N05BA02
|
Chlordiazepoxide
|
|
|
|
|
|
N05BA03
|
Medazepam
|
|
|
|
|
|
N05BA04
|
Oxazepam
|
|
|
|
|
|
N05BA05
|
Potassium clorazepate
|
|
|
|
|
|
N05BA06
|
Lorazepam
|
|
|
|
|
|
N05BA07
|
Adinazolam
|
|
|
|
|
|
N05BA08
|
Bromazepam
|
|
|
|
|
|
N05BA09
|
Clobazam
|
|
|
|
|
|
N05BA10
|
Ketazolam
|
|
|
|
|
|
N05BA11
|
Prazepam
|
|
|
|
|
|
N05BA12
|
Alprazolam
|
|
|
|
|
|
N05BA13
|
Halazepam
|
|
|
|
|
|
N05BA14
|
Pinazepam
|
|
|
|
|
|
N05BA15
|
Camazepam
|
|
|
|
|
|
N05BA16
|
Nordazepam
|
|
|
|
|
|
N05BA17
|
Fludiazepam
|
|
|
|
|
|
N05BA18
|
Ethyl loflazepate
|
|
|
|
|
|
N05BA19
|
Etizolam
|
|
|
|
|
|
N05BA21
|
Clotiazepam
|
|
|
|
|
|
N05BA22
|
Cloxazolam
|
|
|
|
|
|
N05BA23
|
Tofisopam
|
|
|
|
|
|
N05BA56
|
Lorazepam, combinations
|
|
|
|
|
N05BB
|
|
Diphenylmethane derivatives
|
|
|
|
|
|
N05BB01
|
Hydroxyzine
|
|
|
|
|
|
N05BB02
|
Captodiame
|
|
|
|
|
|
N05BB51
|
Hydroxyzine, combinations
|
|
|
|
|
N05BC
|
|
Carbamates
|
|
|
|
|
|
N05BC01
|
Meprobamate
|
|
|
|
|
|
N05BC03
|
Emylcamate
|
|
|
|
|
|
N05BC04
|
Mebutamate
|
|
|
|
|
|
N05BC51
|
Meprobamate, combinations
|
|
|
|
|
N05BD
|
|
Dibenzo-bicyclo-octadiene derivatives
|
|
|
|
|
|
N05BD01
|
Benzoctamine
|
|
|
|
|
N05BE
|
|
Azaspirodecanedione derivatives
|
|
|
|
|
|
N05BE01
|
Buspirone
|
|
|
|
|
N05BX
|
|
Other anxiolytics
|
|
|
|
|
|
N05BX01
|
Mephenoxalone
|
|
|
|
|
|
N05BX02
|
Gedocarnil
|
|
|
|
|
|
N05BX03
|
Etifoxine
|
|
|
|
N05C
|
|
|
Hypnotics and sedatives
|
|
|
|
|
N05CA
|
|
Barbiturates, plain
|
|
|
|
|
|
N05CA01
|
Pentobarbital
|
|
|
|
|
|
N05CA02
|
Amobarbital
|
|
|
|
|
|
N05CA03
|
Butobarbital
|
|
|
|
|
|
N05CA04
|
Barbital
|
|
|
|
|
|
N05CA05
|
Aprobarbital
|
|
|
|
|
|
N05CA06
|
Secobarbital
|
|
|
|
|
|
N05CA07
|
Talbutal
|
|
|
|
|
|
N05CA08
|
Vinylbital
|
|
|
|
|
|
N05CA09
|
Vinbarbital
|
|
|
|
|
|
N05CA10
|
Cyclobarbital
|
|
|
|
|
|
N05CA11
|
Heptabarbital
|
|
|
|
|
|
N05CA12
|
Reposal
|
|
|
|
|
|
N05CA15
|
Methohexital
|
|
|
|
|
|
N05CA16
|
Hexobarbital
|
|
|
|
|
|
N05CA19
|
Thiopental
|
|
|
|
|
|
N05CA20
|
Ethallobarbital
|
|
|
|
|
|
N05CA21
|
Allobarbital
|
|
|
|
|
|
N05CA22
|
Proxibarbal
|
|
|
|
|
N05CB
|
|
Barbiturates, combinations
|
|
|
|
|
|
N05CB01
|
Combinations of barbiturates
|
|
|
|
|
|
N05CB02
|
Barbiturates in combination with other drugs
|
|
|
|
|
N05CC
|
|
Aldehydes and derivatives
|
|
|
|
|
|
N05CC01
|
Chloral hydrate
|
|
|
|
|
|
N05CC02
|
Chloralodol
|
|
|
|
|
|
N05CC03
|
Acetylglycinamide chloral hydrate
|
|
|
|
|
|
N05CC04
|
Dichloralphenazone
|
|
|
|
|
|
N05CC05
|
Paraldehyde
|
|
|
|
|
N05CD
|
|
Benzodiazepine derivatives
|
|
|
|
|
|
N05CD01
|
Flurazepam
|
|
|
|
|
|
N05CD02
|
Nitrazepam
|
|
|
|
|
|
N05CD03
|
Flunitrazepam
|
|
|
|
|
|
N05CD04
|
Estazolam
|
|
|
|
|
|
N05CD05
|
Triazolam
|
|
|
|
|
|
N05CD06
|
Lormetazepam
|
|
|
|
|
|
N05CD07
|
Temazepam
|
|
|
|
|
|
N05CD08
|
Midazolam
|
|
|
|
|
|
N05CD09
|
Brotizolam
|
|
|
|
|
|
N05CD10
|
Quazepam
|
|
|
|
|
|
N05CD11
|
Loprazolam
|
|
|
|
|
|
N05CD12
|
Doxefazepam
|
|
|
|
|
|
N05CD13
|
Cinolazepam
|
|
|
|
|
N05CE
|
|
Piperidinedione derivatives
|
|
|
|
|
|
N05CE01
|
Glutethimide
|
|
|
|
|
|
N05CE02
|
Methyprylon
|
|
|
|
|
|
N05CE03
|
Pyrithyldione
|
|
|
|
|
N05CF
|
|
Benzodiazepine related drugs
|
|
|
|
|
|
N05CF01
|
Zopiclone
|
|
|
|
|
|
N05CF02
|
Zolpidem
|
|
|
|
|
|
N05CF03
|
Zaleplon
|
|
|
|
|
|
N05CF04
|
Eszopiclone
|
|
|
|
|
N05CH
|
|
Melatonin receptor agonists
|
|
|
|
|
|
N05CH01
|
Melatonin
|
|
|
|
|
|
N05CH02
|
Ramelteon
|
|
|
|
|
N05CM
|
|
Other hypnotics and sedatives
|
|
|
|
|
|
N05CM01
|
Methaqualone
|
|
|
|
|
|
N05CM02
|
Clomethiazole
|
|
|
|
|
|
N05CM03
|
Bromisoval
|
|
|
|
|
|
N05CM04
|
Carbromal
|
|
|
|
|
|
N05CM05
|
Scopolamine
|
|
|
|
|
|
N05CM06
|
Propiomazine
|
|
|
|
|
|
N05CM07
|
Triclofos
|
|
|
|
|
|
N05CM08
|
Ethchlorvynol
|
|
|
|
|
|
N05CM09
|
Valerianae radix
|
|
|
|
|
|
N05CM10
|
Hexapropymate
|
|
|
|
|
|
N05CM11
|
Bromides
|
|
|
|
|
|
N05CM12
|
Apronal
|
|
|
|
|
|
N05CM13
|
Valnoctamide
|
|
|
|
|
|
N05CM15
|
Methylpentynol
|
|
|
|
|
|
N05CM16
|
Niaprazine
|
|
|
|
|
|
N05CM18
|
Dexmedetomidine
|
|
|
|
|
N05CX
|
|
Hypnotics and sedatives in combination, excluding barbiturates
|
|
|
|
|
|
N05CX01
|
Meprobamate, combinations
|
|
|
|
|
|
N05CX02
|
Methaqualone, combinations
|
|
|
|
|
|
N05CX03
|
Methylpentynol, combinations
|
|
|
|
|
|
N05CX04
|
Clomethiazole, combinations
|
|
|
|
|
|
N05CX05
|
Emepronium, combinations
|
|
|
|
|
|
N05CX06
|
Dipiperonylaminoethanol, combinations
|
|
|
N06
|
|
|
|
Psychoanaleptics
|
|
|
|
N06A
|
|
|
Antidepressants
|
|
|
|
|
N06AA
|
|
Non-selective monoamine reuptake inhibitors
|
|
|
|
|
|
N06AA01
|
Desipramine
|
|
|
|
|
|
N06AA02
|
Imipramine
|
|
|
|
|
|
N06AA03
|
Imipramine oxide
|
|
|
|
|
|
N06AA04
|
Clomipramine
|
|
|
|
|
|
N06AA05
|
Opipramol
|
|
|
|
|
|
N06AA06
|
Trimipramine
|
|
|
|
|
|
N06AA07
|
Lofepramine
|
|
|
|
|
|
N06AA08
|
Dibenzepin
|
|
|
|
|
|
N06AA09
|
Amitriptyline
|
|
|
|
|
|
N06AA10
|
Nortriptyline
|
|
|
|
|
|
N06AA11
|
Protriptyline
|
|
|
|
|
|
N06AA12
|
Doxepin
|
|
|
|
|
|
N06AA13
|
Iprindole
|
|
|
|
|
|
N06AA14
|
Melitracen
|
|
|
|
|
|
N06AA15
|
Butriptyline
|
|
|
|
|
|
N06AA16
|
Dosulepin
|
|
|
|
|
|
N06AA17
|
Amoxapine
|
|
|
|
|
|
N06AA18
|
Dimetacrine
|
|
|
|
|
|
N06AA19
|
Amineptine
|
|
|
|
|
|
N06AA21
|
Maprotiline
|
|
|
|
|
|
N06AA23
|
Quinupramine
|
|
|
|
|
N06AB
|
|
Selective serotonin reuptake inhibitors
|
|
|
|
|
|
N06AB02
|
Zimelidine
|
|
|
|
|
|
N06AB03
|
Fluoxetine
|
|
|
|
|
|
N06AB04
|
Citalopram
|
|
|
|
|
|
N06AB05
|
Paroxetine
|
|
|
|
|
|
N06AB06
|
Sertraline
|
|
|
|
|
|
N06AB07
|
Alaproclate
|
|
|
|
|
|
N06AB08
|
Fluvoxamine
|
|
|
|
|
|
N06AB09
|
Etoperidone
|
|
|
|
|
|
N06AB10
|
Escitalopram
|
|
|
|
|
N06AF
|
|
Monoamine oxidase inhibitors, non-selective
|
|
|
|
|
|
N06AF01
|
Isocarboxazid
|
|
|
|
|
|
N06AF02
|
Nialamide
|
|
|
|
|
|
N06AF03
|
Phenelzine
|
|
|
|
|
|
N06AF04
|
Tranylcypromine
|
|
|
|
|
|
N06AF05
|
Iproniazide
|
|
|
|
|
|
N06AF06
|
Iproclozide
|
|
|
|
|
N06AG
|
|
Monoamine oxidase A inhibitors
|
|
|
|
|
|
N06AG02
|
Moclobemide
|
|
|
|
|
|
N06AG03
|
Toloxatone
|
|
|
|
|
N06AX
|
|
Other antidepressants
|
|
|
|
|
|
N06AX01
|
Oxitriptan
|
|
|
|
|
|
N06AX02
|
Tryptophan
|
|
|
|
|
|
N06AX03
|
Mianserin
|
|
|
|
|
|
N06AX04
|
Nomifensine
|
|
|
|
|
|
N06AX05
|
Trazodone
|
|
|
|
|
|
N06AX06
|
Nefazodone
|
|
|
|
|
|
N06AX07
|
Minaprine
|
|
|
|
|
|
N06AX08
|
Bifemelane
|
|
|
|
|
|
N06AX09
|
Viloxazine
|
|
|
|
|
|
N06AX10
|
Oxaflozane
|
|
|
|
|
|
N06AX11
|
Mirtazapine
|
|
|
|
|
|
N06AX12
|
Bupropion
|
|
|
|
|
|
N06AX13
|
Medifoxamine
|
|
|
|
|
|
N06AX14
|
Tianeptine
|
|
|
|
|
|
N06AX15
|
Pivagabine
|
|
|
|
|
|
N06AX16
|
Venlafaxine
|
|
|
|
|
|
N06AX17
|
Milnacipran
|
|
|
|
|
|
N06AX18
|
Reboxetine
|
|
|
|
|
|
N06AX19
|
Gepirone
|
|
|
|
|
|
N06AX21
|
Duloxetine
|
|
|
|
|
|
N06AX22
|
Agomelatine
|
|
|
|
|
|
N06AX23
|
Desvenlafaxine
|
|
|
|
|
|
N06AX24
|
Vilazodone
|
|
|
|
|
|
N06AX25
|
Hyperici herba
|
|
|
|
|
|
N06AX26
|
Vortioxetine (proposed code)
|
|
|
|
N06B
|
|
|
Psychostimulants, agents used for ADHD and nootropics
|
|
|
|
|
N06BA
|
|
Centrally acting sympathomimetics
|
|
|
|
|
|
N06BA01
|
Amphetamine
|
|
|
|
|
|
N06BA02
|
Dexamphetamine
|
|
|
|
|
|
N06BA03
|
Dextromethamphetamine
|
|
|
|
|
|
N06BA04
|
Methylphenidate
|
|
|
|
|
|
N06BA05
|
Pemoline
|
|
|
|
|
|
N06BA06
|
Fencamfamin
|
|
|
|
|
|
N06BA07
|
Modafinil
|
|
|
|
|
|
N06BA08
|
Fenozolone
|
|
|
|
|
|
N06BA09
|
Atomoxetine
|
|
|
|
|
|
N06BA10
|
Fenetylline
|
|
|
|
|
|
N06BA11
|
Dexmethylphenidate
|
|
|
|
|
|
N06BA12
|
Lisdexamfetamine
|
|
|
|
|
N06BC
|
|
Xanthine derivatives
|
|
|
|
|
|
N06BC01
|
Caffeine
|
|
|
|
|
|
N06BC02
|
Propentofylline
|
|
|
|
|
N06BX
|
|
Other psychostimulants and nootropics
|
|
|
|
|
|
N06BX01
|
Meclofenoxate
|
|
|
|
|
|
N06BX02
|
Pyritinol
|
|
|
|
|
|
N06BX03
|
Piracetam
|
|
|
|
|
|
N06BX04
|
Deanol
|
|
|
|
|
|
N06BX05
|
Fipexide
|
|
|
|
|
|
N06BX06
|
Citicoline
|
|
|
|
|
|
N06BX07
|
Oxiracetam
|
|
|
|
|
|
N06BX08
|
Pirisudanol
|
|
|
|
|
|
N06BX09
|
Linopirdine
|
|
|
|
|
|
N06BX10
|
Nizofenone
|
|
|
|
|
|
N06BX11
|
Aniracetam
|
|
|
|
|
|
N06BX12
|
Acetylcarnitine
|
|
|
|
|
|
N06BX13
|
Idebenone
|
|
|
|
|
|
N06BX14
|
Prolintane
|
|
|
|
|
|
N06BX15
|
Pipradrol
|
|
|
|
|
|
N06BX16
|
Pramiracetam
|
|
|
|
|
|
N06BX17
|
Adrafinil
|
|
|
|
|
|
N06BX18
|
Vinpocetine
|
|
|
|
N06C
|
|
|
Psycholeptics and psychoanaleptics in combination
|
|
|
|
|
N06CA
|
|
Antidepressants in combination with psycholeptics
|
|
|
|
|
|
N06CA01
|
Amitriptyline and psycholeptics
|
|
|
|
|
|
N06CA02
|
Melitracen and psycholeptics
|
|
|
|
|
|
N06CA03
|
Fluoxetine and psycholeptics
|
|
|
|
|
N06CB
|
|
Psychostimulants in combination with psycholeptics
|
|
|
|
|
|
|
empty
|
|
|
|
N06D
|
|
|
Anti-dementia drugs
|
|
|
|
|
N06DA
|
|
Anticholinesterases
|
|
|
|
|
|
N06DA01
|
Tacrine
|
|
|
|
|
|
N06DA02
|
Donepezil
|
|
|
|
|
|
N06DA03
|
Rivastigmine
|
|
|
|
|
|
N06DA04
|
Galantamine
|
|
|
|
|
|
N06DA52
|
Donepezil and memantine
|
|
|
|
|
N06DX
|
|
Other anti-dementia drugs
|
|
|
|
|
|
N06DX01
|
Memantine
|
|
|
|
|
|
N06DX02
|
Ginkgo folium
|
|
|
N07
|
|
|
|
Other nervous system drugs
|
|
|
|
N07A
|
|
|
Parasympathomimetics
|
|
|
|
|
N07AA
|
|
Anticholinesterases
|
|
|
|
|
|
N07AA01
|
Neostigmine
|
|
|
|
|
|
N07AA02
|
Pyridostigmine
|
|
|
|
|
|
N07AA03
|
Distigmine
|
|
|
|
|
|
N07AA30
|
Ambenonium
|
|
|
|
|
|
N07AA51
|
Neostigmine, combinations
|
|
|
|
|
N07AB
|
|
Choline esters
|
|
|
|
|
|
N07AB01
|
Carbachol
|
|
|
|
|
|
N07AB02
|
Bethanechol
|
|
|
|
|
N07AX
|
|
Other parasympathomimetics
|
|
|
|
|
|
N07AX01
|
Pilocarpine
|
|
|
|
|
|
N07AX02
|
Choline alfoscerate
|
|
|
|
|
|
N07AX03
|
Cevimeline
|
|
|
|
N07B
|
|
|
Drugs used in addictive disorders
|
|
|
|
|
N07BA
|
|
Drugs used in nicotine dependence
|
|
|
|
|
|
N07BA01
|
Nicotine
|
|
|
|
|
|
N07BA03
|
Varenicline
|
|
|
|
|
N07BB
|
|
Drugs used in alcohol dependence
|
|
|
|
|
|
N07BB01
|
Disulfiram
|
|
|
|
|
|
N07BB02
|
Calcium carbimide
|
|
|
|
|
|
N07BB03
|
Acamprosate
|
|
|
|
|
|
N07BB04
|
Naltrexone
|
|
|
|
|
N07BC
|
|
Drugs used in opioid dependence
|
|
|
|
|
|
N07BC01
|
Buprenorphine
|
|
|
|
|
|
N07BC02
|
Methadone
|
|
|
|
|
|
N07BC03
|
Levacetylmethadol
|
|
|
|
|
|
N07BC04
|
Lofexidine
|
|
|
|
|
|
N07BC05
|
Levomethadone
|
|
|
|
|
|
N07BC06
|
Diamorphine
|
|
|
|
|
|
N07BC51
|
Buprenorphine, combinations
|
|
|
|
N07C
|
|
|
Antivertigo preparations
|
|
|
|
|
N07CA
|
|
Antivertigo preparations
|
|
|
|
|
|
N07CA01
|
Betahistine
|
|
|
|
|
|
N07CA02
|
Cinnarizine
|
|
|
|
|
|
N07CA03
|
Flunarizine
|
|
|
|
|
|
N07CA04
|
Acetylleucine
|
|
|
|
|
|
N07CA52
|
Cinnarizine, combinations
|
|
|
|
N07X
|
|
|
Other nervous system drugs
|
|
|
|
|
N07XA
|
|
Gangliosides and ganglioside derivatives
|
|
|
|
|
|
|
empty
|
|
|
|
|
N07XX
|
|
Other nervous system drugs
|
|
|
|
|
|
N07XX01
|
Tirilazad
|
|
|
|
|
|
N07XX02
|
Riluzole
|
|
|
|
|
|
N07XX03
|
Xaliproden
|
|
|
|
|
|
N07XX04
|
Sodium oxybate
|
|
|
|
|
|
N07XX05
|
Amifampridine
|
|
|
|
|
|
N07XX06
|
Tetrabenazine
|
|
|
|
|
|
N07XX07
|
Fampridine
|
|
|
|
|
|
N07XX08
|
Tafamidis
|
|
|
|
|
|
N07XX59
|
Dextromethorphan, combinations
|
| P
|
|
|
|
|
Antiparasitic products, insecticides and repellents
|
|
|
P01
|
|
|
|
Antiprotozoals
|
|
|
|
P01A
|
|
|
Agents against amoebiasis and other protozoal diseases
|
|
|
|
|
P01AA
|
|
Hydroxyquinoline derivatives
|
|
|
|
|
|
P01AA01
|
Broxyquinoline
|
|
|
|
|
|
P01AA02
|
Clioquinol
|
|
|
|
|
|
P01AA04
|
Chlorquinaldol
|
|
|
|
|
|
P01AA05
|
Tilbroquinol
|
|
|
|
|
|
P01AA52
|
Clioquinol, combinations
|
|
|
|
|
P01AB
|
|
Nitroimidazole derivatives
|
|
|
|
|
|
P01AB01
|
Metronidazole
|
|
|
|
|
|
P01AB02
|
Tinidazole
|
|
|
|
|
|
P01AB03
|
Ornidazole
|
|
|
|
|
|
P01AB04
|
Azanidazole
|
|
|
|
|
|
P01AB05
|
Propenidazole
|
|
|
|
|
|
P01AB06
|
Nimorazole
|
|
|
|
|
|
P01AB07
|
Secnidazole
|
|
|
|
|
P01AC
|
|
Dichloroacetamide derivatives
|
|
|
|
|
|
P01AC01
|
Diloxanide
|
|
|
|
|
|
P01AC02
|
Clefamide
|
|
|
|
|
|
P01AC03
|
Etofamide
|
|
|
|
|
|
P01AC04
|
Teclozan
|
|
|
|
|
P01AR
|
|
Arsenic compounds
|
|
|
|
|
|
P01AR01
|
Arsthinol
|
|
|
|
|
|
P01AR02
|
Difetarsone
|
|
|
|
|
|
P01AR03
|
Glycobiarsol
|
|
|
|
|
|
P01AR53
|
Glycobiarsol, combinations
|
|
|
|
|
P01AX
|
|
Other agents against amoebiasis and other protozoal diseases
|
|
|
|
|
|
P01AX01
|
Chiniofon
|
|
|
|
|
|
P01AX02
|
Emetine
|
|
|
|
|
|
P01AX04
|
Phanquinone
|
|
|
|
|
|
P01AX05
|
Mepacrine
|
|
|
|
|
|
P01AX06
|
Atovaquone
|
|
|
|
|
|
P01AX07
|
Trimetrexate
|
|
|
|
|
|
P01AX08
|
Tenonitrozole
|
|
|
|
|
|
P01AX09
|
Dehydroemetine
|
|
|
|
|
|
P01AX10
|
Fumagillin
|
|
|
|
|
|
P01AX52
|
Emetine, combinations
|
|
|
|
P01B
|
|
|
Antimalarials
|
|
|
|
|
P01BA
|
|
Aminoquinolines
|
|
|
|
|
|
P01BA01
|
Chloroquine
|
|
|
|
|
|
P01BA02
|
Hydroxychloroquine
|
|
|
|
|
|
P01BA03
|
Primaquine
|
|
|
|
|
|
P01BA06
|
Amodiaquine
|
|
|
|
|
P01BB
|
|
Biguanides
|
|
|
|
|
|
P01BB01
|
Proguanil
|
|
|
|
|
|
P01BB02
|
Cycloguanil embonate
|
|
|
|
|
|
P01BB51
|
Proguanil, combinations
|
|
|
|
|
P01BC
|
|
Methanolquinolines
|
|
|
|
|
|
P01BC01
|
Quinine
|
|
|
|
|
|
P01BC02
|
Mefloquine
|
|
|
|
|
P01BD
|
|
Diaminopyrimidines
|
|
|
|
|
|
P01BD01
|
Pyrimethamine
|
|
|
|
|
|
P01BD51
|
Pyrimethamine, combinations
|
|
|
|
|
P01BE
|
|
Artemisinin and derivatives, plain
|
|
|
|
|
|
P01BE01
|
Artemisinin
|
|
|
|
|
|
P01BE02
|
Artemether
|
|
|
|
|
|
P01BE03
|
Artesunate
|
|
|
|
|
|
P01BE04
|
Artemotil
|
|
|
|
|
|
P01BE05
|
Artenimol
|
|
|
|
|
P01BF
|
|
Artemisinin and derivatives, combinations
|
|
|
|
|
|
P01BF01
|
Artemether and lumefantrine
|
|
|
|
|
|
P01BF02
|
Artesunate and mefloquine
|
|
|
|
|
|
P01BF03
|
Artesunate and amodiaquine
|
|
|
|
|
|
P01BF04
|
Artesunate, sulphamethopyrazine and pyrimethamine
|
|
|
|
|
|
P01BF05
|
Artenimol and piperaquine
|
|
|
|
|
|
P01BF06
|
Artesunate and pyronaridine
|
|
|
|
|
P01BX
|
|
Other antimalarials
|
|
|
|
|
|
P01BX01
|
Halofantrine
|
|
|
|
P01C
|
|
|
Agents against leishmaniasis and trypanosomiasis
|
|
|
|
|
P01CA
|
|
Nitroimidazole derivatives
|
|
|
|
|
|
P01CA02
|
Benznidazole
|
|
|
|
|
P01CB
|
|
Antimony compounds
|
|
|
|
|
|
P01CB01
|
Meglumine antimonate
|
|
|
|
|
|
P01CB02
|
Sodium stibogluconate
|
|
|
|
|
P01CC
|
|
Nitrofuran derivatives
|
|
|
|
|
|
P01CC01
|
Nifurtimox
|
|
|
|
|
|
P01CC02
|
Nitrofural
|
|
|
|
|
P01CD
|
|
Arsenic compounds
|
|
|
|
|
|
P01CD01
|
Melarsoprol
|
|
|
|
|
|
P01CD02
|
Acetarsol
|
|
|
|
|
P01CX
|
|
Other agents against leishmaniasis and trypanosomiasis
|
|
|
|
|
|
P01CX01
|
Pentamidine isethionate
|
|
|
|
|
|
P01CX02
|
Suramin sodium
|
|
|
|
|
|
P01CX03
|
Eflornithine
|
|
|
P02
|
|
|
|
Anthelmintics
|
|
|
|
P02B
|
|
|
Antitrematodals
|
|
|
|
|
P02BA
|
|
Quinoline derivatives and related substances
|
|
|
|
|
|
P02BA01
|
Praziquantel
|
|
|
|
|
|
P02BA02
|
Oxamniquine
|
|
|
|
|
P02BB
|
|
Organophosphorous compounds
|
|
|
|
|
|
P02BB01
|
Metrifonate
|
|
|
|
|
P02BX
|
|
Other antitrematodal agents
|
|
|
|
|
|
P02BX01
|
Bithionol
|
|
|
|
|
|
P02BX02
|
Niridazole
|
|
|
|
|
|
P02BX03
|
Stibophen
|
|
|
|
|
|
P02BX04
|
Triclabendazole
|
|
|
|
P02C
|
|
|
Antinematodal agents
|
|
|
|
|
P02CA
|
|
Benzimidazole derivatives
|
|
|
|
|
|
P02CA01
|
Mebendazole
|
|
|
|
|
|
P02CA02
|
Tiabendazole
|
|
|
|
|
|
P02CA03
|
Albendazole
|
|
|
|
|
|
P02CA04
|
Ciclobendazole
|
|
|
|
|
|
P02CA05
|
Flubendazole
|
|
|
|
|
|
P02CA06
|
Fenbendazole
|
|
|
|
|
|
P02CA51
|
Mebendazole, combinations
|
|
|
|
|
P02CB
|
|
Piperazine and derivatives
|
|
|
|
|
|
P02CB01
|
Piperazine
|
|
|
|
|
|
P02CB02
|
Diethylcarbamazine
|
|
|
|
|
P02CC
|
|
Tetrahydropyrimidine derivatives
|
|
|
|
|
|
P02CC01
|
Pyrantel
|
|
|
|
|
|
P02CC02
|
Oxantel
|
|
|
|
|
P02CE
|
|
Imidazothiazole derivatives
|
|
|
|
|
|
P02CE01
|
Levamisole
|
|
|
|
|
P02CF
|
|
Avermectines
|
|
|
|
|
|
P02CF01
|
Ivermectin
|
|
|
|
|
P02CX
|
|
Other antinematodals
|
|
|
|
|
|
P02CX01
|
Pyrvinium
|
|
|
|
|
|
P02CX02
|
Bephenium
|
|
|
|
P02D
|
|
|
Anticestodals
|
|
|
|
|
P02DA
|
|
Salicylic acid derivatives
|
|
|
|
|
|
P02DA01
|
Niclosamide
|
|
|
|
|
P02DX
|
|
Other anticestodals
|
|
|
|
|
|
P02DX01
|
Desaspidin
|
|
|
|
|
|
P02DX02
|
Dichlorophen
|
|
|
P03
|
|
|
|
Ectoparasiticides, including scabicides, insecticides and repellents
|
|
|
|
P03A
|
|
|
Ectoparasiticides, including scabicides
|
|
|
|
|
P03AA
|
|
Sulfur containing products
|
|
|
|
|
|
P03AA01
|
Dixanthogen
|
|
|
|
|
|
P03AA02
|
Potassium polysulfide
|
|
|
|
|
|
P03AA03
|
Mesulfen
|
|
|
|
|
|
P03AA04
|
Disulfiram
|
|
|
|
|
|
P03AA05
|
Thiram
|
|
|
|
|
|
P03AA54
|
Disulfiram, combinations
|
|
|
|
|
P03AB
|
|
Chlorine containing products
|
|
|
|
|
|
P03AB01
|
Clofenotane
|
|
|
|
|
|
P03AB02
|
Lindane
|
|
|
|
|
|
P03AB51
|
Clofenotane, combinations
|
|
|
|
|
P03AC
|
|
Pyrethrines, including synthetic compounds
|
|
|
|
|
|
P03AC01
|
Pyrethrum
|
|
|
|
|
|
P03AC02
|
Bioallethrin
|
|
|
|
|
|
P03AC03
|
Phenothrin
|
|
|
|
|
|
P03AC04
|
Permethrin
|
|
|
|
|
|
P03AC51
|
Pyrethrum, combinations
|
|
|
|
|
|
P03AC52
|
Bioallethrin, combinations
|
|
|
|
|
|
P03AC53
|
Phenothrin, combinations
|
|
|
|
|
|
P03AC54
|
Permethrin, combinations
|
|
|
|
|
P03AX
|
|
Other ectoparasiticides, including scabicides
|
|
|
|
|
|
P03AX01
|
Benzyl benzoate
|
|
|
|
|
|
P03AX02
|
Copper oleinate
|
|
|
|
|
|
P03AX03
|
Malathion
|
|
|
|
|
|
P03AX04
|
Quassia
|
|
|
|
|
|
P03AX05
|
Dimeticone
|
|
|
|
P03B
|
|
|
Insecticides and repellents
|
|
|
|
|
P03BA
|
|
Pyrethrines
|
|
|
|
|
|
P03BA01
|
Cyfluthrin
|
|
|
|
|
|
P03BA02
|
Cypermethrin
|
|
|
|
|
|
P03BA03
|
Decamethrin
|
|
|
|
|
|
P03BA04
|
Tetramethrin
|
|
|
|
|
P03BX
|
|
Other insecticides and repellents
|
|
|
|
|
|
P03BX01
|
Diethyltoluamide
|
|
|
|
|
|
P03BX02
|
Dimethylphthalate
|
|
|
|
|
|
P03BX03
|
Dibutylphthalate
|
|
|
|
|
|
P03BX04
|
Dibutylsuccinate
|
|
|
|
|
|
P03BX05
|
Dimethylcarbate
|
|
|
|
|
|
P03BX06
|
Etohexadiol
|
| R
|
|
|
|
|
Respiratory system
|
|
|
R01
|
|
|
|
Nasal preparations
|
|
|
|
R01A
|
|
|
Decongestants and other nasal preparations for topical use
|
|
|
|
|
R01AA
|
|
Sympathomimetics, plain
|
|
|
|
|
|
R01AA02
|
Cyclopentamine
|
|
|
|
|
|
R01AA03
|
Ephedrine
|
|
|
|
|
|
R01AA04
|
Phenylephrine
|
|
|
|
|
|
R01AA05
|
Oxymetazoline
|
|
|
|
|
|
R01AA06
|
Tetryzoline
|
|
|
|
|
|
R01AA07
|
Xylometazoline
|
|
|
|
|
|
R01AA08
|
Naphazoline
|
|
|
|
|
|
R01AA09
|
Tramazoline
|
|
|
|
|
|
R01AA10
|
Metizoline
|
|
|
|
|
|
R01AA11
|
Tuaminoheptane
|
|
|
|
|
|
R01AA12
|
Fenoxazoline
|
|
|
|
|
|
R01AA13
|
Tymazoline
|
|
|
|
|
|
R01AA14
|
Epinephrine
|
|
|
|
|
R01AB
|
|
Sympathomimetics, combinations excluding corticosteroids
|
|
|
|
|
|
R01AB01
|
Phenylephrine
|
|
|
|
|
|
R01AB02
|
Naphazoline
|
|
|
|
|
|
R01AB03
|
Tetryzoline
|
|
|
|
|
|
R01AB05
|
Ephedrine
|
|
|
|
|
|
R01AB06
|
Xylometazoline
|
|
|
|
|
|
R01AB07
|
Oxymetazoline
|
|
|
|
|
|
R01AB08
|
Tuaminoheptane
|
|
|
|
|
R01AC
|
|
Antiallergic agents, excluding corticosteroids
|
|
|
|
|
|
R01AC01
|
Cromoglicic acid
|
|
|
|
|
|
R01AC02
|
Levocabastine
|
|
|
|
|
|
R01AC03
|
Azelastine
|
|
|
|
|
|
R01AC04
|
Antazoline
|
|
|
|
|
|
R01AC05
|
Spaglumic acid
|
|
|
|
|
|
R01AC06
|
Thonzylamine
|
|
|
|
|
|
R01AC07
|
Nedocromil
|
|
|
|
|
|
R01AC08
|
Olopatadine
|
|
|
|
|
|
R01AC51
|
Cromoglicic acid, combinations
|
|
|
|
|
R01AD
|
|
Corticosteroids
|
|
|
|
|
|
R01AD01
|
Beclometasone
|
|
|
|
|
|
R01AD02
|
Prednisolone
|
|
|
|
|
|
R01AD03
|
Dexamethasone
|
|
|
|
|
|
R01AD04
|
Flunisolide
|
|
|
|
|
|
R01AD05
|
Budesonide
|
|
|
|
|
|
R01AD06
|
Betamethasone
|
|
|
|
|
|
R01AD07
|
Tixocortol
|
|
|
|
|
|
R01AD08
|
Fluticasone
|
|
|
|
|
|
R01AD09
|
Mometasone furoate
|
|
|
|
|
|
R01AD11
|
Triamcinolone
|
|
|
|
|
|
R01AD12
|
Fluticasone furoate
|
|
|
|
|
|
R01AD13
|
Ciclesonide
|
|
|
|
|
|
R01AD52
|
Prednisolone, combinations
|
|
|
|
|
|
R01AD53
|
Dexamethasone, combinations
|
|
|
|
|
|
R01AD57
|
Tixocortol, combinations
|
|
|
|
|
|
R01AD58
|
Fluticasone, combinations
|
|
|
|
|
|
R01AD60
|
Hydrocortisone, combinations
|
|
|
|
|
R01AX
|
|
Other nasal preparations
|
|
|
|
|
|
R01AX01
|
Calcium hexamine thiocyanate
|
|
|
|
|
|
R01AX02
|
Retinol
|
|
|
|
|
|
R01AX03
|
Ipratropium bromide
|
|
|
|
|
|
R01AX05
|
Ritiometan
|
|
|
|
|
|
R01AX06
|
Mupirocin
|
|
|
|
|
|
R01AX07
|
Hexamidine
|
|
|
|
|
|
R01AX08
|
Framycetin
|
|
|
|
|
|
R01AX09
|
Hyaluronic acid
|
|
|
|
|
|
R01AX10
|
Various
|
|
|
|
|
|
R01AX30
|
Combinations
|
|
|
|
R01B
|
|
|
Nasal decongestants for systemic use
|
|
|
|
|
R01BA
|
|
Sympathomimetics
|
|
|
|
|
|
R01BA01
|
Phenylpropanolamine
|
|
|
|
|
|
R01BA02
|
Pseudoephedrine
|
|
|
|
|
|
R01BA03
|
Phenylephrine
|
|
|
|
|
|
R01BA51
|
Phenylpropanolamine, combinations
|
|
|
|
|
|
R01BA52
|
Pseudoephedrine, combinations
|
|
|
|
|
|
R01BA53
|
Phenylephrine, combinations
|
|
|
R02
|
|
|
|
Throat preparations
|
|
|
|
R02A
|
|
|
Throat preparations
|
|
|
|
|
R02AA
|
|
Antiseptics
|
|
|
|
|
|
R02AA01
|
Ambazone
|
|
|
|
|
|
R02AA02
|
Dequalinium
|
|
|
|
|
|
R02AA03
|
Dichlorobenzyl alcohol
|
|
|
|
|
|
R02AA05
|
Chlorhexidine
|
|
|
|
|
|
R02AA06
|
Cetylpyridinium
|
|
|
|
|
|
R02AA09
|
Benzethonium
|
|
|
|
|
|
R02AA10
|
Myristyl-benzalkonium
|
|
|
|
|
|
R02AA11
|
Chlorquinaldol
|
|
|
|
|
|
R02AA12
|
Hexylresorcinol
|
|
|
|
|
|
R02AA13
|
Acriflavinium chloride
|
|
|
|
|
|
R02AA14
|
Oxyquinoline
|
|
|
|
|
|
R02AA15
|
Povidone-iodine
|
|
|
|
|
|
R02AA16
|
Benzalkonium
|
|
|
|
|
|
R02AA17
|
Cetrimonium
|
|
|
|
|
|
R02AA18
|
Hexamidine
|
|
|
|
|
|
R02AA19
|
Phenol
|
|
|
|
|
|
R02AA20
|
Various
|
|
|
|
|
R02AB
|
|
Antibiotics
|
|
|
|
|
|
|
|
|
|
|
|
R02AB01
|
Neomycin
|
|
|
|
|
|
R02AB02
|
Tyrothricin
|
|
|
|
|
|
R02AB03
|
Fusafungine
|
|
|
|
|
|
R02AB04
|
Bacitracin
|
|
|
|
|
|
R02AB30
|
Gramicidin
|
|
|
|
|
R02AD
|
|
Anesthetics, local
|
|
|
|
|
|
R02AD01
|
Benzocaine
|
|
|
|
|
|
R02AD02
|
Lidocaine
|
|
|
|
|
|
R02AD03
|
Cocaine
|
|
|
|
|
|
R02AD04
|
Dyclonine
|
|
|
|
|
R02AX
|
|
Other throat preparations
|
|
|
|
|
|
R02AX01
|
Flurbiprofen
|
|
|
R03
|
|
|
|
Drugs for obstructive airway diseases
|
|
|
|
R03A
|
|
|
Adrenergics, inhalants
|
|
|
|
|
R03AA
|
|
Alpha- and beta-adrenoreceptor agonists
|
|
|
|
|
|
R03AA01
|
Epinephrine
|
|
|
|
|
R03AB
|
|
Non-selective beta-adrenoreceptor agonists
|
|
|
|
|
|
R03AB02
|
Isoprenaline
|
|
|
|
|
|
R03AB03
|
Orciprenaline
|
|
|
|
|
R03AC
|
|
Selective beta-2-adrenoreceptor agonists
|
|
|
|
|
|
R03AC02
|
Salbutamol
|
|
|
|
|
|
R03AC03
|
Terbutaline
|
|
|
|
|
|
R03AC04
|
Fenoterol
|
|
|
|
|
|
R03AC05
|
Rimiterol
|
|
|
|
|
|
R03AC06
|
Hexoprenaline
|
|
|
|
|
|
R03AC07
|
Isoetarine
|
|
|
|
|
|
R03AC08
|
Pirbuterol
|
|
|
|
|
|
R03AC09
|
Tretoquinol
|
|
|
|
|
|
R03AC10
|
Carbuterol
|
|
|
|
|
|
R03AC11
|
Tulobuterol
|
|
|
|
|
|
R03AC12
|
Salmeterol
|
|
|
|
|
|
R03AC13
|
Formoterol
|
|
|
|
|
|
R03AC14
|
Clenbuterol
|
|
|
|
|
|
R03AC15
|
Reproterol
|
|
|
|
|
|
R03AC16
|
Procaterol
|
|
|
|
|
|
R03AC17
|
Bitolterol
|
|
|
|
|
|
R03AC18
|
Indacaterol
בעבודה
|
|
|
|
|
R03AH
|
|
Combinations of adrenergics
|
|
|
|
|
|
|
empty
|
|
|
|
|
R03AK
|
|
Adrenergics and other drugs for obstructive airway diseases
|
|
|
|
|
|
R03AK01
|
Epinephrine and other drugs for obstructive airway diseases
|
|
|
|
|
|
R03AK02
|
Isoprenaline and other drugs for obstructive airway diseases
|
|
|
|
|
|
R03AK03
|
Fenoterol and other drugs for obstructive airway diseases
|
|
|
|
|
|
R03AK04
|
Salbutamol and other drugs for obstructive airway diseases
|
|
|
|
|
|
R03AK05
|
Reproterol and other drugs for obstructive airway diseases
|
|
|
|
|
|
R03AK06
|
Salmeterol and other drugs for obstructive airway diseases
|
|
|
|
|
|
R03AK07
|
Formoterol and other drugs for obstructive airway diseases
|
|
|
|
R03B
|
|
|
Other drugs for obstructive airway diseases, inhalants
|
|
|
|
|
R03BA
|
|
Glucocorticoids
|
|
|
|
|
|
R03BA01
|
Beclometasone
|
|
|
|
|
|
R03BA02 Budesonide
|
|
|
|
|
|
R03BA03 Flunisolide
|
|
|
|
|
|
R03BA04 Betamethasone
|
|
|
|
|
|
R03BA05 Fluticasone
|
|
|
|
|
|
R03BA06 Triamcinolone
|
|
|
|
|
|
R03BA07 Mometasone
|
|
|
|
|
|
R03BA08 Ciclesonide
|
|
|
|
|
|
R03BB Anticholinergics
|
|
|
|
|
|
R03BB01 Ipratropium bromide
|
|
|
|
|
|
R03BB02 Oxitropium bromide
|
|
|
|
|
|
R03BB03 Stramoni preparations
|
|
|
|
|
|
R03BB04 Tiotropium bromide
|
|
|
|
|
|
R03BB05 Aclidinium bromide
|
|
|
|
|
|
R03BB06 Glycopyrronium bromide
|
|
|
|
|
R03BC Antiallergic agents, excluding corticosteroids
|
|
|
|
|
|
R03BC01 Cromoglicic acid
|
|
|
|
|
|
R03BC03 Nedocromil
|
|
|
|
|
R03BX Other drugs for obstructive airway diseases, inhalants
|
|
|
|
|
|
R03BX01 Fenspiride
|
|
|
|
R03C Adrenergics for systemic use
|
|
|
|
|
R03CA Alpha- and beta-adrenoreceptor agonists
|
|
|
|
|
|
R03CA02 Ephedrine
|
|
|
|
|
|
R03CB Non-selective beta-adrenoreceptor agonists
|
|
|
|
|
|
R03CB01 Isoprenaline
|
|
|
|
|
|
R03CB02 Methoxyphenamine
|
|
|
|
|
|
R03CB03 Orciprenaline
|
|
|
|
|
|
R03CB51 Isoprenaline, combinations
|
|
|
|
|
|
R03CB53 Orciprenaline, combinations
|
|
|
|
|
|
R03CC Selective beta-2-adrenoreceptor agonists
|
|
|
|
|
|
R03CC02 Salbutamol
|
|
|
|
|
|
R03CC03 Terbutaline
|
|
|
|
|
|
R03CC04 Fenoterol
|
|
|
|
|
|
R03CC05 Hexoprenaline
|
|
|
|
|
|
R03CC06 Isoetarine
|
|
|
|
|
|
R03CC07 Pirbuterol
|
|
|
|
|
|
R03CC08 Procaterol
|
|
|
|
|
|
R03CC09 Tretoquinol
|
|
|
|
|
|
R03CC10 Carbuterol
|
|
|
|
|
|
R03CC11 Tulobuterol
|
|
|
|
|
|
R03CC12 Bambuterol
|
|
|
|
|
|
R03CC13 Clenbuterol
|
|
|
|
|
|
R03CC14 Reproterol
|
|
|
|
|
|
R03CC53 Terbutaline, combinations
|
|
|
|
|
|
R03CK Adrenergics and other drugs for obstructive airway diseases
|
|
|
|
|
|
R03D Other systemic drugs for obstructive airway diseases
|
|
|
|
|
|
R03DA Xanthines
|
|
|
|
|
|
R03DA01 Diprophylline
|
|
|
|
|
|
R03DA02 Choline theophyllinate
|
|
|
|
|
|
R03DA03 Proxyphylline
|
|
|
|
|
|
R03DA04 Theophylline
|
|
|
|
|
|
R03DA05 Aminophylline
|
|
|
|
|
|
R03DA06 Etamiphylline
|
|
|
|
|
|
R03DA07 Theobromine
|
|
|
|
|
|
R03DA08 Bamifylline
|
|
|
|
|
|
R03DA09 Acefylline piperazine
|
|
|
|
|
|
R03DA10 Bufylline
|
|
|
|
|
|
R03DA11 Doxofylline
|
|
|
|
|
|
R03DA20 Combinations of xanthines
|
|
|
|
|
|
R03DA51 Diprophylline, combinations
|
|
|
|
|
|
R03DA54 Theophylline, combinations excluding psycholeptics
|
|
|
|
|
|
R03DA55 Aminophylline, combinations
|
|
|
|
|
|
R03DA57 Theobromine, combinations
|
|
|
|
|
|
R03DA74 Theophylline, combinations with psycholeptics
R03DB Xanthines and adrenergics
R03DB01 Diprophylline and adrenergics
R03DB02 Choline theophyllinate and adrenergics
R03DB03 Proxyphylline and adrenergics
R03DB04 Theophylline and adrenergics
R03DB05 Aminophylline and adrenergics
R03DB06 Etamiphylline and adrenergics
R03DC Leukotriene receptor antagonists
R03DC01 Zafirlukast
R03DC02 Pranlukast
R03DC03 Montelukast
R03DC04 Ibudilast
R03DX Other systemic drugs for obstructive airway diseases
R03DX01 Amlexanox
R03DX02 Eprozinol
R03DX03 Fenspiride
R03DX05 Omalizumab
R03DX06 Seratrodast
R03DX07 Roflumilast
|
|
|
R05
|
|
|
|
Cough and cold preparations
R05C Expectorants, excluding combinations with cough suppressants
R05CA Expectorants
R05CA01 Tyloxapol
R05CA02 Potassium iodide
R05CA03 Guaifenesin
R05CA04 Ipecacuanha
R05CA05 Althea root
R05CA06 Senega
R05CA07 Antimony pentasulfide
R05CA08 Creosote
R05CA09 Guaiacolsulfonate
R05CA10 Combinations
R05CA11 Levoverbenone
R05CA12 Hederae helicis folium
R05CB Mucolytics
R05CB01 Acetylcysteine
R05CB02 Bromhexine
R05CB03 Carbocisteine
R05CB04 Eprazinone
R05CB05 Mesna
R05CB06 Ambroxol
R05CB07 Sobrerol
R05CB08 Domiodol
R05CB09 Letosteine
R05CB10 Combinations
R05CB11 Stepronin
R05CB12 Tiopronin
R05CB13 Dornase alfa (desoxyribonuclease)
R05CB14 Neltenexine
R05CB15 Erdosteine
R05CB16 Mannitol
R05D Cough suppressants, excluding combinations with expectorants
R05DA Opium alkaloids and derivatives
R05DA01 Ethylmorphine
R05DA03 Hydrocodone
R05DA04 Codeine
R05DA05 Opium alkaloids with morphine
R05DA06 Normethadone
R05DA07 Noscapine
R05DA08 Pholcodine
R05DA09 Dextromethorphan
R05DA10 Thebacon
R05DA11 Dimemorfan
R05DA12 Acetyldihydrocodeine
R05DA20 Combinations
R05DB Other cough suppressants
R05DB01 Benzonatate
R05DB02 Benproperine
R05DB03 Clobutinol
R05DB04 Isoaminile
R05DB05 Pentoxyverine
R05DB07 Oxolamine
R05DB09 Oxeladin
R05DB10 Clofedanol
R05DB11 Pipazetate
R05DB12 Bibenzonium bromide
R05DB13 Butamirate
R05DB14 Fedrilate
R05DB15 Zipeprol
R05DB16 Dibunate
R05DB17 Droxypropine
R05DB18 Prenoxdiazine
R05DB19 Dropropizine
R05DB20 Combinations
R05DB21 Cloperastine
R05DB22 Meprotixol
R05DB23 Piperidione
R05DB24 Tipepidine
R05DB25 Morclofone
R05DB26 Nepinalone
R05DB27 Levodropropizine
R05DB28 Dimethoxanate
R05F Cough suppressants and expectorants, combinations
R05FA Opium derivatives and expectorants
R05FA01 Opium derivatives and mucolytics
R05FA02 Opium derivatives and expectorants
R05FB Other cough suppressants and expectorants
R05FB01 Cough suppressants and mucolytics
R05FB02 Cough suppressants and expectorants
R05X Other cold preparations
Empty group
|
|
|
R06
|
|
|
|
Antihistamines for systemic use
R06A Antihistamines for systemic use
R06AA Aminoalkyl ethers
R06AA01 Bromazine
R06AA02 Diphenhydramine
R06AA04 Clemastine
R06AA06 Chlorphenoxamine
R06AA07 Diphenylpyraline
R06AA08 Carbinoxamine
R06AA09 Doxylamine
R06AA52 Diphenhydramine, combinations
R06AA54 Clemastine, combinations
R06AA56 Chlorphenoxamine, combinations
R06AA57 Diphenylpyraline, combinations
R06AA59 Doxylamine, combinations
R06AB Substituted alkylamines
R06AB01 Brompheniramine
R06AB02 Dexchlorpheniramine
R06AB03 Dimetindene
R06AB04 Chlorphenamine
R06AB05 Pheniramine
R06AB06 Dexbrompheniramine
R06AB07 Talastine
R06AB51 Brompheniramine, combinations
R06AB52 Dexchlorpheniramine, combinations
R06AB54 Chlorphenamine, combinations
R06AB56 Dexbrompheniramine, combinations
R06AC Substituted ethylene diamines
R06AC01 Mepyramine
R06AC02 Histapyrrodine
R06AC03 Chloropyramine
R06AC04 Tripelennamine
R06AC05 Methapyrilene
R06AC06 Thonzylamine
R06AC52 Histapyrrodine, combinations
R06AC53 Chloropyramine, combinations
R06AD Phenothiazine derivatives
R06AD01 Alimemazine
R06AD02 Promethazine
R06AD03 Thiethylperazine
R06AD04 Methdilazine
R06AD05 Hydroxyethylpromethazine
R06AD06 Thiazinam
R06AD07 Mequitazine
R06AD08 Oxomemazine
R06AD09 Isothipendyl
R06AD52 Promethazine, combinations
R06AD55 Hydroxyethylpromethazine, combinations
R06AE Piperazine derivatives
R06AE01 Buclizine
R06AE03 Cyclizine
R06AE04 Chlorcyclizine
R06AE05 Meclozine
R06AE06 Oxatomide
R06AE07 Cetirizine
R06AE09 Levocetirizine
R06AE51 Buclizine, combinations
R06AE53 Cyclizine, combinations
R06AE55 Meclozine, combinations
R06AK Combinations of antihistamines
Empty group
R06AX Other antihistamines for systemic use
R06AX01 Bamipine
R06AX02 Cyproheptadine
R06AX03 Thenalidine
R06AX04 Phenindamine
R06AX05 Antazoline
R06AX07 Triprolidine
R06AX08 Pyrrobutamine
R06AX09 Azatadine
R06AX11 Astemizole
R06AX12 Terfenadine
R06AX13 Loratadine
R06AX15 Mebhydrolin
R06AX16 Deptropine
R06AX17 Ketotifen
R06AX18 Acrivastine
R06AX19 Azelastine
R06AX21 Tritoqualine
R06AX22 Ebastine
R06AX23 Pimethixene
R06AX24 Epinastine
R06AX25 Mizolastine
R06AX26 Fexofenadine
R06AX27 Desloratadine
R06AX28 Rupatadine
R06AX29 Bilastine
R06AX31 Quifenadine
R06AX53 Thenalidine, combinations
R06AX58 Pyrrobutamine, combinations
|
|
|
R07
|
|
|
|
Other respiratory system products
R07A Other respiratory system products
R07AA Lung surfactants
R07AA01 Colfosceril palmitate
R07AA02 Natural phospholipids
R07AA30 Combinations
R07AB Respiratory stimulants
R07AB01 Doxapram
R07AB02 Nikethamide
R07AB03 Pentetrazol
R07AB04 Etamivan
R07AB05 Bemegride
R07AB06 Prethcamide
R07AB07 Almitrine
R07AB08 Dimefline
R07AB09 Mepixanox
R07AB52 Nikethamide, combinations
R07AB53 Pentetrazol, combinations
R07AX Other respiratory system products
R07AX01 Nitric oxide
R07AX02 Ivacaftor
|
| S
|
|
|
|
|
Sensory organs
|
|
|
S01
|
|
|
|
Ophthalmologicals
|
|
|
S02
|
|
|
|
Otologicals
|
|
|
S03
|
|
|
|
Ophthalmological and otological preparations
|
| V
|
|
|
|
|
Various
|
|
|
V01
|
|
|
|
Allergens
|
|
|
V03
|
|
|
|
All other therapeutic products
|
|
|
V04
|
|
|
|
Diagnostic agents
|
|
|
V06
|
|
|
|
General nutrients
|
|
|
V07
|
|
|
|
All other non-therapeutic products
|
|
|
V08
|
|
|
|
Contrast media
|
|
|
V09
|
|
|
|
Diagnostic radiopharmaceuticals
|
|
|
V10
|
|
|
|
Therapeutic radiopharmaceuticals
|
|
|
V20
|
|
|
|
Surgical dressings
|
כניסה 
עקבו אחרינו בפייסבוק